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Summary 
Helminth infections such as filariasis can be life long due to immunomodulatory 
mechanisms elicited by the worms that prevent their elimination by the human host. Malaria 
prevalence is frequently high in areas where filarial nematode infections are endemic, originating 
co-infections. It is still an ongoing debate the extent to which worms can alter anti-plasmodial 
responses in a concomitantly infected host. In order to dissect the interactions occurring between 
both parasites, a murine model using the filarial nematode Litomosoides sigmodontis and the 
malaria parasite Plasmodium berghei ANKA in BALB/c and C57BL/6 mice has been established in 
the present work.  
One third of helminth-infected BALB/c mice remained malaria negative and did not 
develop detectable parasitaemia after co-infection with plasmodial sporozoites. Such outcomes 
were not observed after co-infection with blood stage parasites, thereby circumventing the 
plasmodial liver stage, but were only originated after sporozoite inoculation. Protection depended 
on IL-10, since IL-10 deficient co-infected mice were fully susceptible to sporozoite challenge. 
However, systemic IL-10 levels were low, suggesting a local function of this cytokine. 44 h after P. 
berghei sporozoite inoculation increased CD8+ T cell numbers were found in the liver and spleen of 
co-infected mice. Interestingly, protection as well as numbers of CD8+ T cells correlated with the 
presence of microfilaraemia. Since microfilariae are potent stimulators of immune responses, their 
presence in the blood may enhance cross-protective responses against incoming sporozoites. 
Co-infected C57BL/6 mice showed significantly reduced cerebral malaria (CM) rates. CD8+ T 
cell recruitment to brain, a critical condition for CM development, was reduced in co-infected mice. 
Furthermore, in contrast to P. berghei single-infected animals, groups of double infected mice 
presented high levels of circulating IL-10. The absolute requirement for IL-10 in CM protection was 
demonstrated by the total susceptibility to the pathology in IL-10 KO co-infected mice. Hence IL-10-
dependent immunoregulatory mechanisms elicited by filarial nematodes might be able to suppress 
the overwhelming inflammatory reaction usually triggered against malaria parasites by C57BL/6 
mice, preventing full progress to CM.  
Taken together, this work shows that depending on the genetic background different 
mechanisms elicited by filarial worms improve control of both liver and blood stages of 
concomitant malaria parasites, and moreover ameliorate severe pathology in a murine model. The 
main beneficial effects driven by filariae rely on IL-10, which on the one hand prevents CM through 
immunomodulation but on the other enhances protective anti-malarial responses in the liver. 
Worm eradication programs are currently being carried out in endemic countries, but this study 
suggests that their implementation may cause unpredictable consequences on malaria control. 
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1. Introduction 
 
The particular characteristics of plasmodial and filarial infections are the consequence of 
millions of years of evolution that have configured their life cycles, their strategies to survive as 
parasites and the pathologies they cause in the form we know today. Through the development of 
mechanisms to suppress host immune responses, filarial nematodes are the parasites with the 
longest life span in humans and cause a mild disease in most infected people. In contrast, despite 
being an old human parasite, a recent evolutionary bottleneck in Plasmodium falciparum populations 
is thought to have lead falciparum malaria to be one of the deadliest infectious diseases in the world, 
mainly due to the generation of an uncontrolled immune response by the host. Epidemiologically, 
malaria and filariasis share areas of distribution (Fig. 1.1), and thus co-infections are frequent. During 
co-infection antagonistic immune mechanisms driven by each parasite may alter the course of the 
single diseases. Theoretically, immunomodulation elicited by filariae could attenuate host immune 
responses against a concomitant plasmodial infection, preventing the host from developing severe 
malaria pathology. On the other hand, this suppression could lead to higher malaria morbidity and 
pathology due to an exacerbated malaria parasite multiplication. Opposing results from field studies 
supporting either a beneficial or a detrimental malaria outcome in nematode infected individuals 
currently divide the opinion on this matter in the scientific community. However, an urgent solution 
is needed since anti-filarial mass treatments are currently being carried out in endemic countries, 
potentially influencing malaria control. 
The aim of the present study is to supply experimental data from a co-infection murine 
model for filariasis and malaria, using the parasites Litomosoides sigmodontis (Chandler, 1932) and 
Plasmodium berghei ANKA (Vincke, 1948), and thus contribute solving the present debate. The work 
focuses on the extent to which a prior filarial infection influences the pathological course of a 
concurrent plasmodial infection and the underlying immunological processes.  
1.1. GENERAL CONCEPTS ABOUT MALARIA 
1.1.1. Malaria epidemiology 
Malaria is a mosquito-transmitted disease caused by a protozoan from the genus 
Plasmodium that accounts for one of the most devastating infectious diseases in the world. Four 
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Figure 1.1: Global distribution of malaria and lymphatic filariasis. (Based on WHO, Public Health Mapping and GIS, http://www.who.int/globalatlas/)
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plasmodial species can infect humans: Plasmodium vivax, Plasmodium ovale, Plasmodium malariae 
and Plasmodium falciparum. 
Around 3.2 billion people live in malaria endemic areas encompasing 107 countries, and 350 
to 500 million clinical malaria cases are recorded each year (277). Between 270 and 400 million of 
the reported cases are caused by P. falciparum, which is responsible for the majority of the deaths 
caused by malaria every year, estimated in 1 to 3 millions (128, 278). Children in Sub-Saharan Africa 
particularly contribute to this annual death toll. Indeed,  5 % of infected children die from malaria 
before reaching 5 years of age, and many others are born with seriously impaired survival chances 
due to the infection of their mothers during pregnancy (191). Unfortunately, despite malaria being 
curable, there are still high amounts of deaths in regions where poor infrastructures impede access 
to early treatment. 
 
1.1.2. Life cycle of Plasmodium sp. 
 
Plasmodial sporozoites are injected in the host during the blood meal of an infected female 
Anopheles mosquito. It has been estimated that only around 15 parasites are inoculated per bite 
(210). This number does not correlate with the total parasite load in the mosquito’s salivary glands 
but with the number of sporozoites that glide into the salivary ducts before blood ingestion (80).  
Once in the bloodstream sporozoites are transported to the liver, where they specifically 
attach (200). Trapped in the liver sinusoids sporozoites glide in search of Kupffer cells, interspersed 
with endothelial cells, and actively migrate across their cytoplasm accessing the liver parenchyma, 
where they infect hepatocytes (200). Surrounded by the parasitophorous vacuole derived from the 
cell membrane of the hepatocyte parasites undergo schizogony, a cell division process consisting of 
growth and subsequent division of nucleus and cytoplasm into multiple daughter cells within a 
parent cell, differentiating to liver schizonts of increasing size (79). Development in the liver is 
asymptomatic and lasts 6 to 15 days for human malaria parasites and around 50 hours for the murine 
infectious species P. berghei (156, 157, 191). After this time, blood parasites, called merozoites, are 
released from infected hepatocytes. 
Merozoites invade erythrocytes, growing fast inside and multiplying through schizogony (39). 
Eventually the infected erythrocyte bursts and daughter merozoites are released to the bloodstream, 
where they immediately invade new erythrocytes. In parallel, some merozoites differentiate into
 - 11 - 
 
  
 
 
 
 
 
 
 
 
 
 
   
 
 
Figure 1.2: Life cycles of human plasmodial parasites and filarial worms. (A) Life cycle of Plasmodium sp. Sporozoites enter the host during the bloodmeal of an 
infected mosquito. After multiplication inside hepatocytes merozoites are released into the blood, where they invade erythrocytes and transform into 
trophozoites. These divide through schizogony and daughter merozoites are released when the erythrocyte breaks down. Some trophozoites differentiate into 
male and female gametocytes that merge to form the zygote inside the gut of a new mosquito. The zygote differentiates into an ookinete that settles in the wall of 
the mosquito’s gut and develops to an oocyst, containing thousands of sporozoites. These are released in the mosquito haemolymph and transported to the 
salivary glands, where they mature, being able to infect a new host. (B) Life cycle of filarial worms. L3 larvae enter the bloodstream of the host after the feeding of 
an infected mosquito and perform two moulting episodes to become adults that produce L1 larvae (microfilariae). L1 larvae are ingested by a new vector and 
develop into L3 larvae in 2 moulting steps inside the mosquito’s gut, migrating to the insect’s proboscis to infect a new host after bloodmeal.  
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gametocytes, the sexual forms of the parasite, which complete the parasite’s life cycle after ingestion 
by a new mosquito (Fig 1.2 A).  
 
1.1.3. Course of clinical disease 
 
Malaria pathology arises during the parasite’s blood stage. The regular appearance of fever 
peaks in infected individuals is a consequence of the synchronic development of the parasites in 
blood: bursting of infected erythrocytes is accompanied by the release of parasite-derived pyrogenic 
factors causing acute febrile episodes (19). Intraerythrocytic growth rates of human plasmodial 
parasites differ regarding the species, generating fever episodes of characteristic periodicity (also 
known as malaria paroxysm). Namely, P. vivax and P. ovale (tertian malaria) cause fever episodes 
every 48 hours; P. malariae (quartan malaria) every 72 hours, and P. falciparum (designated as 
malignant tertian malaria) at 48 to 72-hour intervals.  
Two features markedly distinguish P. falciparum from the other malaria species, and are the 
possible reasons why infections are of much higher severity. First, the capacity of infected red blood 
cells to adhere to the endothelial cells in the walls of capillaries of muscle and visceral organs; a 
phenomenon known as sequestration. In the brain, immune responses against sequestered parasites 
cause cerebral malaria (CM). Second, P. falciparum generates higher parasitaemia levels (around 
10%) than other human malaria species (rarely exceeding 1%), giving rise to severe malarial anaemia 
(SMA). CM and SMA appearing separately or concomitantly define the term severe malaria 
pathology, which comprises all the processes that increase the risk of death from malaria (204, 233). 
CM is a life-threatening immune-mediated pathology. As a consequence of the inflammatory 
environment created against malaria parasites, endothelial cells express high levels of adhesion 
molecules, favouring the accumulation of immune cells in the capillaries of the major organs of the 
body (225). P. falciparum infected red blood cells (iRBCs) are able to bind endothelial adhesion 
molecules too (15), which is interpreted as a strategy to avoid passage through the spleen, where 
parasites may be eliminated by immune cells. But as a consequence of the activity of effector 
immune cells against the parasites in the brain the blood-brain barrier is damaged, causing internal 
haemorrhages (225), and neuronal injury (154). At this stage the patient lapses into a coma and is 
frequently fatal.  
Two different mechanisms have been proposed for onset of coma: first, neuronal hypoxia 
induced by the clogging of brain capillaries by sequestered immune cells and infected erythrocytes; 
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and second, deterioration of the brain endothelial cells due to the immune responses against 
sequestered parasites (147). The use of the model P. berghei ANKA in C57BL/6 mice, which 
reproduces most of the main features of human CM, like sequestration in the brain of immune cells 
and infected erythrocytes (147, 203), has facilitated understanding the mechanisms leading to this 
pernicious pathology. Data from this murine model suggest the second mechanism is the most 
important contributor to pathology, and this is explained in detail in section 1.2.4.    
SMA results from massive loss of erythrocytes, but this pathology is not merely related to 
parasitaemia or to the direct destruction of erythrocytes by the parasite: indeed, severe anaemia 
may occur in individuals with chronic falciparum infection and low parasitaemia (279). At a given 
parasitaemia such as 1%, haemoglobin concentrations fall at a much more pronounced rate, to levels 
around 50%. In addition, an average of 8.5 uninfected red blood cells (uRBCs) are destroyed in 
addition to each iRBC (118). Intriguingly, an immune-mediated process has been shown to mediate 
loss of circulating uRBCs after P. berghei infection, involving CD4+ T cells and macrophages (73, 106). 
Hence an important component of SMA pathology may have an immunological aetiology. 
 
1.2.  IMMUNOLOGY OF MALARIA 
 
1.2.1. P. berghei as a murine model for malaria 
 
P. berghei is a model which is commonly used to study human falciparum malaria. The 
average protein identity between P. falciparum and P. berghei is 62.9%, and their average nucleotide 
identity is 70.3% (96).   
Susceptibility to sporozoite infection differs between species. As mentioned before, a median 
of just 15 P. falciparum sporozoites were found to be injected into the human host from an infected 
mosquito (210). Regarding P. berghei, infections of BALB/c mice require at least 500 sporozoites (see  
section 3.1.1.1) or even more depending on the P. berghei ANKA strain, but C57BL/6 mice can be 
efficiently infected with a dose of 50 sporozoites (223).  Once inside the hepatocytes P. falciparum 
development requires 5-6 days whereas P. berghei takes only 50 hours; this stage asymptomatic in 
both cases (223, 234). 
Introduction 
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P. berghei infections are lethal at the blood stage. BALB/c mice develop high parasitaemia 
and die after several weeks of progressive debilitation and loss of weight and hematocrit. 
Parasitaemia reaches levels of up to 80% (see section 3.1.1.1) in these mice, which markedly exceed 
the 10% achieved by P. falciparum (19). Unlike human malaria parasites P. berghei does not develop 
synchronously in blood. Nevertheless, parameters such as splenomegaly, extensive erythrocyte loss 
and decrease in haematocrit levels resemble the situation of P. falciparum infected individuals 
developing anaemia, and thereby P. berghei infected BALB/c mice have been used before for SMA 
studies (73).  
As will be explained in section 1.2.4 in detail, strong Th1-type immune responses mainly 
involving IFN-γ and LT-α are elicited against P. berghei blood stages by C57BL/6 mice resulting in CM 
development (116). In this system murine CM resembles human pathology in multiple facets, such as 
the high levels of circulating Th1 cytokines, over-expression of adhesion molecules in brain 
endothelium causing immune cell and iRBC sequestration, or the generation of brain haemorrhages. 
A feature of P. falciparum markedly distinct from P. berghei is the accumulation of parasite-derived 
proteins in spots or “knobs” on the erythrocyte surface, which give the iRBC an irregular form (147). 
Knobs have been related to endothelium binding (14) and to aggregation of iRBCs to leukocytes and 
uRBCs (34), the latter being a known phenomenon termed rosetting that has been linked to full 
blown CM (34, 212). Nevertheless, though scarce, knobless parasites also exist in certain P. 
falciparum strains, presenting similar leukocyte-binding properties than knob-forming parasites in 
vitro (213). P. berghei iRBCs also sequester in brain capillaries (120). Absence of knobs in their 
surface may account for their comparatively lower sequestration capacity than P. falciparum iRBCs 
(147), but this fact does not impede CM generation.  
 
1.2.2. Immune responses against liver stage parasites 
 
Passage through the liver is a very delicate stage in the course of plasmodial infection. Since 
few parasites are injected into the host by the mosquito (210), only a low percentage of them will 
actually invade hepatocytes (7) and even fewer will succeed in completing this developmental phase 
(262). Malaria parasites have developed multiple strategies to ensure maximal success in this 
process.  
Sporozoites progress within a few minutes from the site of injection to the liver (231). In such 
a short period the immune system of a naïve individual is unable to mount an efficient protective 
response against the parasite. A potentially feasible immune mechanism to prevent liver invasion is
 - 15 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.3: Immune response against liver stage malaria parasites. Plasmodial sporozoites as well 
as damaged intrahepatic parasites supply antigens to APCs (DCs and macrophages), which then 
prime parasite-specific T cells and produce IL-12, activating NK cells for IFN-γ production and 
cytotoxicity. Primed CD4+ and CD8+ T cells also produce IFN-γ, which directly kills intrahepatic 
parasites and induces cytotoxicity in CD8+ T cells. Adapted from (110). 
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through specific antibodies preformed after a previous infection, but even this is difficult to achieve 
(224). Monoclonal antibodies against the Pb44 epitope of the circumsporozoite protein (CSP), the 
most abundant in the sporozoite membrane, have been shown to provide resistance against 
infection in a murine model (197). However, repetitive sequences in CSP, which are strong B cell 
epitopes, seem to constitute a way of immunological evasion by a process of clonal dominance: 
numerous B cells specific for immunodominant repetitive sequences might hinder the binding of 
other B cells recognizing adjacent protective domains of CSP, avoiding the generation of efficient 
antibody responses (224). Moreover, though involved in motility, CSP is constantly released by 
gliding sporozoites, which leave a trail behind, possibly impairing sporozoite neutralization through 
anti- CSP antibodies (247). 
Though some of the sporozoites inoculated by a mosquito are trapped in the lymphatic 
system and degraded in lymph nodes, supplying antigen for immune cell priming (7, 41), most of 
them have been found to reach the liver efficiently (210). Once inside hepatocytes malaria parasites 
are combated by specific cellular immune mechanisms elicited by the host (Fig. 1.3). As for any other 
intracellular pathogen, CD8+ T cells are the main mediators of anti-plasmodial cytotoxic responses at 
this stage. Hepatocytes, as any nucleated cell, constitutively present peptides derived from own 
proteins on their membrane. Those peptides are generated by the proteasome and loaded on major 
histocompatibility complex class I (MHC-I) proteins in the endoplasmic reticulum (127). Afterwards, 
complexes are transported in vesicles to the cell membrane (295). Upon infection by an intracellular 
microbe, pathogen-derived peptides are loaded on MHC-I molecules and carried to the cell surface 
through the same mechanism. CD8+ T cells scan MHC-I molecules on the membrane of nucleated 
cells in search for presented non-self antigens; indicating infection. Specific CD8+ T cells recognizing a 
particular peptide-MHC combination induce apoptosis (programmed death) of the infected cell (16, 
18). Following this schema, hepatocytes infected with malaria parasites have been found to present 
parasite-derived peptides to specific CD8+ T cells (21), which in turn mediate protection against 
infection after immunization with attenuated sporozoites (60, 209, 227, 273).  
CD8+ T cells are assisted by natural killer (NK) and natural killer T cells (NKT cells) in 
combating intrahepatic malaria parasites. The presence of NK cells is required for the induction of 
effective anti-plasmodial cytotoxic responses by CD8+ T cells (61). Additionally, NK and NKT cells have 
been proven able to kill intrahepatic parasites in an IFN-γ-dependent mechanism (193, 208). IFN-γ 
directly inhibits parasite growth through the induction of nitric oxide (NO) production by the 
hepatocytes (159). NKT cells artificially activated by α-galactosylceramide enhance IFN-γ production 
by CD8+ T cells in the liver, boosting elimination of malaria liver stages after suboptimal immunization 
with irradiated P. yoelii sporozoites (83). Thus, like CD8+ T cells, NK and NKT cells participate in the 
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clearance of liver stage parasites either directly, killing infected cells, or indirectly, inducing the 
production of IFN-γ by CD8+ T cells and increasing their cytotoxicity (Fig. 1.3). After the initial CD8+ T 
cell activation, specific IL-4-producing CD4+ T cells sustain the proliferation and maintenance of 
parasite-specific CD8+ T cells in an NK- and NKT-independent manner (35, 163, 274).  
Since its intrahepatic development lasts merely 50 hours a fast immune response is required 
to block P. berghei infection in the liver. Dendritic cells (DCs) are able to generate specific and fully 
functional CD8+ T cells 6 to 12 hours after contact with an antigen (201). In the case of malaria, CD8+ 
T cell responses have been shown to start as soon as 8 hours after sporozoite infection (95). 24 hours 
after infection CD8+ T cell proliferation can be detected, as well as their secretion of IFN-γ and 
perforin. Cytotoxic elimination of liver parasites inside hepatocytes occurs between 24 and 48 hours 
(218). Mouse strains with varying susceptibility to P. berghei sporozoite infection differ in their ability 
to establish fast immune responses against liver stage malaria parasites. Thus, 44 hours after 
sporozoite inoculation BALB/c mice accumulate more infiltrating immune cells in the liver than 
C57BL/6 mice, killing liver parasites more efficiently and hence being more resistant to sporozoite 
challenge (223).   
Nevertheless, malaria parasites have developed diverse mechanisms to impair the 
establishment of cytotoxic immune responses in the liver. For instance, sporozoites down-regulate 
MHC-I expression in Kupffer cells, impairing CD8+ activation (244). In addition, intrahepatic parasites 
can impede phosphatidylserine translocation to the outer membrane of infected cells that have been 
induced by CD8+ T cells to undergo apoptosis. Recognition of phosphatidylserine on the surface of an 
apoptotic cell is the signal that triggers its phagocytosis by macrophages. By blocking this process 
malaria parasites remain hidden during their development inside the hepatocytes (262). Indeed, it is 
parasite death (estimated to occur in 9 to 18% of the parasites that achieved hepatocyte invasion) 
that provides antigen for antigen presenting cells (APCs) for the development of specific protective 
CD8+ T cell responses after re-infection (141, 262). With such strategies plasmodial parasites 
maximize their chances of survival and are thus capable of effectively establishing blood infections 
with only a few sporozoites. 
 
1.2.3. Immune responses against blood stage parasites 
 
After completing their liver stage malaria parasites are released into the blood, where they 
infect erythrocytes. During this stage, the parasites grow and divide rapidly increasing their numbers 
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and making total elimination by the host immune system difficult. Malaria pathology exclusively 
develops during the blood stage. Indeed, important processes leading to the main manifestations of 
severe malaria pathology, CM and SMA, originate from inappropriate immune responses against 
blood parasites.  
The capability of the immune system to combat blood stage malaria parasites is limited by 
the fact that erythrocytes lack expression of MHC-I molecules, which mediate the paradigmatic 
mechanism of defence against intracellular pathogens. Nevertheless, immune mechanisms are 
indeed elicited during blood infection. Effective control at the blood stage of the non-lethal murine 
parasite P. chabaudi is first mediated by CD4+ T cell-dependent activation of macrophages (286), and 
subsequently antibody production (269). IFN-γ secretion by CD4+ T cells has been shown to fully 
activate human macrophages for P. falciparum phagocytosis (179). Although Th1 cytokines like IFN-γ 
are required for the elimination of blood stage parasites, high levels may result in CM pathology (see 
next section and Fig. 1.4). Conversely, the absence of these cytokines may lead to exacerbated 
parasitaemia. Hence a precise level of inflammation is necessary for the successful clearance of a 
plasmodial infection in blood. 
None of the classical mouse strains can spontaneously control P. berghei parasitaemia. A key 
factor involved in this susceptibility seems to be the way APCs respond to the parasites. DC 
maturation and capacity to cross-present antigens are impaired during P. berghei infection (282) due 
to high concentrations of systemic TNF-α (284). Moreover, P. berghei iRBCs also decrease IL-12 
production by macrophages in an IL-10-dependent mechanism (287). A similar inhibition of human 
DC and macrophage function after phagocytosis of P. falciparum parasites has been described (228, 
261), underlining the convenience of P. berghei to model blood stage human malaria in the 
laboratory.  
 
1.2.4. Cerebral malaria 
 
CM is the result of a strong inflammatory process against malaria parasites taking place in the 
brain. In a typical inflammatory reaction TNF-α released at the site of infection induces an increased 
expression of adhesion molecules like intercellular adhesion molecule-1 (ICAM-1) by epithelial cells 
(196). Circulating immune cells are then recruited from circulation by binding ICAM-1 through 
leukocyte function-associated antigen-1 (LFA-1) (152), and extravasate to the tissue to combat the 
pathogen (24). A similar process occurs in the brain and other major organs during malaria: pro-
inflammatory cytokines induce the up-regulation of adhesion molecules in the brain capillaries, 
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Figure 1.4: Immune response against blood stage malaria parasites. Parasite-derived catabolites 
activate APCs (DCs and macrophages) for T cell priming and IL-12 production, which in turn activates 
NK cells. NK cells, CD4+ and CD8+ T cells later produce IFN-γ, which on the one hand is essential for 
parasitaemia control but on the other can induce CD8+ T cell-mediated pathology at high 
concentrations. Adapted from (51) 
 
 
 
 
 
 
 
Figure 1.5: Brain histology during cerebral malaria. (A) Cerebral haemorrhages in brain parenchyma 
(arrows). (B) Sequestered erythrocytes in mouse brain capillaries during CM-development (arrows). 
A B 
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leading to the sequestration of immune cells and iRBCs and subsequently to endothelial damage (Fig. 
1.5 A, B). 
It is not TNF-α but a close relative, lymphotoxin α (LT-α), which has been found to be 
essential for CM development (71). Nevertheless TNF-α is produced by both murine and human 
macrophages when exposed to different plasmodial species (11, 192, 253), and also by microglia and 
astrocytes during CM (155). Microinjection of TNF-α in the brain has been demonstrated to reduce 
cerebral blood volume, and even to induce damage to the blood-brain barrier (BBB) (232), indicating 
that this molecule, though not essential, may worsen the course of the pathology.  
On the other hand, ICAM-1 expression was found to be up-regulated in brain endothelial 
cells of CM-developing mice (89), resulting in the sequestration of immune cells (88). Enhancement 
of ICAM-1 expression is driven by TNF-α or LT-α signalling through the TNF receptor 2 (TNFR-2), 
which is up-regulated in CM-susceptible C57BL/6 mice during the onset of the pathology but not in 
CM-resistant BALB/c mice (148). Additionally, Plasmodium-derived glycosylphosphatidylinositol (GPI) 
directly induces ICAM-1 expression on endothelial cells (226).  
Operating in an earlier step than TNF-α or ICAM-1, IFN-γ is critically involved in the cascade 
generating CM. Indeed, IFN-γ is produced by T cells to activate macrophages, enhancing their TNF-α 
production (37, 165). Furthermore, IFN-γ was shown to synergize with TNF-α and LT-α inducing 
increased expression of adhesion molecules by endothelial cells (272). In the context of P. berghei 
infection, deficiency in either IFN-γ or IFN-γ receptor prevents CM development, abolishing increases 
in TNF-α and ICAM-1 in the brain (5, 214, 289). When stimulated with malaria parasites in vitro, 
lymphocytes from CM susceptible mouse strains produce significantly higher IFN-γ levels than those 
from CM resistant mice (50).  
Timing of cytokine peaks is a critical factor defining the eventual malaria outcome. An early 
IFN-γ peak produced by BALB/c mice 24 hours after non-lethal P. chabaudi or P. yoelii infections is 
thought to result in prevention of CM pathology (52). However, absence of the early IFN-γ peak and a 
later increase of this cytokine triggers CM in P. berghei ANKA infected mice. Interestingly, when mice 
are co-infected with two P. berghei strains from which one causes CM and the other does not, 
cerebral pathology is prevented and an early IFN-γ peak induced by the non-CM-inducing parasites 
can be measured (160).  
CM is the result of a sequential cascade of events in which different cell types play defined 
roles at specific time points after the infection. Macrophages, neutrophils and platelets are involved 
in the initial steps for the induction of the pathology. Thus, in C57BL/6 mice CM development is 
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stopped when depletion of macrophages is done before day 5 p.p.i., but not later during the onset of 
CM (13, 40). Upon contact with the parasites macrophages release an initial wave of pro-
inflammatory cytokines generating a Th1 environment required for progression to CM. Sensing of P. 
falciparum GPI by macrophages through TLR2 (133) activates them and induces IL-12, IL-6, TNF-α and 
NO production (294). Additionally, the complex formed by hemozoin, the residual product of the 
heme catabolism by the parasite, and plasmodial DNA engages TLR9-dependent responses in 
macrophages, enhancing IL-12 synthesis (186).  
Neutrophils have also been shown to mediate CM (44, 229) by producing IFN-γ and TNF-α 
(43). However, like macrophages, their late depletion does not prevent pathology and hence their 
contribution to CM is done early after infection (13). Platelets, which express high levels of LFA-1 and 
sequester in the capillaries of brain and other major organs, also promote CM (90). Their early 
depletion hampers CM progression (90, 146), originating IFN-γ down-regulation and the increase of 
IL-10 levels in serum (264).  
CD4+ T cells are a source of IFN-γ, and their depletion at day 4 after P. berghei infection, but 
not at day 6, prevents pathology (13). This places helper T cells in a more posterior stage of the 
immunological cascade which generates CM compared to macrophages or neutrophils. During P. 
berghei infection CD4+ T cells are induced to differentiate into Th1 cells. CD4+ T cells can belong to a 
Th1, Th2 or regulatory phenotype. Polarization of CD4+ T cells to each of these phenotypes can be 
driven between others by the presence of IFN-γ, IL-4 or IL-10 in their surroundings (59, 124). 
Whereas Th1 T cells are involved in IFN-γ production and full activation of cell-mediated immunity 
against intracellular pathogens, Th2 cells produce IL-4, IL-5 and IL-13, which mediate defence against 
extracellular parasites like helminths. Regulatory T cells are generated to suppress both Th1 and Th2 
responses and prevent potential immune-derived damage to the host (124). The direction an 
adaptive immune response takes towards a Th1 or a Th2 type is thought to be determined by cells of 
the innate immune system; particularly NKT cells and DCs. These cells respond against the pathogen 
supplying an early wave of cytokines influencing CD4+ T cell polarization. NKT cells are able to 
produce IFN-γ or IL-4 upon contact with a pathogen, influencing the subsequent immune response 
(99). In accordance with this, shortly after P. berghei infection NKT cells from CM susceptible C57BL/6 
mice induce the production of high amounts of IFN-γ by CD4+ T cells. Absence of NKT cells reduces 
CD4+-derived IFN-γ production in these mice and results in no pathology. In contrast, in the CM-
resistant BALB/c background NKT cells induce IL-4 production in CD4+ T cells after contact with 
malaria parasites, and their absence leads to high IFN-γ production and CM development (100).  
Moreover, substitution of the NKC complex (a genetic region that regulates NK and NKT function) in 
CM resistant BALB/c mice for that of CM susceptible C57BL/6 mice turns transgenic BALB/c mice 
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susceptible to CM (98). Therefore, NKT cells regulate T cell commitment after P. berghei infection 
and also determine susceptibility to CM. On the other hand, priming of anti-plasmodial CD4+ T cells 
for IFN-γ production has been shown to be performed by CD11chigh DCs (55). Apart from DCs and NKT 
cells, neutrophils secreting IFN-γ shortly after infection may also contribute to Th1 differentiation 
and hence CM development.  
CD8+ T cells are the ultimate effector cell in the cascade causing CM. Complete prevention of 
cerebral pathology can be achieved by depletion of these cells as late as day 6 after P. berghei 
infection, and even partial protection is seen after depletion during CM onset (13). After recognizing 
a peptide from the pathogen loaded in a MHC-I molecule, CD8+ T cells exert their cytotoxic activity 
inducing cell death through perforin (123). In the context of CM, perforin has been shown to induce 
apoptosis of brain endothelial cells, and mice deficient for this gene completely evade pathology 
development despite the presence of sequestered CD8+ T cells in the brain (172, 198). Thus, perforin-
dependent apoptosis of brain endothelial cells is the last step in CM. It is important to remark at this 
point that it is not the mere sequestration of immune cells and infected erythrocytes in the 
capillaries of the brain that causes CM, but the immune responses elicited in the brain. However, 
there is still an open question about how activated CD8+ T cells destroy sequestered parasites and 
damage the brain endothelium if such parasites remain inside erythrocytes, which do not possess 
MHC-I molecules.  
Apart from macrophages, CD4+ and CD8+ T cells, NK cells are also sequestered in the brain 
during CM in a CXCR3-dependent manner (97). CXCR3 is a chemokine receptor expressed mainly in 
activated Th1 lymphocytes and NK cells involved in the trafficking of activated T cells to inflammation 
sites in the CNS (47). NK cells enable T cells to migrate to the brain in a IFN-γ dependent mechanism 
by stimulating them for CXCR3 expression (97). This, however, might not be done directly, but 
through NK enhancement of DC function, which is also dependent on IFN-γ and TNF-α (266).  
In summary, after P. berghei infection cells from the adaptive immune system orientate the 
subsequent immune response towards a Th1 type. Th1-polarized CD4+ T cells and NK cells produce 
IFN-γ, which contributes to full activation of macrophages and parasite phagocytosis. However, high 
levels of pro-inflammatory LT-α or macrophage-derived TNF-α also induce the brain endothelium to 
express adhesion molecules. As a consequence, macrophages, CD4+, CD8+ T cells and NK cells are all 
sequestered in the brain. Sequestered effector CD8+ T cells secreting perforin damage the brain 
endothelium and cause haemorrhages and eventually CM.   
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1.3.  GENERAL CONCEPTS ABOUT FILARIASIS 
 
1.3.1. Epidemiology of human filariasis 
 
Filariasis is an infectious disease induced by parasitic nematodes. Several species can infect 
humans. Wuchereria bancrofti in Africa, and Brugia malayi and Brugia timori in Asia live in the 
lymphatic ducts and provoke lymphatic filariasis. Onchocerca volvulus, causing oncocerciasis or river 
blindness, Loa loa and Mansonella streptocerca settle in the subcutaneous tissue, and other filariae 
infect different organs (Mansonella spp. and Dirofilaria spp.) (113).  
W. bancrofti, B. malayi and O. volvulus are responsible for the majority of the filarial 
infections in the world (184). Regarding lymphatic filariasis W. bancrofti causes 90% of the cases, 
being distributed in the tropics throughout the world. The remaining 10% corresponds to Brugia 
malayi, appearing in Southeast and Eastern Asia, and Brugia timori, in Timor and adjacent islands 
(158). O. volvulus is endemic in 28 Sub-Saharan countries in Africa, 6 in Latin America and Yemen. In 
these regions, endemic areas correspond to savannah and rain-forest close to watercourses where 
Simulium vectors breed (258). Distribution of the main filarial nematodes often coincides with that of 
P. falciparum (Fig. 1.1). 
 
1.3.2. Life cycle of filarial nematodes 
 
Filariae belong to the order Spirurida, in the phylum Nematoda. Adult filarial nematodes live 
in different lymphatic tissues and body cavities of the host, depending on the species. Mature female 
worms release microfilariae (Mf), which are first-stage larvae (L1). Mf migrate to blood or peripheral 
tissues, where they remain until ingested by an arthropod vector. In different regions Mf migration is 
performed selectively during the day or the night depending on the feeding behaviour of their 
endemic vector (19). Once inside the insect’s gut, Mf penetrate the midgut wall and reach the 
hemocoel, being transported to the thoracic musculature. There they moult twice becoming 
infectious L3 larvae and migrate to the insect’s proboscis. Such larvae gain access to the vertebrate 
host through the wound made by the insect during the blood feeding. Inside the new host they 
develop to adult worms through two moulting episodes (19) to complete the cycle (Fig. 1.2 B).  
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1.3.3. Onchocerciasis 
 
  O. volvulus worms reside in characteristic nodules of 1-5 cm surrounded by the host by 
fibrous tissue under the skin, known as onchocercomas. Their lifespan reaches 10-15 years (258). 
Millions of Mf are released by adult female worms and spread in the dermal tissue, where they are 
taken up by a new vector during a bloodmeal. Pathology is triggered in the skin by death of Mf, 
which become the target of immune attack. Eye inflammation after Mf death in the cornea causes 
blindness (108).  The most common manifestation of the infection in endemic individuals is the 
generalized onchocerciasis, characterized by massive numbers of Mf in the skin but only mild signs of 
disease. In contrast, some individuals referred to as “sowda” patients present chronic dermatitis and 
lymphadenitis, which are derived from an excessive immune response against the worms. Numbers 
of Mf and adult worms are reduced in these patients as a consequence of such response (32), but at 
the cost of suffering disease (33). Finally, a small proportion of people living in the same areas and 
therefore under the same risk of infection remain free from helminth infection and are denoted 
“putatively immune” individuals (108). Generalized onchocerciasis is thought to reflect the ability of 
the worm to suppress immune effector mechanisms in the host to facilitate its own survival. In 
contrast, parasite clearance in sowda patients implies the failure of regulatory mechanisms, resulting 
in strong inflammation and severe disease (108). 
 
1.3.4. Lymphatic filariasis 
 
Lymphatic filariasis is considered the second leading cause of long-term disability in the 
world (276). In addition, severe social and psychological consequences follow the onset of certain 
pathological stages such as elephantiasis or hydrocoele (63).   
The infection presents three stages: first, an incubation period involving the development of 
L3 larvae into adult worms. This stage is accompanied with mild symptoms and lasts one year or 
more. In some patients worms are eliminated without causing disease in the infected person (19). 
The second acute phase starts after the maturation of adult worms and Mf release. When adult 
worms die, their products trigger inflammation and swelling of arms and legs. In males the scrotal 
region is frequently affected, and results in hydrocoele. Finally, the chronic phase, affecting up to 
10% of the infected population, involves the blockage of lymph vessels through the acute 
granulomatous response against dead and degenerating worms, provoking elephantiasis (19).   
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In correlation with onchocerciasis, areas endemic for lymphatic filariasis have three groups of 
coexisting subjects: asymptomatic microfilaraemia patients resemble those with generalized 
onchocerciasis and comprise the highest percentage of infected people, presenting Mf in blood but 
no evident signs of disease. In these patients, immunosuppression exerted by the worms is assumed 
to prolong parasite survival and prevent pathology development (184). Other individuals, like the 
sowda patients in onchocerciasis, are able to eliminate Mf, but develop pathology. Death of adult 
worms causes episodes of acute filarial lymphangitis (AFL), a local inflammatory response, which 
does not represent a strong clinical course (158). However, secondary bacterial infections elicit acute 
dermatolymphangioadenitis (ADLA), which consists of a local inflammatory reaction followed by 
oedema of the affected limb and eventually results in lymphoedema and elephantiasis (62, 64). 
Finally, individuals designated as “endemic normals” present no evidence of disease and are 
equivalent to putatively immune individuals in onchocerciasis areas, representing a third of the total 
population (less in onchocerciasis areas) (65, 271). Some of these individuals can be cryptically 
infected, appearing positive for infection due to the presence of circulating worm antigen in the 
blood (49). 
 
1.4. IMMUNOLOGY OF FILARIASIS 
 
1.4.1. L. sigmodontis as a murine model for filariasis 
 
Brugia malayi, the human parasite, and Brugia pahangi, which naturally infects felines and 
canines, have all been used in experimental murine infections for immunological studies on filariasis. 
However, such systems are considered artificial since these worms cannot complete their life cycle in 
the mice (137). The establishment of the L. sigmodontis model in mice has become a valuable tool 
for immunological research on filariasis. BALB/c mice are fully susceptible to the infection, allowing 
worms to mature in their pleural cavity and produce Mf (188). L. sigmodontis belongs to the family 
Onchocercidae, which also comprises the human pathogens O. volvulus and W. bancrofti (285). The 
natural host of L. sigmodontis is the cotton rat (Sigmodon hispidus) (111). 
After infection of the fully permissive BALB/c mice, L3 larvae migrate through the lymphatics 
to the lungs and then to the pleural cavity 4 days later, and moult twice there to become adults 
around 30 days post infection.  Migration of immune cells to the pleural cavity starts as early as 4 
days after infection (9). From day 55 onwards, Mf are released by adult female worms (111). A rate 
of roughly 50% of the L. sigmodontis infected mice become microfilaraemic, whereas the rest remain 
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negative (Mf-). Amicrofilaraemia in a susceptible mouse has been reported to be due to Mf clearance 
through a specific immune response mediated by antibodies (91) or to the decrease in fertility of 
female worms (8). The former situation is thought to occur more commonly, whereas the latter has 
been associated with high worm loads.  
Adult worms elicit different immune-suppressive mechanisms, preparing a milder 
environment for the Mf at the moment of their release (109). Thus, Mf+ mice might be considered as 
those in which immunosuppression by the adult worms has been more efficient, whereas their 
amicrofilaraemic counterparts have been able to circumvent suppression and elicit efficient immune 
responses killing Mf. Both groups of mice resemble therefore different manifestations of filariasis in 
human patients. Unlike humans L. sigmodontis infected BALB/c mice do not develop any kind of 
pathology. 
 
1.4.2. Responses against adult L. sigmodontis worms  
 
Adult L. sigmodontis worms are eliminated in the pleural cavity through encapsulation in 
nodules formed by immune cells. These nodules are constituted by a first layer of neutrophils 
followed by a second layer of eosinophils. The same distribution of neutrophils and eosinophils can 
be found in nodules around O. volvulus worms in humans (281). Though eosinophils reach the pleural 
cavity shortly after L. sigmodontis infection they are unable to inititate worm encapsulation at this 
time. This process is started by neutrophils, arriving between days 30 to 60 p.f.i. in an IL-5-dependent 
mechanism (3). Macrophages also mediate anti-filarial immunity, being possibly activated by 
eosinophils for TNF-α-production (241) and then attracting neutrophils to the thoracic cavity (3). In L. 
sigmodontis infections of BALB/c mice the worm encapsulation processes start after the seventh 
week post infection, continuing over 4 to 5 weeks until all worms have been blocked. Finally, worms 
are progressively re-absorbed until week 20 p.f.i. (3).  
Combined Th1 and Th2 responses are naturally developed by the vertebrate host against the 
different life stages of filarial worms. Absence of either IL-5 or IFN-γ impairs nodule formation and 
worm elimination (216). Indeed, both IL-5 and IFN-γ have been shown to work in a synergistic 
manner, and their double deficiency results in more increased worm numbers than the deficiency of 
IL-5 or IFN-γ alone (215). Filariae-induced Th1 and Th2 reactions are not antagonistic, since IL-4 
depletion in BALB/c spleen cell cultures with worm antigen from B. pahangi does not lead to 
enhanced IFN-γ production (183). In contrast, it is the depletion of the regulatory cytokine IL-10 
which results in the production of Th1 cytokines against the same filarial antigen (181). IL-4 
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deficiency allows prolonged worm survival and Mf release in the otherwise resistant C57BL/6 
background (139). However, the additional deficiency of IL-10 restores resistance to worm infection 
(240). This underlines the concept of Th1 and Th2 responses acting simultaneously, but not 
exclusively, against the worms, and the role of IL-10 as a regulatory cytokine for both types of 
responses (252).  
At the cellular level, in addition to eosinophils, neutrophils and macrophages, a variety of 
other cells contributes to the immune response against L. sigmodontis in BALB/c mice. CD4+ T cells 
are involved in the clearance of adult worms. Moreover, IL-4 and IL-5 responses, eosinophilia in the 
blood and pleural cavity and IgE levels are diminished in CD4+ T cell depleted mice (4). Production of 
IL-4, IL-5 and IL-10 is also driven by B1 cells, which are an ancient subtype of B cells found exclusively 
in pleural and peritoneal cavities producing T-cell independent responses (74), and their deficiency 
results in increased worm numbers (2). NK and NKT cells also migrate into the pleural cavity during L. 
sigmodontis infections, and their depletion leads to higher parasite loads (129). Depletion of CD8+ T 
cells has not been found to influence adult worm nor Mf elimination (129).  
Susceptibility to L. sigmodontis infection varies among different mouse strains. Thus, BALB/c 
mice allow the complete development of its life cycle whereas C57BL/6 mice clear adult worms 
before they can produce Mf. Differences in immune responses against adult worms between 
susceptible and resistant mouse strains can be observed on days 10 and 30 after infection, when a 
higher migration of immune cells to the pleura, accompanied by higher levels of IL-4, IL-5, IL-10 and 
IFN-γ is seen in resistant C57BL/6 mice (9). However, worm loads are similar during this period and 
differences only occur in the ability of the helminth to sustain infection (9).  
 
1.4.3.  Responses against microfilariae 
 
Mf are released by adult worms in the thoracic cavity and actively migrate to blood 
thereafter. When injected intravenously in naive C57BL/6  mice they are rapidly killed (within 6 days), 
whereas they are able to survive up to 45 days in susceptible BALB/c mice (190). Similar strain 
differences in elimination efficiency are observed after intrapleural injection of Mf. However, in this 
case Mf amounts in the pleural cavity at day 6 after injection are comparable in both mouse strains, 
indicating that their clearance only takes place in the blood (190). Adult worms in the pleural cavity 
are thought to downregulate immune responses against Mf to prolong their survival. Thus, 
transplantation of female worms to the pleural cavity of a resistant naïve mouse (e.g. C57BL/6) 
allows Mf injected thereafter to persist for several weeks, in an IL-10-dependent mechanism (112). 
Introduction 
 - 28 - 
CD4+ T cells and B1 lymphocytes are involved in Mf clearance, since their depletion leads to 
higher Mf numbers in blood (2, 4). Macrophages, able to adhere to Mf, also contribute to their 
elimination (185). Absence of IL-4 or IL-5 in BALB/c mice causes higher microfilaraemia (3, 267). 
Patency in BALB/c mice is followed by high levels of circulating IFN-γ (182, 252) and the secretion of 
IgG2a, IgG2b and IgG3 (138), but IFN-γ deficiency does not lead to increased Mf loads in blood (215).  
 
1.4.4. Immunomodulation by filarial worms 
 
Parasitic filarial nematodes present a long lifespan inside the host due to the development of 
mechanisms modulating immune responses against them. This is reflected by the fact that, when 
cultured with filarial antigens, peripheral blood mononuclear cells (PBMCs) from subjects living in 
areas with elevated transmission rates, harbouring therefore high worm loads, proliferate less than 
those of people from low transmission areas (125). In addition, children living in endemic areas 
acquire fewer adult worms per year than older people, in whom immunomodulatory mechanisms 
have been established by the worms (67). Such mechanisms eventually result in a benefit for both 
host and parasite, since an excessive immune reaction against the worms reduces parasite loads but 
contributes to pathology (64). As an example, hyperreactive sowda onchocerciasis patients present 
increased numbers of mast cells and eosinophilss in the skin, actively attacking live Mf. This results in 
Mf killing but also in the development of strong dermatitis (130). Skin lesions in such patients have 
been related to strong Th2 responses and absence of immunoregulation (259). In contrast, 
unresponsiveness allows high Mf loads in skin but prevents pathology in patients with generalized 
onchocerciasis (280). As a consequence of filaria-induced immune suppression, lower production of 
IL-5 and IFN-γ by Mf carriers compared to amicrofilaraemic individuals has been reported (27). A 
decrease in IL-5 production with increasing age in both microfilaraemic and amicrofilaraemic groups 
(220), as well as lower T cell proliferation (92) has been observed in individuals living in filaria 
endemic areas. This indicates that the establishment of immunoregulatory processes by filarial 
worms is a slow and long lasting process. 
 IL-10 is a major cytokine mediating immunosuppression by filarial nematodes. Its main 
function is modulating immune responses to avoid damage to the host, as indicated by the fact that 
IL-10 deficient mice develop chronic enterocolitis by reacting against normal bacterial flora in the 
intestine (134). IL-10 impairs APC function, production of Th1 cytokines and T cell co-stimulation by 
macrophages and DCs (53, 57, 72). Engagement of the IL-10 receptor by IL-10 triggers an intracellular 
cascade following the JAK-STAT pathway, involving the Jak family tyrosin kinases Jak1 and Tyk2 (77)
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Figure 1.6: Immune responses against L. sigmodontis worms and their modulation. Mixed Th1 and 
Th2 responses are required to eliminate filarial worms. Adult worms are eliminated through 
encapsulation in nodules formed by macrophages (Mg), eosinophils (EP) and neutrophils (NP), in a 
process dependent on Th1 and Th2 cytokines. Microfilariae (Mf) are combated through adherence of 
activated macrophages and antibodies produced by B cells. However, adult worms induce IL-10 
production by alternatively activated macrophages (AAMq) and regulatory T cells (Treg). IL-10 is 
capable of modulating both Th1 and Th2 responses. Therefore, adult worms protect their offspring 
and themselves through IL-10-mediated suppression of harmful host immune responses. Adapted 
from (109). 
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and the transcription factor STAT3, but also some other factors like STAT1 and 5 whose exact 
function remains unknown (161, 176). As a result, transcription of IFN-induced genes like ICAM-1, IP-
10 or ISG54 is blocked (117). Also NF-κB activation is suppressed by IL-10 (270). However, though its 
main function is immunosuppressive (177), IL-10 has been shown able to stimulate proliferation and 
cytotoxic activity of CD8+ T cells (45, 82, 93, 121, 219, 290) and NK cells (114, 293).  
Filarial worms have taken advantage of the regulatory properties of IL-10, and stimulate its 
production in order to block immune onslaughts (151). Macrophages produce IL-10 in response to 
stimulation with filarial antigen, which in turn down-regulates their expression of co-stimulatory 
molecules CD80 and CD86 (28). Additionally, in vitro stimulated PBMCs from filarial-infected patients 
show an IL-10 mediated decrease in IFN-γ production (151), and IL-10 blockage restores proliferative 
capacity of lymphocytes (58, 126). IL-10 also skews Ig production by B cells to the IgG4 isotype, which 
does not bind complement and only binds weakly to Fc receptors, thus avoiding induction of 
inflammation (222).  
Another important cytokine mediating immunosuppression is TGF-β. This cytokine engages a 
cellular cascade of Smad family proteins through ligand-induced activation of specific kinases. Smad 
proteins 2, 3 and 4 form a complex in the cytoplasm that translocates to the cell nucleus and induces 
expression of target genes (260). The main regulatory function of TGF-β is exerted on T cells, 
inhibiting proliferation of naive lymphocytes but not of activated cells (251). The latter are however 
impaired in their differentiation into Th1 or Th2 (85) by TGF-β, as well as the cytotoxic activity of 
CD8+ T cells is inhibited (235).  
Filarial parasites induce the formation of regulatory T cells, which are capable of producing 
IL-10 and TGF-β (58), and suppressing proliferation of other T cells (221). At the molecular level, such 
suppression is mediated by CTLA-4, which is highly expressed in CD4+, CD8+ and CD4+CD25+ T cells of 
Mf+ individuals compared to Mf- (243). Immunoregulation is also mediated by alternatively activated 
macrophages, characterized by the expression of arginase. In contraposition to classically activated 
macrophages, which perform respiratory burst and present enhanced TNF-α production upon IFN-γ 
stimulation (84), differentiation to an alternative phenotype is driven by IL-4 and IL-13 adn these 
macrophages become potent suppressors of T cell proliferation (145). Further functions of 
alternatively activated macrophages are down-regulation of Th1 responses (103) and the production 
of arginase, a component necessary for wound repair (84). Classically and alternatively activated 
macrophages can be interconverted by their exposure to Th2 or Th1 cytokines respectively (87).    
Similarly to human parasites, the rodent filaria L. sigmodontis develops multiple strategies to 
hinder the attack of the host immune system. Apart from IL-10 induction (112, 252), regulatory T 
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cells mediate hyporesponsiveness to L. sigmodontis, and their depletion leads to a faster clearance of 
the infection (256). Differentiation of CD4+ T cells to a regulatory phenotype is induced by 
alternatively activated macrophages (255).  Moreover, conventional non-regulatory CD4+ T cells in 
the pleural cavity of L. sigmodontis infected mice present a strongly reduced proliferation capacity 
(254). 
 
1.5. CO-INFECTIONS OF HELMINTHS AND PLASMODIUM 
 
1.5.1. Co-infections in humans 
 
Discrepancies exist in the scientific community as to whether the final effect of nematode 
worms on malaria is beneficial or detrimental for the host. In terms of both epidemiological and 
scientific data very little is known about the the particular case of filarial nematode worms and 
Plasmodium co-infections scarce background can be found in the literature. In contrast, some field 
studies have analysed the co-infection of other nematode species and malaria. Intestinal worms 
present similar properties to filarial nematodes. For instance, Ascaris lumbricoides is able to induce 
immunomodulation (38), and hookworms (Ancylostoma duodenale or Necator americanus) have 
been shown to evoke combined Th1/Th2 responses (202). 
Several independent studies in different parts of the world have shown an association 
between intestinal nematode infections and higher malaria morbidity. More frequent malaria attacks 
(defined as body temperature higher than 38°C and a P. falciparum parasitaemia density higher than 
5000 parasites/µl blood) were observed in subjects of 1-14 years of age co-infected with intestinal 
worms and P. falciparum in Senegal (242). Studies on adults in Thailand also showed similar results 
(42, 170). In concordance with this, higher percentages of mixed P. falciparum and P. vivax infections 
could be associated to Ascaris infection (167), suggesting that nematode immunomodulation might 
impair anti-parasitic immune responses and increase susceptibility to the plasmodial infection. 
Moreover, increased P. falciparum densities in the blood were found in Cameroonian children aged 
0-14 carrying high loads of intestinal helminths (173). In addition to the co-infections with intestinal 
worms, Schistosoma mansoni infections have also been associated with increased malaria morbidity 
in Senegalese children (238). In this study, children presenting either high or low Schistosoma egg 
loads (defined as more than 400 or 1-100 eggs per gram stool respectively) presented increased 
malaria attacks compared to those which were Schistosoma-negative. However, no significant 
differences (indeed a trend for lower malaria incidence) were seen in children harbouring medium 
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worm loads (101 to 400 eggs per gram stool), and hence the interpretation of the results is 
complicated. Nevertheless, all these studies point to the same conclusion that a worm-mediated 
suppression impairs immune responses against malaria parasites increasing malaria morbidity. 
Druilhe et al. postulated that the production of the cytophilic antibodies IgG1 and IgG3, which are 
effective against blood stage malaria parasites (22), may have been shifted by the worms to the 
production of unprotective noncytophilic isotypes IgG2, IgG4 or IgM (23). Cytophilic antibodies are 
those whose constant regions (therefore unrelatedly to their antigen specificity) present affinity for 
receptors on certain cell types like macrophages or NPs, leading their engagement to the activation 
of cytotoxic and phagocytic effector functions in such cells. Unfortunately, no immunological 
parameters were measured in either of the co-infection studies to ascertain the immunological 
mechanism behind the observations.  
In contrast to these results, a study on S. haematobium-P. falciparum co-infections showed 
lower malaria parasite loads in children with low amounts of Schistosoma eggs (1-9 eggs per ml 
urine), reflecting again the importance of worm loads in the outcome of Schistosoma-malaria co-
infections (29). Moreover, in another study Madagascarean children over the age of 5 years were 
treated against Ascaris lumbricoides infection and presented an increase in P. falciparum densities in 
the blood. Surprisingly, this was not observed in younger children (30) or adults older than 15 years 
(31). Thus, age may also be an important factor in defining malaria outcome in co-infected patients.    
On the other hand, Nacher et al. have shown in studies on adult patients that a prior Ascaris 
infection results in protection from CM (166). The same group reported a decrease in the intensity of 
fever peaks after P. falciparum infection in patients co-infected with Necator americanus (169). 
Moreover, jaundice and acute renal failure, both related to liver inflammation, were ameliorated in 
helminth co-infected patients (168). All three studies, performed on adult patients, are consistent 
with an immunosuppressive effect of parasitic nematode worms on malaria, reducing pathology. 
Thus, despite the possible increase of malaria incidence caused by worm infections, suppression of 
immune responses could account for the prevention of immune-derived malaria pathology. In 
contraposition to this, a study on Senegalese children by Le Hesran et al. showed a higher prevalence 
of severe malaria cases in Ascaris co-infected patients (140). The main difference between both 
studies seems to be again the age of the participants (being adults in the Thai study, with a median 
age of 24 years, and children in the Senegalese one, with a median age of 6.6 years).  
Age has an important influence in the kind of response elicited against plasmodium or 
nematodes. Nematode infections are more prevalent in adults than children in endemic populations, 
which is interpreted as the long time required for worm infections to fully establish immune 
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suppression (68). Therefore, only responses to Plasmodium in adults, with a long history of worm 
exposure, are likely to be modulated by the latter.  
Children living in endemic areas develop CM after several contacts with the parasite and the 
development of a strong pro-inflammatory response. Accumulation of inflammatory mediators after 
repeated infections triggers cerebral pathology. In a region of moderate transmission like Gambia, 
the median age of children developing CM is 3-4 years (105). CM in children is associated with strong 
IFN-γ production by T cells (205). In a context where suppressive mechanisms against the worms 
have still not been fully established, combined Th1/Th2 responses against the worms, and absence of 
regulation by IL-10 or TGF-β, may constitute an extra source of Th1 cytokines accelerating CM 
development. Supporting this explanation, a study by Diallo et al. on the co-infection of Schistosoma 
haematobium and P. falciparum showed co-infected children expressing more IFN-γ than P. 
falciparum single infected (56). Additionally, immunity to malaria pathology is gradually achieved in 
older children by the generation of a repertoire of antibodies against the parasites inhibiting 
cytoadherence (171, 206), erythrocyte invasion (94) or inducing phagocytosis by macrophages (180). 
An alteration in the antibody production inducing non-protective antimalarial antibody isotypes 
might delay the apparition of immunity in co-infected children. In adults, however, 
immunoregulatory mechanisms driven by the worms may modulate the production of Th1 cytokines 
resulting in lower CM rates. In the study by Diallo et al. co-infected adults presented higher levels of 
IL-10 and TGF-β, and higher ratios of IL-10/TNF-α than single infected patients. Interestingly, IFN-γ 
levels were not decreased in co-infected adults, but remained higher than those of P. falciparum 
single infected individuals. Moreover, parasitaemia in co-infected children and adult patients was not 
significantly higher than in single infected subjects (56), indicating that specific independent 
mechanisms are elicited during malaria, being not all of them equally susceptible to alteration by the 
worms. 
Finally, another study in Uganda from a population living in an area with unstable malaria 
transmission worms were neither related to higher malaria susceptibility nor to stronger pathology 
(230), showing that undefined parameters in particular regions may add variability to the malaria 
outcome during co-infection. 
 
1.5.2. Murine models for filarial-plasmodial co-infection 
 
Several animal studies on the occurrence of concurrent malaria and filariasis can be found in 
the literature giving controversial results, which somehow reflect those from human studies. A 
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detrimental outcome was observed after non-lethal P. chabaudi co-infection of C57BL/6 mice 
previously infected with the intestinal nematode Heligmosomoides polygyrus. Co-infected mice 
developed higher parasitaemia and suffered higher mortality than their single infected counterparts. 
They presented lower IFN-γ and the cytophilic Th1-type immunoglobulin IgG2a, protective against 
malaria parasites, but higher IL-10 and TGF-β levels (248). Moreover, in the same co-infection setting 
immune-modulation by the worms decreased the efficiency of a blood-stage vaccine P. chabaudi 
antigen (249). Co-infection with another intestinal worm, Echinostoma caproni, and P. yoelii also 
resulted in higher parasitaemia and death rates in the co-infected group of mice (174). Moreover, 
impairment of anti-plasmodial immunity by the worm could be noticed at the liver stage of malaria in 
the same co-infection setting, as reflected by the higher susceptibility to sporozoite infection in co-
infected mice (175). In a different model, co-infection with Schistosoma mansoni and P. berghei 
ANKA in C57BL/6 mice resulted in higher plasmodial parasitaemia. In this case circulating TNF-α, but 
not IFN-γ, was decreased in co-infected mice (102). Interestingly, this resembles the results obtained 
by Diallo et al. on S. haematobium-P. falciparum co-infection in Senegal, in which immune 
suppression in adults was not exerted on IFN-γ but on TNF-α levels (56). Furthermore, all these data 
resemble those from human studies in which higher risk of P. falciparum infection and malaria 
attacks were found in co-infected individuals (42, 167, 170, 242), and support the assumption that 
suppression of anti-plasmodial Th1 responses by the worms impair parasite control. On the other 
hand, consistently with the regulatory effect of worms on pathology development during subsequent 
plasmodial infections reported by Nacher et al. (166), CM was prevented in susceptible CBA/J mice 
by previous injection of Brugia pahangi L3 larvae. In this co-infection setting filarial infection induced 
high IL-4, IL-5 and IFN-γ, but downregulating cytokines like IL-10 or TGF-β were not measured (288).  
Additionally, a study on co-infection of BALB/c mice with the non-lethal P. chabaudi and L. 
sigmodontis showed an important role of microfilaraemia defining malaria outcome. Consistent with 
the lack of detectable immunomodulation in amicrofilaraemic mice, these mice lost more weight and 
suffered more severe anaemia than their Mf+ counterparts (86). Interestingly, parasitaemia levels in 
Mf+ mice, (which suffered higher immunoregulation and consequently presented lower IFN-γ and IL-
4 production by splenocytes during co-infection), were lower than those of Mf- mice, contradicting 
the assumption exposed above that immunoregulation is related to higher plasmodial parasitaemia. 
This is indeed in accordance with the observation that co-infected adult human patients do not 
present higher parasitaemia than P. falciparum single infected. Different unknown mechanisms may 
be elicited by filarial infections altering the natural means of control of blood parasites, giving a new 
perspective on the effects that the worm co-infection may have on malaria. 
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1.6.  AIMS OF THE STUDY 
 
Parasitical nematodes persist during an unusually long lifespan inside the infected host due 
to their capacity of inducing immunomodulation. Mechanisms involved in immunosuppression may 
however influence responses against concomitant plasmodial infections. Current literature does not 
provide a uniform answer on whether worm infections are beneficial or detrimental against malaria, 
leaving this question still under debate. Differences in several parameters such as the involved worm 
species, host age and environmental conditions between field studies may contribute to this 
heterogeneity, and specific analyses are therefore required to dissect the relationships between both 
kinds of parasites residing in the same host. 
In order to contribute with experimental data to a better understanding of the mechanisms 
occurring during co-infection of filarial nematode worms and malaria, a murine model using the 
filarial worm L. sigmodontis and P. berghei ANKA has been established and analysed in the present 
work. The use of laboratory mice allows detailed studies of immune responses under well controlled 
conditions. Taking advantage of their different susceptibilities to the parasites, BALB/c and C57BL/6 
mice were used to resemble the stages of the life cycles and a wide range of the manifestations that 
filarial and plasmodial infections present in humans. 
The present study aimed at: 
1. Assessing the effect of a L. sigmodontis infection to the susceptibility of a P. berghei 
sporozoite infection in BALB/c mice.  
a. Does worm-derived immunoregulation alter susceptibility to sporozoite infection?  
b. Does patency of filariae influence anti-plasmodial immunity? 
 
2. Monitoring the effect of a L. sigmodontis infection on the susceptibility to blood stages of P. 
berghei in BALB/c mice.  
a. Does worm-derived immunoregulation impair control of plasmodial blood stages? 
b. Is the development of severe anaemia pathology altered by filarial infection? 
 
3. Estimating the effect of a L. sigmodontis infection on the development of CM in C57BL/6 
mice. 
a. Does worm-derived immunoregulation impair control of plasmodial blood stages? 
b. Given the immunological aetiology of CM, can worm-mediated immunomodulation 
reduce this pathology? 
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2. Materials and methods 
 
2.1.  MATERIALS 
 
2.1.1. Animals 
 
Sigmodon hispidus rats, Ornithonyssus bacoti mites, Anopheles stephensi mosquitoes and the 
different mice strains used, listed in the following table, were bred at the animal facilities of the 
Institute for Medical Microbiology, Immunology and Parasitology in Bonn.   
 
BALB/c background C57BL/6 background 
Wild type Wild type 
IL-10 KO IL-10 KO 
μMT  
 
 
2.1.2. Buffers and solutions 
 
• Anesthetic  
 
Components Concentration Company 
Rompun 
Kylazinhydrochloryde 
Methyl-4-hydroxybenzoate 
 
23.32 mg/ml 
1.5 mg/ml 
Bayer, Leverkusen, Germany 
Ketanest 
Esketaminhydrochloryde 
 
25 mg/ml 
Pfizer Pharma GmbH, Karlsruhe, 
Germany 
Preparation: 40 μl Rompun + 10 μl Ketanest per mouse (intramuscular injection). 
Storage:  4°C 
 
• Cell depletions 
 
Components Concentration Company 
Anti-Mouse CD4 monoclonal 
antibody 
1 mg/ml BIOZOL Diagnostica Vertrieb 
GmbH, Eching, Germany 
Anti-Mouse CD8a monoclonal 
antibody 
1 mg/ml BIOZOL Diagnostica Vertrieb 
GmbH, Eching, Germany 
Clodronate liposomes 250 mg/ml See below 
Preparation: see below 
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• ELISA 
 
Components Concentration Company 
Coating buffer 
NaH2PO4 
 
0.1 M 
MERCK KGaA, Darmstadt, 
Germany 
Washing buffer 
PBS 
Tween 
 
x1 
0.05% 
 
MERCK KGaA, Darmstadt, 
Germany 
Blocking buffer 
PBS 
BSA 
 
x1 
1% 
 
SIGMA-ALDRICH CHEMIE 
GmbH, Munich, Germany 
Enzyme solution 
PBS 
Streptavidin 
 
x1 
 
 
 
Roche, Mannheim, Germany 
Substrate buffer (pH=5.5) 
NaH2PO4 
 
0.1 M 
MERCK KGaA, Darmstadt, 
Germany 
Substrate (diluted in DMSO) 
3,3‘,5,5’Tetramethylenbenzidine 
(TMB) 
 
6 mg/ml 
 
Roth, Karlsruhe, Germany 
Developer 
Substrate buffer 
TMB 
H2O2 
 
10 ml 
200 μl 
2 μl (30%) 
 
Stopper 
H2SO4 
 
2 N 
MERCK KGaA, Darmstadt, 
Germany 
 
 
• ELISA antibodies 
 
Components Concentration Dilution Company 
IL-10 
Coating 
Detection 
 
1 mg/ml 
0.5 mg/ml 
 
1:500 
1:500 
 
BD Pharmingen, Heidelberg, 
Germany 
IFN-γ 
Coating 
Detection 
 
1 mg/ml 
0.5 mg/ml 
 
1:250 
1:500 
 
BD Pharmingen, Heidelberg, 
Germany 
IgG1 
Coating 
Detection 
 
0.5 mg/ml 
0.5 mg/ml 
 
1:500 
1:500 
 
BD Pharmingen, Heidelberg, 
Germany 
IgG2a 
Coating 
Detection 
 
0.5 mg/ml 
0.5 mg/ml 
 
1:500 
1:500 
 
BD Pharmingen, Heidelberg, 
Germany 
TGF-β 
Coating 
Detection 
 
0.5 mg/ml 
0.5 mg/ml 
 
1:250 
1:500 
 
BD Pharmingen, Heidelberg, 
Germany 
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• Flow cytometry antibodies 
 
Specificity Fluorescence Concentration Dilution Company 
CD3 PerCP Cy5.5 0.2 mg/ml 1:100 BD Pharmingen 
CD4 FITC 0.1 mg/ml 1:400 Caltag/Invitrogen 
CD8 PE 0.1 mg/ml 1:400 Caltag/Invitrogen 
CD25 APC 0.2 mg/ml 1:400 BD Pharmingen 
CD19 FITC 0.1 mg/ml 1:400 Caltag/Invitrogen 
F4/80 APC 0.2 mg/ml 1:400 Caltag/Invitrogen 
Gr1 PE 0.1 mg/ml 1:400 Caltag/Invitrogen 
DX5 PE 0.2 mg/ml 1:400 BD Pharmingen 
NK1.1 PE 0.2 mg/ml 1:400 BD Pharmingen 
Γδ PE 0.2 mg/ml 1:200 BD Pharmingen 
 
• Freezing solution 
 
Components Concentration Company 
NaCl 0.72% SIGMA-ALDRICH CHEMIE 
GmbH, Munich, Germany 
Sorbitol 3.36% SIGMA-ALDRICH CHEMIE 
GmbH, Munich, Germany 
Glycerine 28% MERCK KGaA, Darmstadt, 
Germany 
Dilution: ddH2O 
Preparation: solve 0.9 g NaCl and 4.2 g sorbitol in 90 ml ddH20. Add 35 ml glycerine. 
Storage: -20°C 
 
• Giemsa 
 
Components Concentration Company 
Giemsa’s azur eosin blue 
solution 
- MERCK KGaA, Darmstadt, Germany 
Buffer tablets pH 7.2 
Na2HPO4x2H2O 
KH2PO4 
 
0.63 g/l 
0.31 g/l 
MERCK KGaA, Darmstadt, Germany 
Dilution (Buffer): ddH2O 
Preparation: One tablet was diluted per liter ddH2O. 20ml buffer were mixed with 1ml 
Giemsa’s azur eosin blue solution. 
Storage: 4°C (buffer), RT (Giemsa’s azur eosin blue solution). Giemsa solution was used fresh. 
 
• Hinkelmann solution 
 
Components Concentration Company 
Eosin 0.5% (w/v) MERCK KGaA, Darmstadt, Germany 
Phenol 0.5% (w/v) MERCK KGaA, Darmstadt, Germany 
Formaldehyde 0.185% (w/v) MERCK KGaA, Darmstadt, Germany 
Dilution: ddH2O 
Storage: 4°C 
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• Paraformaldehyde solution 
 
Components Concentration Company 
Paraformaldehyde 4% MERCK KGaA, Darmstadt, 
Germany 
Dilution: 1xPBS 
Preparation: diluted at 56°C. 
Storage: RT (fixed worms). Paraformaldehyde solution for fixing cells was used fresh.  
 
• Phenylhydrazine solution  
 
Components Concentration Company 
Phenylhydrazine 1.2 mg/ml  SIGMA-ALDRICH CHEMIE GmbH, 
Munich, Germany 
Dilution: 1xPBS 
Storage: -20°C 
 
• (20x) Phosphate buffered saline (PBS)  
 
Components Concentration Company 
NaCl 160 g/l SIGMA-ALDRICH CHEMIE GmbH, 
Munich, Germany 
Na2HPO4·2H2O 23.6 g/l MERCK KGaA, Darmstadt, 
Germany 
KH2PO4 4 g/l MERCK KGaA, Darmstadt, 
Germany 
KCl 4 g/l MERCK KGaA, Darmstadt, 
Germany 
Dilution: ddH2O 
Preparation: All components were diluted in H2O and pH adjusted to 7.0; pH in 1xPBS was 
adjusted to 7.2.  
Storage: RT 
 
• Polymerase chain reaction reagents 
 
Components Company 
Omniscript RT Kit Qiagen, Hilden, Germany 
Oligo-d(T) primer Invitrogen, Karlsruhe, Germany 
DNAse I Ambion, Hamburg, Germany 
DNAse inactivator Ambion, Hamburg, Germany 
RNAse inhibitor Peqlab Biotechnologie GmbH, Erlangen, Germany 
HotStar Taq polymerase Qiagen, Hilden, Germany 
SYBR Green  Roche, Mannheim, Germany 
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• RNA extraction 
 
Components Company 
TRIzol reagent Invitrogen, Karlsruhe, Germany 
1-Bromo-3-chloropropan SIGMA-ALDRICH CHEMIE GmbH, Munich, Germany 
Isopropanol MERCK KGaA, Darmstadt, Germany 
Ethanol MERCK KGaA, Darmstadt, Germany 
 
• Supplemented RPMI Medium 
 
Components Concentration Company 
RPMI 1640  PAA laboratories, Pasching, 
Austria 
Foetal calf serum (FCS) 10% PAA laboratories, Pasching, 
Austria 
L-Glutamine 2 mM PAA laboratories, Pasching, 
Austria 
Gentamicin sulphate 50 μl/ml Cumbrex Bio Science, Walkerville, 
MD, USA 
Preparation: 500ml RPMI medium were supplemented with 50ml FCS inactivated at 56°C for 
30’, 5 ml 200mM L-Glutamine and 500 μl 50 mg/ml gentamicin sulphate 
Storage: -20°C (FCS, L-Glutamine), 4°C (RPMI 1640, gentamicin sulphate) 
 
• Tris-Ammonium chloride 
 
Components Concentration Company 
NH4Cl 0.1 M MERCK KGaA, Darmstadt, 
Germany 
C4H11NO3 (Tris) 0.17 M Roth, Karlsruhe, Germany 
Dilution: ddH2O 
Preparation: 100 ml Tris solution were prepared and pH adjusted to 6.65; and then 900 ml 
NH4Cl. Both solutions were mixed and pH adjusted to 7.2. 
Storage: 4°C  
 
• Other solutions or products 
 
Components Company 
Isofluoran Abbott GmbH, Wiesbaden, Germany 
Methanol MERCK KGaA, Darmstadt, Germany 
Diethyl ether MERCK KGaA, Darmstadt, Germany 
Drabkins solution SIGMA-ALDRICH CHEMIE GmbH, Munich, Germany 
Lyophilized bovine haemoglobin SIGMA-ALDRICH CHEMIE GmbH, Munich, Germany 
Lymphocyte Separation Medium 1077 PAA Laboratories GmbH, Parsching, Austria 
Percoll SIGMA-ALDRICH CHEMIE GmbH, Munich, Germany 
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2.1.3. Consumables 
 
Components Company 
1.5 ml-test tubes Eppendorf, Hamburg, Germany 
2 ml-test tubes Eppendorf, Hamburg, Germany 
EDTA-coated tubes KABE Labortechnik GmbH, Nümbrecht-Elsenroth, Germany 
15 ml-Falcon tubes, sterile Greiner bio-one, Frickenhausen, Germany 
50 ml-Falcon tubes, sterile Greiner bio-one, Frickenhausen, Germany 
Cryotube vials Nunc, Roskilde, Denmark 
Micro-haematocrit tubes Brand GmbH, Wertheim, Germany 
Neubauer cell-count chamber Brand GmbH, Wertheim, Germany 
Microscope slides Engelbrecht, Germany 
Glass Pasteur pipettes Brand GmbH, Wertheim, Germany 
50ml-syringes B. Braun Melsungen, Melsungen, Germany  
Butterflies B. Braun Melsungen, Melsungen, Germany 
S-Monovette blood collection 
system 10ml 
Sarstedt, Nümbrecht, Gremany 
Steel beads (tissue 
homogenization) 
PeqLab, Erlangen, Germany 
3ml graduated Pasteur 
Pipettes unsterile 
Copan, Brescia, Italy 
 
2.1.4. Equipment  
 
Device Name 
Spectra-photometer Plate 
reader 
Spectra MAX 340PC, MTX lab systems, Virginia, USA 
Flow Cytometer FACS Canto, BD biosciences, Heidelberg, Gremany 
Cell counter CASY model DT, Innovatis, Reutlingen, Germany 
Centrifuge (cell extractions) Heraeus Multifuge 4 KR, Kendro Laboratory Products GmbH, 
Hanau, Germany 
Bead grinder Precellys 24, PeqLab, Erlangen, Germany 
RNA measurement Eppendorf biophotometer, Eppendorf 
Thermal cycler (PCR) Primus, MWG biotech, Ebersberg, Germany 
Thermal cycler (Real time-PCR) RG-3000, Corbett Research, Sydney, Australia 
Block Thermostat HLC HBT-1 131, Progen Scientific Ltd, Mexborough, England 
Centrifuge (RNA extraction) Universal 32 R, Hettich Zentrifugen, Tuttlingen, Germany 
 
2.1.5. Computer software 
 
Action Program 
Data processing Excel 2007 
Statistical analyses Graph Pad Prism 4.0 
FACS FACS Diva 
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2.2.  METHODS 
 
2.2.1. Animal cycles and infections 
 
2.2.1.1. Maintenance of Anopheles stephensi mosquitoes 
 
BALB/c mice were infected with sporozoites extracted from the salivary glands of 
mosquitoes. Anopheles stephensi mosquitoes were bred at the mosquito facility at IMMIP, Bonn, at 
28ºC and 80% air humidity. Solutions of 10% fructose in water were used for their daily feeding. 25 
ml were placed in a 50-ml Erlenmeyer flask, and a scrolled paper was inserted in it to allow the 
mosquitoes to suck the solution. Sugar solutions were renewed every 2-3 days to avoid microbial 
contamination. Every mosquito cage was provided with a water glass to maintain air humidity. 
Mosquito blood feeding for egg production was done by exposure to mice. 3 Naive NMRI 
mice were anesthetized (see anestheticum description above), and their ventral fur was shaved prior 
to exposure to hungered mosquitoes (sugar solution removed 24 hours before). Mice were laid on 
the mosquito cage for 20 minutes, allowing all the mosquitoes to feed. 2 days after the bloodmeal 
mosquitoes layed eggs on a water glass, which were then transferred to water cages. After another 2 
days, larvae hatched out and were fed with pulverized commercial fish food. 10 to 14 days after the 
mosquito bloodmeal, emerging pupae were fished out and introduced in a new mosquito cage. 
Mosquitoes came out after 2 days. Blood feeding of new mosquitoes for a new cycle or for infection 
was done one week after the last addition of pupae to the cage.  
2.2.1.2. P. berghei infection of mosquitoes 
 
Frozen stock containing 8x107 iRBCs/ml was injected intraperitoneally (i.p.) into 2 naive NMRI 
mice. 4 days before the planned bloodmeal for the mosquitoes, 3 new naive NMRI mice were 
injected i.p. with 200 µg phenylhydrazine (10 µg per gram of body weight) to enhance their 
erythropoiesis. 2 days before mosquito bloodmeal, the mouse with the highest parasitaemia in the 
first group was bled from the retro-orbital vein, and blood was injected intraperitoneally to the 
phenylhydrazine-injected mice. 40-48 hours later, parasitaemia was measured and the presence of 
P.berghei gametocytes in blood assessed. Mice were anesthetized, shaved and exposed to hungered 
mosquitoes as described in the previous section. Immediately after feeding mosquitoes were 
transferred to an incubator at 21°C and 80% air humidity, optimal for plasmodial development. 5 
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Figure 2.1: Parasite cycles and experimental design. (A) Laboratory cycle of L. sigmodontis. (B) Laboratory cycle of P. berghei. (C) Design of co-infection 
experiments. See text for detailed descriptions. 
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days after blood feeding mosquitoes were fed again with blood from naive mice following the 
standard protocol to boost parasite development. 10 days after infection 4-5 mosquitoes were 
anesthetized with diethyl ether and dissected to test the presence of oocysts in their gut, in order to 
evaluate the quality of the infection. From day 20 after infection mosquitoes were dissected for 
sporozoite recovery from salivary glands (Fig. 2.1, B). 
2.2.1.3. Preparation of P. berghei stock 
Mosquitoes were infected following the standard protocol (see above). Sporozoites were 
extracted from their salivary glands 20 days after infection. At least 20000 sporozoites per mouse 
were injected intravenously in NMRI mice. After 10 days, parasitaemia was assessed. Mice were bled 
from the retro-orbital vein and the blood diluted with PBS to a concentration of 1.6x108 parasites/ml. 
250 μl blood were quickly mixed with 250 μl of freezing solution (see materials) in cryotube vials and 
frozen immediately in liquid nitrogen. Stock tubes were further stored in liquid nitrogen. 
2.2.1.4. Litomosoides sigmodontis lab cycle 
 
Ornithonyssus bacoti mites were maintained by allowing feeding on young mice replaced 
each 2-3 days. The natural host of L. sigmodontis is the cotton rat (Sigmodon hispidus), which can 
bear high Mf (L1 larvae) levels in blood. Ornithonyssus bacoti mites were infected through a blood 
meal on an infected rat, and placed in incubators at 25ºC and 80% air humidity for 14 days. 10 days 
later some mites were dissected to assess infection quality. After 14 days mice were anesthetized 
and exposed to the infected mites, which transmit L3 larvae through the bloodmeal (Fig. 2.1, A).       
2.2.1.5. P.berghei ANKA infections 
 
P. berghei ANKA co-infections, either with sporozoites or iRBCs, were done 60 days after L. 
sigmodontis infection (Fig. 2.1, C). 
 
Sporozoite infection 
30 mosquitoes were anesthetized with diethyl ether and dissected. Salivary glands were 
collected in a 1.5 ml Eppendorf tube on ice containing 100 μl PBS. Salivary glands were homogenized 
with a plastic mortar to release sporozoites. After assessing their concentration using a Neubauer 
chamber, sporozoites were diluted to a concentration of 500 per 200 μl PBS per mouse, and injected 
intravenously in the lateral tail-vein.   
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iRBC infection 
Frozen stock containing 8x107 iRBCs/ml in freezing solution was injected i.p. into 2 naive 
C57BL/6 mice 5 days before the beginning of the experiment. After assessing their parasitaemia and 
erythrocyte concentration in blood, a new blood sample was taken from the same mouse and diluted 
with PBS to the desired concentration of iRBCs for the infection. 200 μl of the iRBC solution were 
injected per mouse via the tail vein. Mice were pre-warmed under red light in order to facilitate 
injections. 
 
2.2.2. Animal manipulations 
 
2.2.2.1. Mouse perfusion 
A mouse was anesthetized by intramuscular injection (see above). The mouse’s snout was 
placed within a 15ml-Falcon tube that contained a piece of paper soaked in isofluoran until death. 
Immediately after respiratory arrest, the thoracic cavity was open and a butterfly connected to a 
50ml-syringe filled with PBS was put in the left ventricle of the mouse. A cut was applied in the 
mouse’s right auricle. Blood was collected from the pleural cavity with a monovette syringe. 10ml 
PBS were carefully flushed into the mouse’s heart until proper complete perfusion of the liver, noted 
by colour fading from red to brown. 
2.2.2.2. Macrophage depletion  
Macrophages were depleted in L. sigmodontis co-infected mice by daily intravenous and 
intrapleural injections of 200 µl chlodronate liposomes at 250 mg/ml for 4 consecutive days. 
Chlodronate liposomes were provided by Nico van Rooijen (Vrije Universiteit, Amsterdam, 
Netherlands).  
2.2.2.3. CD4+ and CD8+ depletion 
Depletions were done one day before P. berghei infection using 100 μg anti-CD4+ or 50 μg 
anti-CD8+ antibodies injected intravenously in 200 μl PBS. Such amounts of antibodies had been 
shown by flow cytometry to completely eliminate the respective cell types for 7 days (data not 
shown).   
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2.2.3. Laboratory methods 
 
2.2.3.1. Assessment of body weight and splenomegaly 
 
Mice were daily weighed using a top-pan electronic balance. For splenomegaly assessment, 
the spleens were removed and placed in a tube with 10 ml RPMI medium, which was weighted 
before and after placing the spleen in it. 
2.2.3.2. Haematocrit  
 
10 μl tail blood was diluted in 200 μl Drabkins solution and pipetted in standard 96-well Flat-
bottom plates. Lyophilized bovine haemoglobin was solved in Drabkins solution at 300 mg/ml and 
serially diluted to obtain a standard curve. Plates were incubated for 15 minutes at RT, and 
afterwards absorbance was measured at 570 nm. 
2.2.3.3. Serum separation 
For measurement of levels of circulating cytokines or immunoglobulins mice were bled every 
two days from tail vein. 50-60 μl blood were collected per mouse with micro-haematocrit tubes and 
stored in EDTA-coated tubes. After centrifugation at 8000 rpm for 5 min, supernatants were pipetted 
to new test tubes and stored at -20°C.    
2.2.3.4. Giemsa staining and assessment of parasitaemia 
Blood smears were dried and fixed with methanol for 5 minutes. Giemsa solution was 
prepared with 1 ml of Giemsa’s azur eosin blue solution diluted in 20 ml of pH 7.2 buffer. Blood 
smears were soaked in giemsa solution for 12 to 15 minutes, washed with tap water and let dry 
before examination. 
Samples were observed under the microscope using a 100x immersion objective. 3 fields 
were counted, containing at least 300 erythrocytes in total. In cases of low erythrocyte numbers due 
to high parasitaemia additional fields were counted until reaching 300 erythrocytes per slide. 
2.2.3.5. Microfilaraemia 
50 μl blood were extracted from the tail vein of L. sigmodontis infected mice one day before 
sporozoite co-infection and added to 300 μl of Hinkelmann solution in a 0.5 ml test tube. After 
vortexing, tubes were kept at room temperature for 1 hour. Afterwards, they were centrifuged at 
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1800 rpm for 5 minutes. Supernatants were discarded with a glass Pasteur pipette, leaving 20-30 µl 
on the pellet. Pellets were resuspended in that volume, pipetted on a glass slide and covered with a 
cover-glass. Mf through the whole preparation were counted under the microscope (20x objective).  
2.2.3.6. Cell extraction 
 
Spleen 
Spleens were aseptically removed, weighed for splenomegaly assessment and homogenized 
through a metallic strainer in 10 ml of supplemented RPMI 1640. After centrifugation, pellets were 
resuspended in 10ml of cold Tris-ammonium chloride solution, incubated 10 min at RT and washed 
twice with PBS. Membrane debris was removed after the second wash by filtration through a nylon 
net. Finally, cells were resuspended in supplemented 10ml RPMI medium and kept at 4°C until 
further use. 
Pleura: cell and worm extraction 
Pleural cavity of the mice was flushed with 10 ml PBS with a plastic Pasteur pipette to collect 
cells and worms. The first ml pleural wash was pipetted to a 2 ml test tube, and further 9 ml were 
pipetted in a 15 ml tube. Cells in the 2 ml test tube were removed by centrifugation and supernatant 
stored for cytokine measurements. Pellet was resuspended in 1 ml PBS and pooled with the 
remaining 9 ml pleural wash. Worms were allowed to sediment, separated from the supernatant 
containing pleural cells and fixed in paraformaldehyde solution. Cells were then filtered through a 
nylon-screen, centrifuged, resuspended in 2 ml supplemented RPMI medium and counted.   
Liver 
After aseptic removal and homogenization in supplemented RMPI 1640 medium, cell 
suspensions were carefully pipetted over 5 ml of Lymphocyte Separation Medium 1077 and 
centrifuged for 20 minutes at 2000 rpm and 4°C without break. Cells in the interphase between LSM 
and RPMI medium were transferred to a new tube and washed twice with PBS. Cells were then 
resuspended in 2 ml supplemented RPMI medium and kept at 4°C until further use.  
Brain 
Brains were extracted to 15 ml tubes containing supplemented RPMI medium and 
homogenized to single-cell suspensions through a metallic strainer. After centrifugation supernatant 
was discarded and 5 ml 35% Percoll added. Tubes were centrifuged for 20 minutes at 1200 rpm and 
4°C without break to allow the lymphocytes to sediment. Supernatant was then discarded and cells 
washed twice before further preparation for FACS analyses.   
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2.2.3.7. Flow cytometry 
250 μl cells were pipetted in a 96-well U-bottom cell culture plate and centrifuged. After 
discarding supernatants, Fc receptors were blocked by incubation at 4°C for 10 minutes with rat IgG2 
antibodies diluted 1:100 in 50 μl PBS. Plates were centrifuged, supernatants discarded and cells 
marked with the corresponding antibody dilution in a total volume of 50 μl, by incubating at 4°C for 
15 min. Non-binding antibodies were removed by two wash steps with PBS and cells were fixed in 4% 
paraformaldehyde and measured with a BD FACS Canto. 
2.2.3.8. Enzyme linked immunosorbent assay 
Concentrations of IL-10, IFN-γ were determined by specific two-site enzyme-linked 
immunosorbent assay (ELISA) using standard protocols: coating antibody was diluted in coating 
buffer and incubated on ELISA plates overnight at 4°C. After washing with wash buffer, plates were 
treated with blocking buffer for 1 hour at RT. Samples and standards were pipetted into 
corresponding wells and incubated overnight at 4°C. After 3 wash steps the biotinylated antibody 
was added and incubated for 1 h at RT. After addition of the streptavidin solution for 1 h and 5 wash 
steps, the developing solution containing TMB substrate was applied. Colouring reaction was 
stopped with sulphuric acid and absorbance measured with a spectra-photometer (λ1- λ2, being 
λ1=450nm, λ2=630nm).  
Dilutions: pleura wash samples were used undiluted. Serum samples were diluted 1:10 in 
PBS/BSA for cytokine measurements. For IgG1 and IgG2a measurements samples were diluted 
1:500000 and 1:100000 respectively.  
TGF-β ELISA 
At the blocking step of the standard ELISA protocol an additional ELISA plate was used to 
perform HCl-activation of TGF-β: Standards and samples were pipetted to the additional plate and 
HCl was added to reach a concentration of 0.02 N per well. After 15 min incubation at RT, NaOH was 
added to a final concentration of 0.02 N. Standards and samples were then transferred from this 
plate to the standard one, already coated and blocked, and processed normally as described above.   
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2.2.3.9. Assessment of RNA expression in brain 
 
Extraction of brain RNA 
Brain samples were frozen in liquid nitrogen and stored at -80 °C until RNA-isolation. RNA 
was homogenized in 1 ml TRIzol Reagent using a Precellys 24 grinder. After 5 min incubation at room 
temperature to permit the complete dissociation of nucleoprotein complexes, the homogenate was 
supplemented with 0.1 ml 1-bromo-3-chloropropane. Samples were then shaken vigorously for 1 
min. The resulting mixture was incubated at RT for 10 min and centrifuged at 12000 g for 20 min at 
4°C. Following centrifugation, the colourless upper aqueous phase containing RNA was transferred to 
a fresh tube. 500 μl Trizol-Reagent and 100 μl 1-Bromo-3-chloropropan were added, and samples 
shaken for 1 min again and centrifuged at 12000 g for 15 min at 4°C. RNA was precipitated by mixing 
supernatant with 0.8 ml isopropanol in a new tube. Samples were stored for 1 hour at –20°C and 
centrifuged at 12000 g for 15 min at 4°C. RNA pellet was washed twice with 1 ml of 75% ethanol, 
centrifuging at 12000 g for 10 min at 4°C. Ethanol was removed and the pellet dried at 37°C for 3-5 
min. Then, the RNA was dissolved in 300 μl DEPC-water. To remove genomic DNA, 5 μl 10x buffer 
and 1 μl DNAseI were added and incubated for 30 min at 37°C. Quality of extracted RNA was assured 
by spectrophotometric determination at 260 nm. 
Transcription to cDNA 
1 μg of total RNA was reverse transcribed with an Omniscript RT Kit according to the 
manufacturer’s instructions with oligo-d(T) primer, binding to the poly-A tail of mRNA. Reagents 
listed below were combined and vortexed for 5 sec. Template RNA was added and again vortexed for 
5 sec. This was followed by 60 min incubation at 37°C to reverse transcribe the template RNA into 
cDNA. The cDNA was then stored at –20°C for further analysis. 
Components Volume Final concentration 
x10 buffer 2 µl 1x 
dNTP mix 2 µl 0.5 mM (each dNTP) 
Oligo-dT primer (10 µM) 2 µl 1 µM 
RNAse inhibitor (10 units/µl) 1 µl 10 units 
Omniscript reverse transcriptase 1 µl 4 units 
RNAse free water variable  
RNA variable  
Total reaction volumen: 20 μl 
Materials and Methods 
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Real-time PCR 
Real Time PCR reactions were performed in a 20 μl reaction volume containing the 
components listed below. 
Components β-actin ICAM-1 
Water 10.8 10.8 
x10 buffer 2 2 
MgCl2(25 mM) 2.4 0.8 
Forward primer (5 μM) 1.2 1.2 
Reverse primer (5 μM) 1.2 1.2 
dNTP mix (40 mM) 0.1 0.1 
SYBR Green (1:1000) 0.2 0.2 
Hotstar Taq polymerase (250 
U/µl) 
0.1 0.1 
DNA 2 2 
Total reaction volumen: 20 μl (numbers denote μl of the specific component per sample) 
Reaction conditions in the light cycler were 15 min at 95°C followed by 45 cycles of 15 s at 
94°C, 20 s at 58°C and 20 s at 72°C. Temperature change rates were 20°C/s. Copy numbers were 
normalized to expression of ß-actin in each sample. 
Primers 
 
Gen Forward Reverse 
β-actin 5’- AGA GGG AAA TCG TGC GTG AC- 3’ 5’ – CAA TAG TGA TGA CCT GGC CGT- 3’ 
ICAM-1 5’- CCG CAG GTC CAA TTC ACA CT - 3’ 5’ – TCC AGC CGA GGA CCA TAC AG - 3’ 
 
2.2.4. Statistics 
 
A Kolmogorov-Smirnov test for normality was done in order to check data distribution and 
choose the appropriate test for the statistical analyses.  
Parametrically distributed data was analyzed with unpaired T test (2 groups) or one-way 
ANOVA (more than 2 groups) and Tukey´s multiple comparisons test to check differences between 
single groups. Parametric data were represented as mean ± SD.   
Non-parametrically distributed data were analyzed using Mann-Whitney test (2 groups) or 
Kruskal-Wallis test (more than 2 groups), plus Dunn´s multiple comparisons test to check differences 
between single groups. Non parametric data were represented as median & range.   
  - 51 - 
  - 52 - 
3. Results 
 
3.1. BALB/C MICE 
 
3.1.1. Malaria outcomes in co-infected BALB/c mice  
 
3.1.1.1. 500 sporozoites render naive BALB/c mice malaria-positive 
 
 
In order to resemble natural plasmodial infections, which are known to require very few 
sporozoites (210), co-infection of BALB/c mice was aimed to be performed using the lowest number 
of P. berghei sporozoites necessary to render naive mice malaria-positive. A preliminary experiment 
was performed to select the most suitable dose for co-infection. In that experiment different groups 
of naive mice were infected with a range of 250 to 15000 sporozoites. One out of 6 mice in the group 
infected with 250 sporozoites was found malaria-negative, but all other mice infected with 500, 5000 
or 15000 sporozoites became malaria-positive (Fig. 3.1 A). Therefore, the dose of 500 sporozoites per 
mouse was considered the threshold for infection in BALB/c mice and further used for co-infection 
experiments. BALB/c mice cannot survive P. berghei infections and all malaria-positive animals 
succumbed within 27 days of plasmodial infection. No significant differences in survival could be 
found between groups (p=0.1365, logrank test, Fig. 3.1 A). 
 
The course of parasitaemia in malaria-positive mice showed a typical pattern: a slow increase 
could be observed until day 11 post plasmodial infection (p.p.i.), followed by a steep raise until day 
16 p.p.i. and the maintenance of constantly high levels thereafter, which progressively debilitated 
the mice until they eventually died. Despite of the use of markedly different doses a similar 
parasitaemia pattern was observed in all mice and no significant differences could be found 
throughout the experiment (p>0.05 for each day p.p.i., Kruskal-Wallis test, Fig. 3.1 B).   
 
3.1.1.2. Prolonged survival in co-infected BALB/c mice 
 
L. sigmodontis infected BALB/c mice were co-infected with 500 P. berghei sporozoites at day 
60 p.f.i., during the period of Mf release in pleural cavity and hence the highest expected
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Figure 3.1: Range of P. berghei sporozoite infection of BALB/c mice. (A) Survival. Naive mice were 
infected with the indicated parasite doses and monitored for survival. The highlighted survival curve 
corresponds to mice infected with 500 sp, which was the infection dose elected for further co-
infection experiments. No differences in survival were found (p=0.1365, logrank test). (B) 
Development of P. berghei parasitaemia. Lines represent median of parasitaemia and error bars 
denote interquartile range. Data corresponding to the group infected with 500 sp/mouse is 
highlighted. Only one side of the range is shown in the remaining groups for a better clarity of the 
graphic (p>0.05 for each day p.p.i., Kruskal-Wallis test). n=5-6 mice per group.  
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worm-mediated immunomodulation. Variations in survival, P. berghei parasitaemia and alterations 
of different physiological parameters related to malaria severity were monitored in single and co-
infected mice after plasmodial infection.  
 
Co-infected BALB/c mice survived P. berghei infection significantly longer than their single 
infected littermates (p=0.0113, logrank test, Fig. 3.2 A). Whereas the latter all died within the first 25 
days p.p.i. 40% of the co-infected mice survived the whole observation period of the experiment, 
which was performed until day 40 p.p.i. L. sigmodontis infection is not lethal in BALB/c mice, and 
hence no animal infected only with filariae died.  
 
In order to find out potential reasons for the prolonged survival of co-infected mice, P. 
berghei parasitaemia levels were assessed in the single and co-infected group. 100% of P. berghei 
single infected control mice became malaria-positive, presenting the characteristical parasitaemia 
pattern described before (Fig 3.1 B). In contrast, co-infected mice could be divided into 2 clear sub-
groups: 64.6% of co-infected animals (7 out of 11) had malaria parasites in the blood, and were 
denoted as malaria-positive, and the remaining 36.4% (4 out of 11) did not show P. berghei 
parasitaemia and were referred to as malaria-negative mice (Fig. 3.2 B). Malaria-positive co-infected 
mice developed a course of parasitaemia similar to that of their P. berghei single infected littermates. 
At a particular time-point after plasmodial infection these mice showed significantly lower 
parasitaemia levels than their single infected counterparts (day 15 p.p.i., p=0.0369, Mann-Whitney 
test comparing malaria-positive single and co-infected mice, Fig. 3.2 B). Significant differences in 
parasitaemia between both groups were consistently found in further co-infection experiments, 
although the exact day p.p.i. they appeared was variable (see Fig. 3.8 B for cumulative analysis of 
parasitaemia from 13 independent experiments). Eventually all malaria-positive co-infected mice 
died. On the other hand, malaria-negative co-infected mice survived the whole experiment, 
contributing decisively to the prolonged survival observed in the co-infected group (Fig. 3.2 A).  
 
Though consistently present in different independent experiments, the frequency of malaria-
free co-infected mice was highly variable. A cumulative analysis of 13 independent co-infection 
experiments was performed to obtain a more precise estimation of the resistance to malaria in co-
infected mice, resulting in a median of 31.7% malaria-negative mice per experiment (interquartile 
range 18.18-47.73%) compared to 0% in the single infected group (interquartile range 0-4.55%). 
Differences in percentages of malaria-positive mice between both groups were significant (Mann-
Whitney test, p<0.0001, Fig. 3.2 C. See also Table 3.2). 
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Figure 3.2: Differential malaria 
outcomes of the co-infection of BALB/c 
mice. Mice were co-infected with 500 P. 
berghei sporozoites at day 60 after L. 
sigmodontis infection. (A) Survival. 
Differences in survival to P. berghei 
infection in single and co-infected mice 
were calculated using logrank test (*, 
p=0.0113). Survival of L. sigmodontis 
single infected mice was excluded from 
the statistical analysis. (B) Plasmodial 
parasitaemia. Blood smears were done 
daily after P. berghei infection. The co-
infected group was split into malaria-
positive (co-infected Mal+) and malaria-
negative mice (co-infected Mal-). 
Statistical analysis was done between P. 
berghei and co-infected Mal+ mice, using 
Mann-Whitney test (*, p<0.05). Lines 
and error bars denote median of 
parasitaemia and interquartile range 
respectively. Only one tail of the range 
was shown for a better clarity of the 
graphic. In A and B, data are 
representative for 2 independent 
experiments, illustrating consistently 
reproducible effects. 7 to 11 mice were 
used per experiment in each group. (C) 
Percentages of malaria-positive single 
and co-infected mice. Data were pooled 
from 13 independent experiments. A 
Mann-Whitney test was employed for 
the statistical analysis (***, p<0.0001). 
Columns represent median of 
percentage of malaria-positive mice per 
experiment. Error bars denote 
interquartile range. 
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Taken together, these data show that the filarial infection enhances the capacity of BALB/c 
mice to control malaria parasites and prolongs their survival to P. berghei malaria.  
 
3.1.1.3. Characterization of malaria-positive and –negative co-infected 
BALB/c mice 
 
Certain physiological parameters are altered during murine malaria. In order to further 
characterize the course of P. berghei infections in co-infected mice their body weight, hematocrit and 
spleen size were monitored and compared to single infected controls. Malaria-positive co-infected 
mice suffered strong reductions in body weight and haemoglobin concentrations as parasitaemia 
increased, showing no significant differences with their single infected counterparts (Fig. 3.3 A, B). 
Significant drops in body weight could be measured from day 10 p.p.i. in both groups compared to 
naive or L. sigmodontis single infected mice (*, p<0.05, one-way ANOVA and Tukey’s multiple 
comparison test, Fig. 3.3 A), whereas significant decreases in hematocrit became evident from day 12 
p.p.i. (*, p<0.05, one-way ANOVA and Tukey’s multiple comparison test, Fig. 3.3 B). In contrast, 
malaria-negative co-infected mice presented unaltered values of both variables during the 
experiment, showing no significant differences with L. sigmodontis single infected and naive mice 
(p>0.05, one-way ANOVA and Tukey’s multiple comparison test, Fig. 3.3 A and B). As with the case of 
human patients infected with P. falciparum the spleen also increases in size during murine malaria (1, 
153). At day 14 p.p.i. spleen size was comparable in P. berghei single infected and malaria-positive 
co-infected mice, and markedly higher than the rest of the groups (*, p<0.05, one-way ANOVA and 
Tukey’s multiple comparison test, Fig 3.3 C). As occurred for body weight and splenomegaly, malaria-
negative co-infected mice presented similar values of spleen size than L. sigmodontis single infected 
and naive controls (p>0.05, one-way ANOVA and Tukey’s multiple comparison test, Fig 3.3 C). Thus, 
malaria-positive co-infected mice apparently followed a disease course similar to that of single 
infected mice, whereas malaria-negative co-infected mice resembled worm infected and naive mice, 
showing no evidence of being infected with malaria parasites.  
Natural L. sigmodontis infections performed through the exposition of mice to infected mites 
entail a high variation in infection loads that each single mouse receives, potentially accounting for 
the different malaria outcomes observed in co-infected mice. Therefore the number of worms 
harboured by co-infected animals in each experiment (Fig. 3.3 C) was evaluated. Similar worm 
numbers (p=0.8513, Mann-Whitney test) were found in malaria-positive and –negative mice (median 
of 12 with interquartile range 8-23 and 9 with interquartile range 5-21 respectively). 
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Figure 3.3: Characterization of 
vitality parameters after P. berghei 
co-infection of BALB/c mice. Mice 
were co-infected with 500 P. berghei 
sporozoites at day 60 after L. 
sigmodontis infection and indicated 
parameters evaluated thereafter. (A) 
Body weight variations. Lines and 
bars represent mean of % of initial 
body weight ± SD of 7 mice. (B) 
Hematocrit variations. Lines and bars 
represent mean of % of initial 
haemoglobin concentration ± SD of 7 
mice. Naive control mice in A and B 
showed a similar behaviour than their 
L. sigmodontis single infected 
littermates and were not included in 
the present illustration. (C) 
Splenomegaly. Mice were sacrificed 
at day 14 p.p.i. for spleen recovery. 
Data were normalized to total mouse 
body weight at the same day 
following the formule (Spleen 
weight/total body weight)*1000. 
Columns and error bars indicate 
mean normalized spleen weight ± SD 
of 7 mice. Comparisons between 
groups in A-C were done by one-way 
ANOVA and Tukey’s multiple 
comparisons test (*, p<0.05). Data 
are representative for 2 independent 
experiments. 
0 4 8 12 16 20 24
50
60
70
80
90
100
110
P.berghei
Co-infected Mal+ Co-infected Mal-
L.sigmodontis
*
Days post P.berghei infection
B
o
d
y
 w
e
ig
h
t 
(%
 o
f 
d
a
y
 0
)
0 4 8 12 16 20 24
0
10
20
30
40
50
60
70
80
90
100
110
P.berghei
Co-infected Mal+ Co-infected Mal-
L.sigmodontis
*
Days post P.berghei  infection
H
a
e
m
o
g
lo
b
in
 (
%
 o
f 
d
a
y
 0
)
0
10
20
30
40
50
60 *
*
P.berghei
Co-infected Mal+ Co-infected Mal-
L.sigmodontis
Naïve
N
o
rm
a
li
z
e
d
 s
p
le
e
n
 w
e
ig
h
t
C
B
A
Results 
 - 58 - 
3.1.2. Analysis of malaria-negative co-infected BALB/c 
mice: protective effects of filarial infections on the 
liver stage of malaria  
 
Results concerning the analyses of those co-infected mice that remained malaria-negative 
after co-infection with 500 P. berghei sporozoites (Fig. 3.2 A-C) are shown in the following section.  
 
Given the different stages of the malaria cycle in the mouse, several possibilities could be 
hypothesized to explain absence of plasmodial infection in some co-infected mice: a) blockage of 
sporozoite entrance in the liver; b) elimination of malaria parasites during their development inside 
hepatocytes, or c) once liver stage is completed, control of P. berghei parasitaemia. Different 
experimental approaches exposed below were undertaken to evaluate the suitability of these 
hypotheses to the co-infection model. 
3.1.2.1. Malaria protection is not mediated by antibodies 
 
Immune defense mechanisms against L. sigmodontis worms involve the generation of 
specific antibodies (2), and the presence of cross-reactive antibodies between helminth worms and 
plasmodial parasites has been reported before (194). Thus, antibodies synthesized against L. 
sigmodontis might cross-react with proteins on the surface of P. berghei sporozoites and block their 
entrance in the liver. To ascertain this possibility, µMT mice, which are homozygous mutant mice 
with a targeted disruption of the membrane exon of the immunoglobulin µ chain gene and therefore 
deficient in mature B cells, were co-infected with P. berghei at day 60 after L. sigmodontis infection. 
B cell KO mice presented an equivalent degree of resistance to malaria sporozoites (p=0.0078, 
Fisher’s exact test, Table 3.3) than their wild type counterparts (p=0.001, Fisher’s exact test, Table 
3.3). Furthermore, survival to P. berghei was significantly prolonged in wild type and B cell deficient 
co-infected mice compared to their respective single infected counterparts (P. berghei wt vs. co-
infected wt; ***, p<0.001; P. berghei μMT vs. co-infected μMT; **, p=0.0078, logrank test, Fig. 3.4).  
 
Malaria protection in co-infected mice was hence exerted at a later stage, either during intra-
hepatic development or against the blood stage of the parasite. 
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Figure 3.4. Survival of co-infected B-cell deficient μMT mice. Naive or L. sigmodontis infected wild 
type BALB/c and μMT mice (BALB/c background) were infected with 500 P. berghei sporozoites 60 
days p.f.i. Statistical analyses of survival were performed using the logrank test (P. berghei wt vs. co-
infected wt; ***, p<0.001; P. berghei μMT vs. co-infected μMT; **, p=0.0082). n=8 mice per group. 
Data are representative for 2 independent experiments. 
 
 
 
 
Figure 3.5. Survival of IL-10 KO co-infected mice. Naive and L. sigmodontis single infected wild type 
BALB/c and IL-10 deficient mice (BALB/c background) were infected with 500 P. berghei sporozoites 
at day 60 p.f.i. Significance was calculated using the logrank test (P. berghei wt vs. co-infected wt, 
***, p= 0.0008; P. berghei IL-10 KO vs. co-infected IL-10 KO, n.s., p=0.4820) 
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3.1.2.2. Protective mechanisms are not principally directed against 
blood stage malaria parasites 
 
The presence of malaria-negative co-infected mice after blood smear examination could not 
be directly attributed to the development of complete sterile immunity against the parasites at this 
point, since these mice could have been able to control parasitaemia to levels below detection limit 
by microscopical observation, but still harbour blood stage malaria parasites. Such phenomenon has 
been described in human and murine malaria (257, 268). Therefore, to ascertain their real malaria 
status 500 µl blood from each of 19 malaria-negative co-infected mice from 2 independent 
experiments were transferred i.p. to a respective naive mouse at day 9 p.p.i. Given that a naïve 
mouse contains approximately 9x109 RBCs/ml blood, the amount of RBCs transferred was 4.5x109. As 
a result, only 1/19 mice (5.26%) became positive for P. berghei blood stage parasites, indicating that 
the majority of malaria-negative co-infected mice are not cryptically infected (Table 3.1).  
 
Experiment 
Blood 
transfer (µl) 
Total 
mice 
Malaria-positive 
recipient mice 
% malaria-positive 
recipient mice 
1 500 7 1 14.28 
2 500 12 0 0 
Total 
 
19 1 5.26 
 
Table 3.1: Malaria status of recipient BALB/c mice after blood transfer from 
malaria-negative co-infected donor mice. Mice were co-infected with 500 P. berghei 
sporozoites at day 60 after L. sigmodontis infection and malaria status assessed 9 
days after P. berghei infection. Blood from each co-infected mouse proven malaria-
negative was injected intraperitoneally the same day p.p.i. into a naive recipient. 
Malaria status of recipient mice was assessed at day 9 after blood transfer.  
 
Thus, the mechanism responsible for generating malaria-protection in co-infected mice was 
very likely to occur during the liver stage of P. berghei. 
3.1.2.3. Malaria protection is related to microfilaraemia 
 
After maturation inside the thoracic cavity of BALB/c mice, female L. sigmodontis worms 
start releasing Mf from day 55 p.f.i. on. However, around 50% of the mice remain amicrofilaraemic 
during this period. Since Mf are known to stimulate potent immune responses (252), data pooled 
from 13 independent experiments were analysed to assess the relevance of microfilaraemia in the 
generation of malaria protection in the liver of co-infected mice (Table 3.2). As a result, malaria-
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Figure 3.6 (see next page) 
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Figure 3.6 (see previous page): Cell distributions in the liver 40 hours after P.berghei co-infection of 
BALB/c mice. Mice were co-infected with 500 P. berghei sporozoites at day 60 after L. sigmodontis 
infection and sacrificed 40 hours later. Total amounts of CD8+ T cells and macrophages in liver (A and C 
respectively) or spleen (B and D respectively). Data were compared using one-way ANOVA test together 
with the Tukey’s multiple comparison test (*, p<0.05). Asterisks over the columns denote significance 
against naive mice. Data are representative for 2 independent experiments. Columns and error bars 
represent mean of cell numbers ± SD. n=7 mice per group. Pleural cells from a non- depleted (E) and a 
macrophage-depleted mouse (F) infected with L. sigmodontis. Absence of these cells in the second figure 
demonstrates that Gr1highF4/80high cells are macrophages. Correlation of micro-filaraemia and CD8+ T cells 
in liver (G) and spleen (H). Significance was calculated using Spearman correlation (r= -0.4679, p=0.1467 in 
liver; r= 0.6422, p=0.0331 in spleen). 
 
 
negative co-infected mice were clearly associated to the presence of microfilaraemia (26 out of 53 
mice), whereas most of the amicrofilaraemic mice (51 out of 62 mice) were malaria-positive 
(p=0.0006, Fisher’s exact test, Table 3.2). 
 
Group 
P. berghei 
infection 
Total 
mice 
Malaria-
negative 
% malaria-
negative 
p-value 
P. berghei 500 sp 108 5 4.62  
Co-infected 500 sp 115 37 32.17 <0.0001a 
      
Co-infected      
Mf+ 500 sp 53 26 49.05  
Mf- 500 sp 62 11 17.74 0.0006b 
 
Table 3.2. Malaria status in co-infected BALB/c mice regarding microfilaraemia.  
a Comparisons were done by Fisher’s exact test. Data were pooled from 13 
independent experiments.  
b Co-infected group was sub-divided regarding microfilaraemia. Comparisons were 
done by Fisher’s exact test. 
  
3.1.2.4. IL-10 is required for malaria protection in co-infected mice 
 
Since microfilaraemia was clearly related to protection in co-infected mice and a key cytokine 
involved in Mf survival in blood is IL-10 (151), IL-10 deficient BALB/c mice were used in order to 
assess the relevance of this cytokine in the present model. Unlike the wild type control group, in 
which usual rates of malaria-negative mice arose (p=0.0341, Fisher’s exact test, Table 3.3), co-
infected IL-10 KO mice showed no malaria protection and became all positive,  
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Figure 3.7. Survival to iRBC co-infection of BALB/c mice. Naive and L. sigmodontis single infected 
mice were co-infected with (A) 50 or (B) 50000 iRBC at day 60 p.f.i. Survival was analysed by logrank 
test (P. berghei 50 iRBC vs. Co-infected 50 iRBC, p=0.9453; P. berghei 50000 iRBC vs. Co-infected 
50000 iRBC, *,  p=0.0355). n=8 mice per group. Data representat 2 independent experiments.  
 
 
 
 
Mice Group 
P. berghei 
Infection 
Malaria-negative/ 
Total no. of mice 
% Malaria-
negative 
Total no. of 
experiments 
p-value 
Wt P. berghei 500 sp            5/108       4.62 13  
Wt Co-infected 500 sp            37/115       32.17 13 <0.0001a 
      Mf+      500 sp      26/53      49.05   
      Mf-      500 sp      11/62      17.74  0.0006b 
       
Wt Blood tr.# -            18/19       94.73 2  
       
µMT P. berghei 500 sp            2/15       13.3 2  
µMT Co-infected 500 sp            10/15       66.6 2 0.0078c 
       
IL-10 KO P. berghei  500 sp            0/15       0 2  
IL-10 KO Co-infected 500 sp            0/15       0 2 n.s.d 
       
Wt P. berghei 50000 iRBC            0/14       0 2  
Wt Co-infected 50000 iRBC            0/14       0 2 n.s.e 
Wt P. berghei 50 iRBC            0/14       0 2  
Wt Co-infected 50 iRBC            0/28       0 2 n.s.f 
Table 3.3 (see next page) 
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Table 3.3 (see previous page): Summary of experiments for the characterization of the mechanism 
of malaria protection in co-infected BALB/c mice. Mice were co-infected with indicated P. berghei 
stages at day 60 after L. sigmodontis infection.  
# Transfer of 500 µl blood from each malaria-negative co-infected mouse to a naïve animal. 
a One-tailed Mann-Whitney test of percentages of malaria-positive single and co-infected mice from 
13 independent experiments. 
b Fisher’s exact test contrasting numbers of a- or microfilaraemic co-infected mice against malaria 
status, positive or negative.  
c Fisher’s exact test of B cell-deficient mice contrasting malaria status and type of infection 
(protection of co-infected Wt control mice in the corresponding experiments, p=0.001) 
d Fisher’s exact test of IL-10 deficient mice contrasting malaria status and kind of infection (protection 
of co-infected Wt control mice in the corresponding experiments, p=0.0341) 
e,f Fisher’s exact test contrasting malaria positive mice in the single or the co-infected group, for the 
indicated P. berghei iRBC dose. 
 
 
like their single infected littermates (p>0.999, Fisher’s exact test, Table 3.3). As a consequence, 
survival of wild type co-infected mice was significantly prolonged compared to their single infected 
littermates (***, p=0.0008, logrank test, Fig. 3.5) whereas single and co-infected IL-10 KO mice 
presented no differences in this parameter (p=0.4820, logrank test, Fig. 3.5). This demonstrated an 
implication of IL-10 in the generation of malaria-negative co-infected mice.  
 
3.1.2.5. Co-infection alters CD8+ T cell distributions in spleen and liver 
 
Data so far (Fig. 3.4 and Table 3.1) suggest that the major mechanisms mediating malaria 
protection in co-infected mice were elicited during the liver stage of P. berghei.  To further 
investigate this hypothesis immune cell distributions in the liver were analysed in single and co-
infected mice 40 hours after P. berghei infection with 500 sporozoites. At this time point malaria 
parasites were close to completing their intrahepatic development. Total CD8+ T cells were found to 
be increased in co-infected and L. sigmodontis single infected mice compared to controls, whereas 
no such increase could be observed in P. berghei single infected mice. (*, p<0.05, one-way ANOVA 
and Tukey’s multiple comparison test, Fig. 3.6 A). In contrast, macrophages were increased only in L. 
sigmodontis single infected mice, but not in co-infected ones (*, p<0.05, one-way ANOVA and 
Tukey’s multiple comparison test, Fig. 3.6 C). Macrophages were defined as Gr1highF4/80high cells, as 
assessed by depletion with chlodronate lyposomes (Fig. 3.6 E, F). 
 
Immune cell distributions were also assessed in spleen, a paradigmatic organ for generation 
of T cell responses. Compared to P. berghei single infected control mice, a significant increase in CD8+  
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Figure 3.8: Cumulative analyses of survival and parasitaemia of single and co-infected BALB/c mice. 
Mice were co-infected with 500 P. berghei sporozoites at day 60 after L. sigmodontis infection. (A) 
Survival. Statistical analyses were done using logrank test (p=0.1016, analysis of the survival curve), 
or Fisher’s exact test (p=0.007, analysis of contingency table in which mice were divided into those 
surviving further than day 30 p.p.i. or not. Only 4 co-infected mice (2 Mf+ and 2 Mf-) survived longer 
than day 30 p.p.i.). (B) Plasmodial parasitaemia. Statistical analysis was done using unpaired student 
t test (*, p<0.05). Data were pooled from 8 independent experiments.       
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T cells was found in the spleen of co-infected mice (*, p<0.05, one-way ANOVA and Tukey’s multiple 
comparison test, Fig. 3.6 B). Moreover, co-infected mice presented a significantly increased number 
of macrophages in the spleen compared to naive mice (**, p<0.01, one-way ANOVA and Tukey’s 
multiple comparison test, Fig. 3.6 D).  
 
Since microfilaraemia has been linked to malaria resistance in co-infected mice and anti-
malarial immune responses in the liver, elicited by CD8+ T cells (209), these cells were hypothesized 
to be relevant in this process, the relation between microfilarial loads in blood and CD8+ T cell 
numbers was analysed. Interestingly, microfilaraemia levels correlated with CD8+ T cell numbers in 
spleen (p=0.0331, Spearman correlation, r= 0.6422, Fig. 3.6 H) but not in the liver of co-infected mice 
(p=0.1467, Spearman correlation, r= -0.4679, Fig. 3.6 G). Thus, microfilaraemia seems to favour the 
increase in CD8+ T cells in the spleen. 
 
3.1.2.6. Parasitaemia control at subpatent levels is conditioned to 
parasite passage through the liver 
 
In light of the last results the major mechanisms implicated in malaria protection upon 
sporozoite co-infection seem to operate in the liver. Nevertheless, the blood transfer experiment 
from malaria-negative co-infected mice to naive counterparts described before (Table 3.2) showed 
that effective control of parasitaemia to levels undetectable by blood smear examination was 
achieved by some co-infected mice. Such capacity has never been reported before in P. berghei 
infected mice. In order to know the approximate amount of parasites within the infectious blood of 
donor mice naive BALB/c mice were intraperitoneally infected with varying doses of iRBCs (Table 
3.4).  
 
Infection 
dose (iRBC)  
Total 
mice  
Malaria-
positive  
% malaria-
positive  
50000  10  10  100  
5000  10  10  100  
500  10  10  100  
50  10  10  100  
5  10  6  60  
1  10  3  30  
 
Table 3.4: Range of P. berghei iRBC infection of BALB/c mice. Naive mice were 
injected intraperitoneally with the indicated amount of infected erythrocytes, and 
malaria status was assessed at day 12 p.p.i. in Giemsa stained blood smears. 
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Figure 3.9: Cell distributions in pleural cavity and spleen after P. berghei co-infection of BALB/c 
mice. Mice were co-infected with 500 P. berghei sporozoites at day 60 after L. sigmodontis infection 
and sacrificed at days 8 or 14 after P. berghei infection. Total cells (A, B) and macrophage numbers in 
pleural cavity (C, D), and macrophage numbers in spleen (E, F) at the respective time points are 
depicted. In A-D scarce pleural cells in P. berghei single infected and naive mice are not shown. 
Significance was analysed using Mann-Whitney tests (A-D) or Kruskal-Wallis tests complemented 
with Dunn’s multiple comparison test (E, F). 6 to 10 mice were used per group. Asterisks over 
columns denote significance with naive mice (*, p<0.05; **, p<0.01; ***, p<0.001). 
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50 iRBC/mouse was the lowest dose rendering all BALB/c mice positive, and was therefore 
the minimum amount of iRBCs that the mentioned donor mouse might have had. 50 iRBC contained 
in 500 µl blood of the donor mouse corresponds to a parasitaemia of 1.11x10-6%, or 1 parasite per 
100 million erythrocytes.  
 
To further define the capacity of control of blood stage malaria parasites in double infected 
mice a new experiment was performed in which co-infections were done directly with iRBCs, hence 
skipping the malaria passage through the liver. A low dose of 50 iRBC per mouse, markedly lower 
than the theoretical number of merozoites released by one single sporozoite successfully completing 
the liver stage, estimated in 8000 to 10000 merozoites (81), and a standard dose of 50000 iRBCs, 
closer resembling the amount of merozoites arising from the liver in BALB/c mice, were used. All 
mice co-infected with either dose developed high parasitaemia and died (p>0.999, Fisher’s exact test, 
Table 3.3), being unable to hold blood infection under control. These results further underline the 
major importance of protective mechanisms actuating against liver stage than blood stage malaria 
parasites in negative co-infected mice. They also indicate that parasitaemia control at undetectable 
levels in malaria-negative co-infected mice might require parasite passage through the liver. 
Nevertheless, survival of BALB/c mice co-infected with 50000 iRBC but not with 50 iRBC was 
significantly longer than that of their respective single infected littermates (P. berghei 50 iRBC vs. Co-
infected 50 iRBC, p=0.9453, logrank test, Fig. 3.7 A; P. berghei 50000 iRBC vs. Co-infected 50000 iRBC, 
*, p=0.0355, logrank test, Fig. 3.7 B), showing that additional beneficial mechanisms operate in co-
infected mice during the patent blood stage of malaria. 
 
 
3.1.3. Analysis of malaria-positive co-infected BALB/c 
mice: protective effect of filarial infections on the 
blood stage of malaria 
 
 
As shown in Figs. 3.2 A-C a percentage of co-infected mice developed detectable plasmodial 
parasitaemia after challenge with 500 P. berghei ANKA sporozoites. The present section describes 
the analyses performed on such malaria-positive co-infected mice, and hence to the effects of worm 
infections on the blood stage of malaria in BALB/c mice.  
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Figure 3.10: Courses of relevant 
circulating cytokine and immuno-
globulin levels after P. berghei co-
infection of BALB/c mice. Mice were 
co-infected with 500 P. berghei 
sporozoites at day 60 after L. 
sigmodontis infection and (A) IL-10, 
(B) IFN-γ and (C) ratio of IgG2a and 
IgG1 are represented. Cytokine and 
immunoglobulin concentrations were 
measured by ELISA in plasma samples 
taken daily. Data represent 2 
independent experi-ments. Lines and 
error bars represent median of 
cytokine levels and interquartile 
range respectively of 5 to 7 mice. Only 
one side of the range was shown for a 
better clarity of the graphic. Statistical 
analyses were done using Kruskal-
Wallis tests complemented with 
Dunn’s multiple comparison test to 
specifically compare P. berghei single 
and co-infected mice. No significant 
differences were found (p>0.05). 
Significance against L. sigmodontis 
and naive mice is not shown. 
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3.1.3.1. Prolonged survival and reduced parasitaemia in malaria-
positive co-infected mice  
 
After the single infection of 500 P. berghei sporozoites no naive BALB/c mouse survived 
longer than 30 days, a mark which was reached by some of their malaria-positive co-infected 
counterparts. For the statistical analysis of survival, animals in the single and co-infected group from 
different independent experiments were classified regarding their capacity to survive P. berghei 
infection below or beyond 30 days. As a result, a significantly increased number of long-surviving 
mice was found in the co-infected group compared to the single infected controls (p=0.007, Fisher’s 
exact test, Fig. 3.8 A). Indeed numbers of co-infected mice presenting a prolonged survival were 
significantly higher compared to single infected from day 26 p.p.i. (p=0.0203, Fisher’s exact test, Fig. 
3.8 A). 
 
Consistent differences in parasitaemia levels between single and co-infected mice had been 
regularly observed in each independent experiment (Fig. 3.2 B), but presenting high variability in 
intensity and frequency between experiments. Therefore a cumulative analysis of parasitaemia in 
single and double infected mice was done in data pooled from different independent experiments 
(Fig. 3.8 B). Parasitaemia levels were found lower in co-infected mice at late stages of the infection, 
namely day 11 and from day 14 p.p.i. onwards (*, p<0.05, unpaired T test, Fig. 3.8 B). However, the 
course of parasitaemia in both groups of mice during the early stage of the plasmodial infection, until 
day 10 p.p.i., presented no differences (p>0.05, unpaired T test, Fig. 3.8 B). 
 
3.1.3.2. Increased macrophage numbers in spleen in co-infected mice 
 
Malaria-positive single and co-infected mice were sacrificed at days 8 and 14 p.p.i., 
representative for an early and a late time point after infection respectively, to analyse the 
distribution of immune cells in the main sites where responses against the parasites take place: 
namely the spleen for P. berghei and the pleural cavity for L. sigmodontis. A pronounced decrease in 
the number of total immune cells in the thoracic cavity could be observed in co-infected mice 
compared to L. sigmodontis single infected controls at both day 8 (***, p=0.0008, Mann-Whitney 
test, Fig. 3.9 A) and 14 p.p.i. (*, p=0.0317, Mann-Whitney test, Fig. 3.9 B).  
Macrophages are among the major cell types involved in the defence against L. sigmodontis 
infections in mice (3, 9). Pleural macrophage numbers were significantly decreased at day 8 (***, 
p=0.0013, Mann-Whitney test, Fig. 3.9 C) and 14 (**, p=0.0027, Mann-Whitney test, Fig. 3.9 D) after
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Figure 3.11: CM and parasitaemia development by P. berghei single- and co-infected C57BL/6 mice. 
Mice were co-infected with 50000 P. berghei iRBCs at day 60 after L. sigmodontis infection. (A) 
Survival. Significance was calculated using the logrank test (***, p=0.0002). (B) Parasitaemia. Lines 
represent median of parasitaemia and data range. Significance was calculated by Mann-Whitney test 
(*, p<0.05). Data in A and B represent 2 independent experiments. Shadowed zones denote potential 
CM period. 10 to 12 mice were used in each group.  
A
B
0 5 10 15 20 25
0
20
40
60
80
P.berghei
Co-infected
* **
Days post P.berghei infection
P
a
ra
s
it
a
e
m
ia
 (
%
)
0 5 10 15 20 25
0
20
40
60
80
100 P.berghei
Co-infected
***
Days post P.berghei infection
S
u
rv
iv
a
l 
(%
)
Results 
 - 72 - 
P. berghei infection. Macrophages are also involved in the defence against malaria parasites in the 
spleen (70). Higher numbers of macrophages were present in spleen of co-infected mice than P. 
berghei or L. sigmodontis single infected mice at day 8 (*, p<0.05, Kruskal-Wallis test with Dunn’s 
multiple comparison test, Fig. 3.9 E) and 14 p.p.i. (***, p<0.001, Kruskal-Wallis test with Dunn’s 
multiple comparison test, Fig. 3.9 E, F).  
 
3.1.3.3. Similar cytokine and immunoglobulin patterns in single and 
co-infected mice 
 
In order to further characterize the response to P. berghei in single and co-infected mice 
circulating cytokines were measured in plasma. IFN-γ, which mediates macrophage activation and 
parasite phagocytosis (291), presented comparable levels in both single and co-infected mice, 
peaking at day 7 p.p.i. (p>0.05, Kruskal-Wallis test and Dunn’s multiple comparison test, Fig. 3.10 A). 
Similarly, the immunoregulatory cytokine IL-10 followed a similar pattern in both P. berghei infected 
groups, also peaking at day 7 p.p.i. (p>0.05, Kruskal-Wallis test and Dunn’s multiple comparison test, 
Fig. 3.10 B).  
 
Different immunoglobulin G isotypes are secreted by B cells depending on the kind of 
polarization induced by the cytokine environment (236). In order to know the prevailing type of 
helper T cell response occurring in the mice, IgG1 (representative for Th2 responses) and IgG2a levels 
(representative for Th1 responses) were monitored after P. berghei infection. Both single and co-
infected mice presented equivalent increases in IgG2a levels from day 8 p.p.i. on, whereas IgG1 
remained at background levels throughout the infection (p>0.05, Kruskal-Wallis test with Dunn’s 
multiple comparison test, Fig. 3.10 C). In summary, the filarial infection did not substantially alter the 
cytokine patterns normally developed against malaria by BALB/c mice. 
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Figure 3.12: Physiological parameters after P. berghei co-infection of C57BL/6 mice. Mice were co-
infected with 50000 P. berghei iRBCs at day 60 after L. sigmodontis infection. (A) Body weight. 
Variations in body weight were monitored after P. berghei infection until mice developed CM. Lines 
represent mean±SD of body weight. (B) Splenomegaly. Mice were sacrificed at day 7 p.p.i., during the 
CM period. Spleen weights were normalized with total body weights following the formula: (Spleen 
weight/total body weight)*1000. Columns represent mean of normalized spleen weight ± SD of 7 
mice. Data in A and B were compared by one-way ANOVA and Tukey’s multiple comparison test for 
differences between groups (*, p<0.05; **, p<0.01), and represent 2 independent experiments. 
Shadowed areas define potential CM period. 
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3.2. C57BL/6 MICE 
 
3.2.1. Protective effects of filarial infections on cerebral 
malaria in C57BL/6 mice 
 
P. berghei co-infection of L. sigmodontis infected C57BL/6 mice was performed on day 60 
p.f.i. P. berghei infections were done with a dose of 50000 iRBCs, which generates CM pathology in 
100% of the P. berghei single infected mice after 6 to 9 days. 
 
3.2.1.1. Lower CM rates and parasitaemia in co-infected mice 
 
Prior infection with L. sigmodontis resulted in a reduced number of mice developing CM after 
P. berghei infection. Whereas single infected mice developed typical pathological symptoms between 
days 6 and 10 p.p.i., 76.9% of co-infected mice survived this period and presented no evidence of 
severe pathology (p=0.0002, logrank test, Fig. 3.11 A). During the CM period, significantly lower 
parasitaemia was found in co-infected mice compared to their single infected littermates (*, p<0.05, 
Mann-Whitney test, Fig. 3.11 B).  
 
Vitality parameters known to vary during malaria were monitored to compare the course of 
P. berghei infections. Co-infected mice suffered a comparable loss of body weight than the P. berghei 
single infected controls during the CM period (*, p<0.05, one-way ANOVA and Tukey’s multiple 
comparison test, Fig. 3.12 A). Splenomegaly also occurred in a similar extent in single and co-infected 
mice (*, p<0.05, **, p<0.01, one-way ANOVA and Tukey’s multiple comparison test, Fig. 3.12 B).  
 
3.2.1.2. CD8+ T cells accumulate in the spleen but not in the brain of co-
infected mice 
 
Since many cell types are known to be involved in induction of malaria pathology, immune 
distributions were analyzed by flow cytometry in single and co-infected mice during the CM period at 
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Figure 3.13 (see next page) 
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Figure 3.13 (see previous page): Cell distributions in spleen, pleural cavity and brain during CM in 
co-infected C57BL/6 mice. Mice were co-infected with 50000 P. berghei iRBCs at day 60 after L. 
sigmodontis infection and sacrificed 7 days later. Total cells in pleural cavity (A) and spleen (B) during 
the CM period. (C) Distribution of immune cells in the spleen of P. berghei single and co-infected mice 
during CM. The mean of cell population percentages are shown. Numbers in brackets denote SD. Cell 
names in red squares denote statistical differences between groups, and those in black squares 
correspond to non-significant differences. (D) Total CD8+ T cells in the spleen during CM. (E) Total 
CD8
+
 T cells in the brain during CM. In all figures mice were sacrificed at day 7 p.p.i. and cells analysed 
by flow cytometry. Columns in A, B, D and E represent mean of cell numbers ± SD. Data were 
compared by one-way ANOVA and Tukey’s multiple comparison test (**, p<0.01; ***, p<0.001). 
Asterisks over columns denote significance against naive controls. Data in A and B were pooled from 
2 independent experiments, whereas data in C, D and E are representative for at least 2 independent 
experiments. 5 to 7 mice per group were used in each experiment. Shadowed areas define potential 
CM period. 
 
relevant sites involved in the development of immune responses against P. berghei and L. 
sigmodontis, namely pleura, spleen, and brain. In correlation to the findings in BALB/c mice, the total 
amounts of immune cells in the pleural cavity of co-infected C57BL/6 mice are significantly reduced 
compared to L. sigmodontis single infected controls at day 7 p.p.i. (p<0.001, one-way ANOVA and 
Tukey’s multiple comparison test, Fig. 3.13 A). At the same time in the spleen, only a modest increase 
in total cell numbers could be observed in co-infected mice compared to their naïve littermates 
(p<0.05, one-way ANOVA and Tukey’s multiple comparison test, Fig. 3.13 B).  
 
The analysis of particular cell populations revealed that CD8+ T cells were present in 
significantly higher percentages in the spleen of co-infected mice compared to P. berghei single 
infected counterparts (p<0.05, one-way ANOVA and Tukey’s multiple comparison test, Fig. 3.13 C). 
Co-infected mice also showed a trend for increased percentages of macrophages and CD4+ T cells in 
the spleen. These increases were counterbalanced by a significant decrease in the percentages of B 
cells (p<0.05, one-way ANOVA and Tukey’s multiple comparison test, Fig. 3.13 C). No significant 
differences were found for NK cell, NKT cell or γδ T cell numbers.  
 
Absolute numbers of CD8+ T cells were significantly higher in the spleen of co-infected mice 
compared to their single infected littermates during the CM period (p<0.01, Kruskal-Wallis test with 
Dunn’s multiple comparison test, Fig. 3.13 D). No significant differences in total numbers could be 
found for other analysed cell types (data not shown). In turn, less total CD8+ T cells were found
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Figure 3.14 (see previous page): Cytokine levels after P. berghei co-infection of C57BL/6 mice. Mice 
were co-infected with 50000 P. berghei iRBCs at day 60 after L. sigmodontis infection. (A) IL-10 and 
(B) IFN-γ course in plasma. Mice were bled every two days from the tail vein and cytokine 
concentrations measured by sandwich ELISA. Lines represent median and range of cytokine levels. 
Data were compared using Kruskal-Wallis test and Dunn’s multiple comparison test for differences 
between groups (*, p<0.05). Data are representative for 2 independent experiments.(C) IL-10 and (D) 
TGF-β levels in the pleural cavity after P. berghei infection. Mice were sacrificed during the onset of 
CM (7 days p.p.i., left) or after the CM period (14 days p.p.i., right) and cytokine levels were 
measured in pleural wash by ELISA. Data were compared by Kruskal-Wallis test completed with 
Dunn’s multiple comparison test for differences between groups (*, p<0.05), and are representative 
for 2 independent experiments. Each group was composed of 5 to 7 mice. (E) ICAM-1 expression in 
brain at day 7 p.p.i. Mice were sacrificed during onset of CM and RNA was extracted from brain for 
RT-PCR quantification. ICAM-1 expression was normalized to β-actin copies. Shadowed zones 
represent potential CM period. 
 
in the brain of co-infected mice at the same time-point p.p.i. (Fig. 3.13 E). The distribution of CD8+ T 
cells, critical mediators of CM (172), was markedly different in single and co-infected mice. 
 
3.2.1.3. IL-10 is essential for CM protection 
 
Cytokine analyses in plasma were performed to evaluate the type of immune response 
against malaria parasites that developed in co-infected mice. Similarly to BALB/c mice, single and co- 
infected C57BL/6 mice showed a peak of circulating IFN-γ at day 4 post infection, which was 
comparable in both groups (p>0.05, Kruskal-Wallis test with Dunn’s multiple comparison test, Fig. 
3.14 B, day 4 p.p.i.).  However, strikingly high levels of the immune-regulatory cytokine IL-10 could be 
measured in co-infected mice and L. sigmodontis single infected controls during the whole course of 
the experiment (*, p<0.05, Kruskal-Wallis test with Dunn’s multiple comparison test, Fig. 3.14 B). 
Hence, worms seemed to induce an immune-regulation that was possibly altering the immune 
response against malaria parasites. Further pointing to a direct worm inducement of its production, 
IL-10 levels were significantly high in all L. sigmodontis infected mice compared to P. berghei single 
infected or naïve mice at days 7 and 14 p.p.i. (p<0.05, Kruskal-Wallis test with Dunn’s multiple 
comparison test, Fig. 3.14 C). TGF-β is another important immunomodulatory cytokine induced by L. 
sigmodontis (255). However, no significant differences between groups could be found in the 
thoracic cavity of the mice at day 7 p.p.i. (p>0.05, Kruskal-Wallis test, Fig. 3.14 D).  
 
In the search for the factors responsible for CM modulation in co-infected mice mRNA levels 
of the adhesion molecule ICAM-1, which mediates immune cell sequestration during CM (89), were  
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Figure 3.15: Survival of single- and co-infected IL-10-deficient C57BL/6 mice after P. berghei 
infection. Mice were co-infected with 50000 P. berghei iRBCs at day 60 after L. sigmodontis 
infection. Curves from wild type or KO mice were analysed separately with logrank test (wild 
type mice,**, p=0.0018; IL-10 KO mice, p=0.1257). Data represent 2 independent experiments. 
Groups contained 7 mice each.  Shadowed zone represents potential CM period.   
                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: P. berghei parasitaemia during CM period in CD4
+
 or CD8
+
 depleted single and 
co-infected C57BL/6 mice. Mice were co-infected with 50000 P. berghei iRBCs at day 60 after 
L. sigmodontis infection. Depletion of CD4+ and CD8+ T cells with specific antibodies were 
performed 24 h before P. berghei infection, and blood smears were done 7 days p.p.i. Data 
were analyzed with Kruskal-Wallis test and Dunn’s multiple comparison test (***, p<0.001). 
Each group contained 7 mice. nt=not treated. 
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measured in the brain. Surprisingly, both P. berghei single and co-infected mice showed increased 
ICAM-1 expression levels in brain (p=0.0095, Kruskal-Wallis test, Fig. 3.14 E).  
 
Finally, in order to assess the relevance of high IL-10 levels on CM protection, co-infection of 
IL-10 deficient mice was performed, monitoring them for development of pathology. Both single and 
co-infected IL-10 KO mice developed high CM rates (p=0.1257, logrank test, Fig. 3.15), in contrast to 
their wild type co-infected counterparts, which showed the typical CM protection and increased 
survival (p=0.0018, logrank test, Fig. 3.15). Therefore, induction of IL-10 by the worms is an essential 
factor preventing CM development in co-infected mice.  
 
3.2.1.4. Improved control of parasitaemia in co-infected mice is 
not mediated by CD4+ T cells 
 
An important remaining question concerns the mechanism for improved parasite clearance 
exerted by co-infected mice during CM period. CD4+ T cells are a source of IFN-γ, which mediates 
elimination of malaria parasites (250, 292). Depletion of CD4+ and CD8+ T cells was done to assess the 
role of these cell types on parasitaemia. Parasitaemia in CD8+ T cell-depleted single and co-infected 
mice was comparable to that of non-depleted mice, excluding CD8+ T cells from playing any relevant 
role in control of blood stage P. berghei parasites (p>0.05, Kruskal-Wallis and Dunn’s multiple 
comparison test, Fig. 3.16). However, depletion of CD4+ T cells led to higher parasitaemia in both 
single and co-infected mice, suggesting that CD4+ T cells stronlgy influence P. berghei parasitaemia 
control (p<0.05, Kruskal-Wallis and Dunn’s multiple comparison test, Fig. 3.16). Nevertheless, such 
higher parasitaemia still showed the same ratio between the single and co-infected depleted group, 
with co-infected mice presenting lower levels than the single infected controls (***, p<0.001, 
Kruskal-Wallis and Dunn’s multiple comparison tests,  Fig. 3.16). Thus, a different cell type than CD4+ 
T cells must be responsible for the extra decrease in parasitaemia that all co-infected mice show 
compared to their respective single infected control groups.  
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4. Discussion 
 
During infection immune cells receive through their multiple receptors danger signals from 
the pathogen or other cells that activate them, resulting in the development of specific mechanisms 
directed toward the clearance of the infective agents. Millions of years of evolution have trained the 
immune system to respond in specific ways to different infections. However, individuals are usually 
exposed to multiple perilous organisms, and the possibility of being concomitantly infected is high in 
particular environments. Co-infection implies the priming of the same immune cell types with 
different stimuli, and the result in terms of efficiency against the single pathogens may be profoundly 
altered. The final outcome of co-infection can be either detrimental or beneficial for the host, 
depending on the characteristics of the single infections (189).  
Filarial nematodes are among the human parasites with the highest life span in the host. To 
achieve this, they have developed downregulatory mechanisms that prevent attack by the host 
immune system (109). Such mechanisms may however alter the course of concomitant infections 
such as malaria. In order to determine the extent in which susceptibility to plasmodial infections and 
malaria pathology is modified as a result of filarial-derived mechanisms a murine co-infection model 
has been established and analysed in the present work. Preceeding filarial infections of L. 
sigmodontis improved malaria outcome in several ways; protecting BALB/c mice from sporozoite 
infection, modulating severe cerebral malaria pathology in C57BL/6 mice and even enhancing 
parasitaemia control in both mice strains. 
 
 4.1. SELECTION OF MICE AND PARASITES  
 
In order to generate different manifestations of malaria and filariasis, a co-infection murine 
model was established using two mouse strains, BALB/c and C57BL/6, with contrasting 
susceptibilities to each of the parasites used (Table 4.1).  
BALB/c mice are unique in their capacity to allow the complete development of adult L. 
sigmodontis worms (188). Some infected mice develop microfilaraemia whereas others do not, 
hence resembling filariasis in human patients. Thus, these mice provide the opportunity to study the 
effect of different stages of filarial parasites on the outcome of malaria in a co-infection model. Mf 
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appear in blood from day 55 p.f.i. and can be detected over a period of some weeks (8, 111). In order 
to analyse the influence of microfilariaemia on plasmodial infections, BALB/c mice were co-infected 
with P. berghei at day 60 after L. sigmodontis infection. 
To  simulate natural human plasmodial infections, which usually require the injection of very 
few sporozoites in the bloodstream (210), co-infections of BALB/c mice were performed with 500 P. 
berghei sporozoites; the lowest dose able to render 100% of naive mice malaria-positive (Fig. 3.1 A). 
This allowed analyses of relative variation in susceptibility to sporozoite challenge between single 
and co-infected mice. On the other hand, BALB/c mice develop severe malarial anaemia (SMA) after 
P. berghei infection in blood. Parasitaemia rises to high levels causing anaemia that progressively 
debilitates the mice, which die within 3-4 weeks after infection. Therefore P. berghei infections in 
BALB/c mice were also utilized to analyse SMA pathology in co-infection.  
C57BL/6 mice are generally used to model cerebral malaria (CM), since they mount strong 
Th1 reactions against P. berghei and develop this pathology 5-10 days after infection, resembling 
most of the features of this pathology in humans. On the other hand, C57BL/6 mice are partially 
permissive to L. sigmodontis, allowing worm development to L4 stages (9). However, differently to 
the BALB/c strain, worms are cleared progressively from day 40 to 70 p.f.i. and all mice remain 
amicrofilaramic (240). Co-infections were done with 50000 P. berghei iRBCs injected intravenously, 
which is a dose already used in other studies (195) and can induce CM rates of 100% in naive mice. 
 
4.2. CO-INFECTION IN BALB/C MICE 
 
Co-infection of BALB/c mice generated two different malaria outcomes revealed by blood 
smear examination: approximately two thirds of the mice became malaria-positive and presented a 
parasitaemia pattern similar to that of their single infected counterparts, whereas the rest remained 
malaria-negative during the whole surveillance period (Figs. 3.2 B). Analysis of relevant physiological 
parameters further supported the division of co-infected mice into malaria-positive mice suffering 
from a characteristic malaria course, and malaria-negative without evident signs of infection or 
disease (Fig. 3.3 A-C). Hence, two separated lines of investigation, discussed in sections 4.2.1 and 
4.2.2 respectively, were designed for the specific analysis of either subgroup. 
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Note that in this work the term “malaria-negative” is used for co-infected mice without 
patent parasitaemia, referring to the absence of pathology or disease (malaria) but not necessarily to 
the absence of the parasite (Plasmodium).  
 
4.2.1. Protection against the liver stage of malaria in 
BALB/c mice 
 
Three potential hypotheses could be formulated to explain the absence of patent plasmodial 
infection in malaria-negative co-infected BALB/c mice. Parasite elimination might have been achieved 
at the time of migration of the sporozoites to the liver, during their development inside the 
hepatocytes, or later during the blood stage.  
Since sporozoites are able to enter hepatocytes within a few minutes after their injection into 
the host (231), the development of an effective sterilizing immune response is unlikely to occur in 
such a short time. Nonetheless, monoclonal antibodies against specific epitopes of the CSP have 
been shown to protect mice against sporozoite challenge (197). Analogously, in the present system 
antibodies generated against L. sigmodontis surface proteins might have cross-reacted with 
membrane proteins of the P. berghei sporozoites, triggering their fast clearance already in the 
bloodstream and rendering co-infected mice malaria-negative. The presence of antibodies against 
Schistosoma mansoni antigens that are cross-reactive with P. falciparum has been reported before 
(194).  Therefore µMT mice, deficient in mature B cells and therefore unable to generate antibodies, 
were used in the co-infection setting. The fact that such deficient mice were protected against 
sporozoite challenge to the same extent as their wild-type co-infected counterparts ruled out a role 
of antibodies in malaria protection upon co-infection (Fig. 3.4). This suggested that sporozoites 
possibly entered the liver and infected hepatocytes in co-infected mice, being parasites controlled 
either during their liver or blood stage. 
The fact that malaria-negative co-infected mice did not present evidence of P. berghei 
parasitaemia did not necessarily mean that they were completely free of blood stage parasites. 
Persistent subpatent parasitaemia is a phenomenon observed in human (10, 78) and murine malaria 
(1, 268). To assess if protection in co-infected mice was sterile, blood was transferred from malaria-
negative co-infected mice to naive counterparts, resulting in absence of infection in 94.74% (Table 
3.1). This indicated that protective mechanisms allowed complete clearance of the parasites in these 
mice.  
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To further analyse the plasmodial stage at which protection was elicited, co-infection was 
performed with 50 or 50000 P. berghei iRBC, therefore circumventing the liver stage of malaria. As a 
result, all mice became malaria-positive (Fig. 3.7 A, B). If protection was directed against blood stages 
of P. berghei, iRBC co-infected mice should have been able to remain malaria-negative. Hence this 
result pointed to the liver as the main site where protective mechanisms against malaria parasites 
occurred in co-infected mice.  
Further supporting the hypothesis of an enhanced hepatic anti-malarial response, 
distributions of immune cells in liver and spleen at the final period of the liver stage of P. berghei 
strongly differed in single and co-infected animals. More CD8+ T cells were also found in both organs 
in co-infected mice 40 hours after sporozoite infection (Fig. 3.6 A, B). Cytotoxic T cells are essential 
mediators of immunity against liver stage malaria parasites after immunization (164). Transfer of 
CD8+ T cell clones specific for epitopes of the circumsporozoite protein confers protection against 
parasite challenge (209). Since the liver stage of P. berghei lasts 50 hours, a fast response is required 
to achieve sterile immunity during this period. It has been observed that CD8+ T cell proliferation and 
development of effector functions (production of IFN-γ and perforin, and cytotoxic activity) occurs 
simultaneously 24 hours after contact with the parasites. The degree of protection against liver stage 
plasmodial forms has been shown to depend strictly on the total number of specific CD8+ T cells 
being formed during intra-hepatic development of the parasite (218). Increased cytotoxic cells 
observed in the liver in co-infected mice might therefore result in a higher clearance capacity of 
hepatic stages of P. berghei. The fact that L. sigmodontis single infected mice also presented similarly 
increased CD8+ T cell numbers in the spleen (Fig. 3.6 A) suggested that these cells may have been 
specific for L. sigmodontis-derived antigens rather than for P. berghei liver parasites. Nevertheless, a 
state of pre-activation of immune cells occurring in L. sigmodontis infected mice at patency may have 
boosted priming and proliferation of P. berghei-specific CD8+ T cells in the spleen of co-infected mice 
after sporozoite infection.  
In accordance with this argument, microfilaraemia was related to protection in malaria-
negative co-infected mice (Table 3.2), and microfilarial counts correlated with CD8+ T cell numbers in 
the spleen (Fig. 3.6 H). Once released by female worms in the pleural cavity, Mf must gain access to 
the lymphatic system and eventually to blood, in order to be taken up by a new vector. In this 
journey they must pass through capillary systems where they may be trapped because of their large 
size. 15 min after intravenous injection of L. sigmodontis Mf in cotton rats Wenk et al. could recover 
32,9% in the liver and 6.4% from kidneys and spleen (275). Mf are known to stimulate strong immune 
responses (115, 182). Thus, trapped Mf may generate a local inflammatory environment favouring 
CD8+ T cell priming and proliferation.  
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Though comparatively more Mf may become trapped in the liver (275) no association 
between CD8+ T cell numbers and microfilaraemia could be found in this organ (Fig. 3.6 G). This 
suggested that the spleen was the main site involved in the generation of anti-plasmodial CD8+ T 
cells. Activated cytotoxic cells may later migrate to the liver to exert their anti-parasitical function. 
Indeed, an equivalent mechanism has been proposed before: CD8+ T cells specific for P. berghei liver 
stage parasites have been shown to be primed in draining lymph nodes after parasite inoculation 
through infected mosquitoes, and then exert their protective function in the liver (41). Since the 
spleen’s main function is pathogen recognition and processing of blood (132), intravenous injection 
of sporozoites done in the present model might have resulted in CD8+ T cell priming in the spleen.  
Potentially contributing to the establishment of more effective anti-sporozoite, macrophage 
numbers were found to be increased in the spleens of co-infected mice (Fig. 3.6 D). Macrophage 
migration from the pleural cavity to the blood after patency in L. sigmodontis infected mice has 
already been described (255), and in the work presented here, L. sigmodontis single infected mice 
showed significantly more macrophages in the liver than any other group (Fig. 3.6 C). Interestingly, 
macrophage numbers were lower in the pleural cavity of malaria-positive co-infected mice when 
compared to L. sigmodontis single infected controls (Figs. 3.9 C, D), suggesting that an additional 
number of these cells left the thoracic cavity after P. berghei infection. Increased macrophage 
numbers in the spleen of co-infected mice compared to L. sigmodontis single infected controls 
indicated that P. berghei infection may also drive their accumulation in the spleen. Induction of CD8+ 
T cell responses against P. berghei sporozoites would require antigen presentation by APCs, and 
macrophages are known to be able to exert this function (199). Therefore, an increased number of 
macrophages in the spleen of co-infected mice might augment the amount of specific cytotoxic T 
cells generated against plasmodial parasites and contribute to more efficient parasite elimination. 
A factor potentially favouring T cell priming by macrophages in microfilaraemic mice is the 
presence of symbiontic Wolbachia bacteria in filarial worms. It has been observed that Wolbachia-
derived antigens are sensed by APCs through TLR2 and 4 (25, 48). TLR engagement in macrophages 
induces their maturation and enhances APC functions (17, 207, 265). Trapping and eventual death of 
Mf in the spleen may result in the release of endosymbiotic Wolbachia bacteria and the induction of 
macrophage activation. Interestingly, malaria parasite-derived antigens also stimulate TLR2 and 4-
dependent responses (133). Thus, bacteria may synergize with plasmodial antigens in co-infected 
mice in the induction of APC maturation and T cell priming.  
 As mentioned before, adult worms stimulate the production of downregulatory cytokines 
like IL-10 to suppress host immune responses against Mf, prolonging their survival until taken up by a 
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new vector (112). Since filarial patency correlated with malaria protection the effect of IL-10 in the 
model was assessed using IL-10 deficient mice. All IL-10 KO co-infected mice were rendered malaria-
positive after sporozoite challenge, and thus malaria protection was proven to be dependent upon 
IL-10 (Fig. 3.6). Circulating IL-10 levels were not increased 60 days after L. sigmodontis infection (Fig. 
3.10 B), indicating that the function of IL-10 is local rather than systemic. Interestingly, immunity to 
malaria in individuals living in endemic areas has been shown in several studies to be related to 
increased IL-10 levels. This cytokine is produced by peripheral blood mononuclear cells (PBMC) 
against P. falciparum liver stage antigen-1 (LSA-1) (162). High IL-10,  but neither IFN-γ nor TNF-α 
responses to P. falciparum LSA-1 by PBMCs were associated to resistance to sporozoite infection in 
different studies in Kenya (135) and Gabon (150). In agreement with these studies, John et al. 
observed that individuals whose PBMCs generated IL-10 responses when exposed to LSA-1 during 
the dry season where more resistant to infection during the subsequent rainy season. In that work, 
an association between protection from P. falciparum re-infection and LSA-1-driven IL-10 but not 
TNF-α, IFN-γ, or IL-5 responses was shown (122). Moreover, IL-10 could not be related to down-
regulation of immune responses against LSA-1 in another study on malaria immunity in children 
(149).  
However, the mechanism by which IL-10 is related to protection from sporozoite challenge in 
these studies is unknown. Still, examples of an IL-10 mediated enhancement of CD8+ T cell function 
have been shown in several studies: IL-10 has been shown to increase proliferation (290) and 
cytotoxic activity (45, 82, 93, 121, 219) of effector CD8+ T cells. Therefore, in the present work worm 
induced IL-10 may favour the generation and function of cytotoxic T cells and favour elimination of 
malaria parasites.  
Another possible explanation is an enhanced production of counterbalancing regulatory 
cytokines in IL-10 KO mice: deficiency in IL-10 has been shown to induce up-regulation of TGF-β (54, 
144), which is another characteristic worm-induced immunoregulatory cytokine (58, 255) involved in 
wound healing (75). This cytokine might be up-regulated in co-infected IL-10-deficient mice to repair 
damage caused by excessive immune responses, for example against trapped Mf. TGF-β has been 
shown to mediate CD8+ T cell hyporresponsiveness against P. yoelii sporozoites caused by 
concomitant blood stage plasmodial infections (178). Compensation by TGF-β for the absence of IL-
10 may account for the lack of protection in IL-10-deficient co-infected mice.  
In summary, filarial infection has been shown to promote protection against plasmodial 
sporozoite challenge in a mechanism mediated by locally produced IL-10 and with the involvement of 
microfilaraemia and potentially CD8+ T cells and macrophages. Trapped Mf in the spleen of co-
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infected mice might create a local inflammatory environment resulting in the accumulation of 
macrophages and the generation of CD8+ T cells specific for P. berghei intra-hepatic parasites. IL-10 
might enhance proliferation and cytotoxic activity of these cells, increasing the efficiency of 
elimination of malaria parasites in the liver. Depletion of cytotoxic T cells should be performed in 
order to prove the relevance of these cells in resistance to sporozoite infection in co-infected mice.     
 
4.2.2. Improved outcome of blood stage malaria in 
BALB/c mice 
 
A trend could be seen in individual experiments suggesting a prolonged survival and lower 
parasitaemia in co-infected mice. Some animals in this group were found to survive P. berghei 
infection for more than 30 days, a phenomenon that single infected mice cannot achieve. 
Furthermore, mice co-infected with 50000 iRBC 60 days after L. sigmodontis infection survived 
significantly longer when compared with their single infected littermates (p=0.0355, logrank test, Fig 
3.7 B). In order to obtain definitive proof of a beneficial effect of co-infection on the blood stage of 
malaria several independent experiments were pooled for the analysis of survival and P. berghei 
parasitaemia (Figs. 3.8 A, B).   
No significant differences in survival could be found between groups using the logrank test 
(p=0.1016, Fig 3.8 A). However, the logrank test calculates significance throughout the whole survival 
curve, but in the present setting a specific analysis of late survival to malaria was of special interest. 
Hence, single and co-infected mice were classified regarding their capacity to survive malaria longer 
than a threshold defined at day 30 p.p.i. Using the Fisher’s exact test then revealed that there was a 
significantly higher number of long-term survivors in the co-infected group when compared to P. 
berghei single infected mice (p=0.007, Fig. 3.8 A).  
Compared to their single infected counterparts, co-infected mice presented a significantly 
lower parasitaemia during the late stage of infection: the first time point when differences could be 
found was on day 11 p.p.i, which coincided with a fast rising in parasitaemia. Later, during days 13-15 
p.p.i. co-infected mice partially stabilized parasitaemia growth, which remained thereafter below the 
levels of their single infected counterparts (Fig.3.8 B).  
Lower parasitaemia at a late stage of blood infection might explain the prolonged survival of 
co-infected mice by delaying anaemia. Immunological analyses were performed on day 8 p.p.i., an 
early time point in the responses of BALB/c mice to malaria (50), and day 14 p.p.i., a late time point 
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after co-infection consistently found to show differences in parasitaemia.  Generally there was a  
reduced amount of immune cells in co-infected mice compared to their L. sigmodontis single infected 
littermates in the pleural cavity at both time points p.p.i. (Fig. 3.9 A, B). More specifically, 
macrophage numbers were strongly decreased in the pleural cavity of co-infected mice, but 
increased in the spleen (Fig. 3.9 C-F). The fact that a reduction in macrophage numbers could already 
be observed 8 days after P. berghei infection in the pleural cavity of co-infected mice compared to L. 
sigmodontis controls suggests that these cells actively leave this site. Since macrophages are 
considered long lived cells, with a life-span of several weeks (119), other possibilities such as cell 
death are unlikely to occur. Indeed, as commented before, macrophage migration from the pleural 
cavity to the periphery at day 60 post L. sigmodontis infection in single infected BALB/c mice has 
been previously reported (255), and the present results suggest that this process may be enhanced 
after P. berghei infection.  
Macrophages can phagocyte and destroy blood stage malaria parasites (291). Therefore, 
higher macrophage numbers in the spleen, which is considered the main site of elimination of these 
pathogens (70), may allow a better control of parasitaemia by co-infected mice. Macrophage 
phagocytosis is enhanced through IFN-γ (179). Plasma levels of this cytokine in single and co-infected 
mice were comparable, peaking at day 7 p.p.i. with similar intensity (Fig. 3.10 A). This indicates that 
IFN-γ production driven by P. berghei, and therefore Th1 polarization, was not altered by the worms, 
and could not account for the observed differences in parasitaemia between both groups. Analysis of 
immunoglobulin patterns further supported this conclusion. IgG2a is an immunoglobulin produced in 
the context of a Th1 immune response, and isotype switching to IgG2a in B cells is driven by IFN-γ 
(237). In contrast, switching to IgG1 production is induced by IL-4 during Th2 responses (236). After 
day 8 p.p.i. a similar production of IgG2 was found in both groups. The similarities between single 
and co-infected mice were further emphasied in the development of anti-plasmodial immune 
responses; equivalent IL-10 levels in plasma were detected in both groups after infection, peaking at 
day 7 p.p.i. like IFN-γ (Fig. 3.10 B). Comparable cytokine and immunoglobulin patterns in single and 
co-infected mice excludes an important role for immune responses triggered by T or B cells and 
suggests that differences in parasitaemia and survival may be mainly due to the higher amount of 
macrophages present in spleens of co-infected mice.  
In summary, co-infection of L. sigmodontis infected BALB/c mice with P. berghei at patency 
induces one third of mice remaining malaria-negative in an IL-10-dependent mechanism, and the rest 
malaria-positive. A more pronounced accumulation of CD8+ T cells in the spleen and liver takes place 
in co-infected mice, potentially improving sporozoite clearance. Additionally, macrophages 
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accumulate in the spleen and may account for improved CD8+ T cell priming against liver stage 
parasites and enhanced control of blood stage parasites in malaria-positive co-infected mice.  
 
A beneficial effect of filarial patency agasint blood stage malaria parasites was also shown in 
a previous study of co-infection with non-lethal P. chabaudi chabaudi 60 days after L. sigmodontis 
infection (96). The present work could show in addition that microfilaraemia results advantageous 
against plasmodial liver stages.  
   
4.3. CO-INFECTION IN C57BL/6 MICE  
 
Co-infection of C57BL/6 mice with P. berghei at day 60 after L. sigmodontis infection resulted 
in a significant protection from CM. All single infected mice developed pathology within the first 10 
days of infection, whereas more than 70% of their co-infected littermates survived the critical period 
when CM occurs (Fig. 3.11 A). Co-infected mice also presented a significantly lower parasitaemia 
than their single infected counterparts (Fig. 3.11 B). CM is an immune-mediated pathology triggered 
by the up-regulation of Th1 cytokines such as LT-α (71) or IFN-γ (214). Thus, CM prevention in co-
infected mice might reflect a modulation of the inflammatory process exerted by the worms. Indeed, 
IL-10 levels in L. sigmodontis single and co-infected mice were significantly increased compared to P. 
berghei single infected or naïve controls in plasma and pleural cavity (Fig. 3.14 A, C). IL-10 is an 
immunomodulatory cytokine typically induced by filarial worms (58, 151, 181), suppressing not only 
Th1 but also Th2 responses (181, 240). The higher levels of this cytokine not only in plasma but also 
in the pleural cavity clearly indicated a worm-induced production in infected mice. In confirmation of 
this, co-infection of IL-10 deficient C57BL/6 mice resulted in absence of CM protection (Fig. 3.15).  
Protective effects of IL-10 on malaria have been reported before. Injection of recombinant IL-
10 in CM-susceptible mice abrogates pathology development after P. berghei infection (131). In 
contrast, infection of IL-10 deficient C57BL/6 mice with non-lethal P. chabaudi results in CM 
development and death of some mice (217), presenting increased levels of circulating IFN-γ and TNF-
α (143). Depletion of TNF-α in IL-10 deficient mice significantly improves pathology development 
(144). Therefore, IL-10 naturally regulates excessive Th1 inflammation after P. chabaudi infection, 
and its deficiency leads to increased immune-mediated pathology. IL-10 regulatory function is 
complemented by TGF-β, another paradigmatic immunomodulatory cytokine. Increased levels of 
TGF-β are found in IL-10 KO mice after P. chabaudi infection, partially counterbalancing the defect in 
IL-10. Additional depletion of TGF-β in this model results in pathology development and death in all 
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mice (144). TGF-β has been found to mediate worm induced immunosuppression (58, 255). However, 
in the present co-infection model this cytokine was found at similar levels in all groups (Fig. 3.10 D), 
underlining the higher importance of IL-10 mediating immunoregulation. 
The analysis of the course of IFN-γ after P. berghei infection showed no differences between 
single and co-infected mice (Fig. 3.14 B). Both groups presented a peak in a similar range at day 4 
post-infection. It is of note to comment that a similar IFN-γ peak was observed in all single and co-
infected C57BL/6 and BALB/c mice at days 4 and 7 post infection respectively. Taking into account 
that C57BL/6 mice were infected with blood parasites, and thus by passing the liver stage of P. 
berghei, this IFN-γ peak is likely to be triggered by a similar mechanism in both strains. As discussed 
before, CD4+ T cells are good candidates for the production of this peak (107). Since no differences 
could be found between single and co-infected mice, this cell population does not seem to be 
affected by worm-induced mechanisms in both mouse strains. 
Differences between single and co-infected mice arose when examining the distribution of 
immune cells in the organs implicated in CM generation, namely spleen and brain. CD8+ T cells were 
found in lower numbers in the brain but higher in the spleen in co-infected mice compared to their 
single infected counterparts (3.13 D, E). CD8+ T cells are critical mediators of CM, accumulating in the 
brain and damaging the endothelium in a perforin-dependent manner (12, 13, 172, 198). Depletion 
of CD8+ T cells even during the onset of the pathology can prevent death in susceptible mice (13). 
Therefore the absence of these cells in the brain could explain the lack of pathology shown in co-
infected mice.  
Interestingly, ICAM-1 expression in the brain was similar in single and co-infected mice (Fig. 
3.14 E). This result is therefore likely to reflect a particular alteration of CD8+ T cell migration, but not 
the complete abrogation of the inflammatory process in the brain, in co-infected mice. Supporting 
this, physiological parameters related to malaria like loss of body weight or splenomegaly were 
comparable in both P. berghei infected groups (Fig. 3.12 A, B), reflecting a similar development of 
pathology. The striking difference in susceptibility between single and co-infected mice was hence 
limited to a late step in the cascade of events triggering CM, namely CD8+ T cell migration and 
effector function. Indeed, a very similar mechanism of impairment of CD8+ T cell migration to the 
brain resulting in CM prevention has been described before: depletion of CD4+CD25+Foxp3+ T cells 
(natural regulatory T cells) in P. berghei infected C57BL/6 mice surprisingly arrested progression to 
CM (6). Protection was found to be linked to a decreased specific recruitment of CD8+ T cells in the 
brain, and to their accumulation in the spleen, in a process mediated by IL-10. Interestingly, in that 
study ICAM-1 levels were up-regulated in brain in both depleted and non-depleted mice (6). The 
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chemokine receptor CCR5 has been related to CD8+ T cell migration to the brain during CM, and CCR5 
KO mice do not develop pathology (12). CCR5 expression has been shown to be down-regulated in 
CD4+ T cells in the presence of IL-10 (187). Analogously, high levels of circulating IL-10 might prevent 
CCR5 expression and migration of CD8+ T cells to the brain, protecting co-infected mice from CM. 
Despite the proven regulatory properties of IL-10 in macrophages, neutrophils and 
eosinophils (53, 211, 283), which are the main mediators of immune responses against worms, high 
IL-10 levels in the pleural cavity and plasma did not hinder parasitaemia control by co-infected 
animals, which indeed developed a significantly lower parasitaemia than the single infected controls 
during the whole period of infection (Fig. 3.11 B). Recent advances in understanding the peculiarities 
of TLR stimulation in alveolar macrophages under immunomodulatory conditions may however 
explain this phenomenon. Alveolar macrophages are found in the lung, where constitutively high IL-
10 expression by bronchial epithelial cells keeps a state of permanent immunosuppression (20). 
Despite this, they are able to efficiently respond to pathogens upon cross-stimulation of their TLR2, 4 
or 9 by specific agonists (76). In the present co-infection model immune cells were found in lower 
numbers in pleural cavity of co-infected mice compared to L. sigmodontis single infected controls at 
day 7 p.p.i., during the CM period (Fig. 3.13 A). In contrast, more cells were found in the spleen of co-
infected mice (Fig. 3.13 B). Though not significant, a trend of increased macrophage numbers could 
be observed (Fig. 3.13 C). Similarly to co-infected BALB/c mice, macrophages might leave the pleural 
cavity to home to the spleen upon P. berghei co-infection in C57BL/6 mice. Malaria parasites are 
recognized by macrophages through TLR2, 4 and 9 (133, 186), and therefore it is possible that the 
cross-activation mechanism described for alveolar macrophages may also apply in co-infected 
C57BL/6 mice. An extra number of macrophages leaving the thoracic cavity and homing to the spleen 
might be cross-activated by malaria parasites and allow an improved control of parasitaemia. Indeed, 
macrophage cross-activation might already occur in the pleural cavity since Wolbachia engagement 
of TLRs can also activate macrophages for TNF-α production through TLR2 and 4 (25). Release of 
Wolbachia from damaged worms is known to elicit neutrophil accumulation for granuloma formation 
and worm elimination (26). Therefore macrophages may be pre-activated in the pleural cavity 
through Wolbachia and migrate to blood upon co-infection, resulting in an improved control of the 
malaria parasites. 
CD4+ T cells are known to contribute to parasitaemia clearance through IFN-γ production and 
macrophage activation (136, 179, 246). In order to further clarify the mechanism of reduction of 
parasitaemia in co-infected mice, CD4+ and CD8+ T cells were depleted and the parasitaemia 
measured at day 7 p.p.i., during the CM period. All depleted mice were protected from CM, as 
expected (data not shown). Depletion of CD4+ T cells lead to an increase in parasitaemia in both 
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single and co-infected mice, but surprisingly, CD4+ depleted single infected mice still had significantly 
higher parasitaemias than their co-infected counterparts (Fig. 3.16), suggesting that an additional 
mechanism in the co-infected mice is responsible for the further reduction of parasitaemia. This 
result supports the hypothesis that pre-activated macrophages leaving the pleural cavity after P. 
berghei infection might be involved in the enhanced parasite elimination. 
A remaining question refers to the source of IL-10. Many cell types are able to produce IL-10: 
CD4+ T cells, CD8+ T cells, B cells, mast cells, eosinophils, macrophages and DCs (reviewed in (161, 
177)). In the co-infection model used here, P. berghei infection caused extensive loss of B and T cells 
in CM-surviving mice after the CM period (data not shown). Selective apoptosis of B and T cells in the 
P. chabaudi model (101), as well as specific anti-P. berghei CD4+ T cells have been already reported 
(107). However, since elevated IL-10 levels do not significantly decrease after the CM period when 
compared to those of L. sigmodontis single infected mice (at day 12 p.p.i., p=0.0927, Mann-Whitney 
test, Fig. 3.10 A), a cell type other than B and T cells is more likely to produce IL-10. From the immune 
cells mentioned before macrophages and eosinophils could be good candidates, since they are the 
main mediators of the response against L. sigmodontis in the thoracic cavity (3), and therefore 
susceptible to be altered by the worms. Macrophages have been shown to produce IL-10 upon 
contact with S. mansoni eggs (46) and L. sigmodontis (239). 
In summary, a delicate equilibrium must be achieved for a successful outcome after a 
plasmodial infection: a Th1 reaction is necessary to kill the parasites, but an exaggerated response 
will derive in pathology. In this model, co-infection seems to provide a mechanism to establish such 
equilibrium. First, co-infected mice presented markedly enhanced levels of circulating IL-10 that 
prevent pathology, potentially impeding CD8+ T cell migration to the brain. But second, high IL-10 
levels do not interfere with the production of IFN-γ, necessary to kill the parasites (5, 104, 245), and 
additionally an extra number of macrophages coming from the pleural cavity may contribute in 
holding the parasitaemia at lower levels in co-infected mice.  
In agreement with the results presented here, development of cerebral pathology was 
abrogated in CM-susceptible CBA/J mice previously injected with Brugia pahangi L3 larvae (288). 
Splenic cells were found to produce increased levels of IL-4, IL-5 and IFN-γ at the moment of their co-
infection, thus developing combined Th1 and Th2 responses typically generated against filarial 
nematodes (215), but no IL-10 measurement was performed and the data shown does not allow a 
comparison to the mechanisms of CM protection presented in the model here. Interestingly, in 
contrast with the results of this work, P. berghei parasitaemia was markedly increased in B. pahangi-
P. berghei co-infected mice when compared to their single infected littermates, reflecting a profound 
  Discussion 
 
 - 93 - 
immunosuppression in these mice. In the present L. sigmodontis-P. berghei model, improved 
parasitaemia elimination might have been achieved by an extra number of macrophages that 
escaped pleural cavity to combat malaria parasites after long exposure to L. sigmodontis, as 
discussed before. However, in B. pahangi-P. berghei co-infected mice a significant macrophage 
accumulation in the spleen might not have taken place since co-infection was performed only 10 
days after the first L3 injection.    
In summary, a prior filarial infection significantly protected C57BL/6 mice from CM 
development after P. berghei infection in an IL-10-dependent manner, resulting in a lower 
recruitment of CD8+ T cells in the brain. Moreover, P. berghei parasitaemia was reduced in co-
infected mice notwithstanding high circulating IL-10 levels. 
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4.4.  UNIQUE FEATURES OF FILARIAL WORMS 
PROTECT AGAINST MALARIA  
 
Filarial infections have been shown to play important beneficial roles against malaria in the 
co-infection model studied here, increasing resistance to sporozoite infection, modulating CM 
development and prolonging the survival of the mice. Important protective mechanisms against 
malaria in co-infected mice were found to rely on IL-10 in both mouse strains. The genetic 
background of the mice critically determined the intensity of IL-10 responses against the parasites: 
whereas BALB/c mice showed low systemic levels of this cytokine, which probably acted locally, 
C57BL/6 mice presented a clearly enhanced production resulting in high plasma concentrations at 
day 60 after L. sigmodontis infection. Such differences produced completely different results: IL-10 
strikingly increased resistance of BALB/c mice against sporozoite infection, but also mediated a 
reduction of CM rates in C57BL/6 mice, which may be more “expected” outcome, given its major 
downregulatory function (161). Both mechanisms involved CD8+ T cells. Though high systemic IL-10 
concentrations may prevent migration of these cells to the brain in C57BL/6 mice, low systemic levels 
in BALB/c mice may not be sufficient to suppress CD8+ T cell accumulation in the liver. Moreover, IL-
10-mediated enhancement of CD8+ T cell function may be only possible at low concentrations.  
A different relevance of IL-10 on altering specific immunological mechanisms was further 
supported by similar findings in both strains showing that despite the differences in IL-10 levels, P. 
berghei parasitaemia was combated more efficiently, and that blood stage plasmodial-induced IFN-γ 
peaks were unaltered in co-infected animals. Particularly intringuing is the observation that C57BL/6 
mice were able to control parasitaemia more efficiently than their single infected counterparts 
despite their high systemic IL-10 levels and clearly shows that independent mechanisms mediate the 
elimination of blood stage malaria parasites and development of immune pathology, even though all 
rely on Th1 responses, and all are differently affected by IL-10.  
Macrophage numbers were decreased in pleural cavity and elevated in the spleen of co-
infected mice from both strains. This fact may be advantageous since more phagocytic cells could 
exert a better control of plasmodial parasitaemia. In the particular case of C57BL/6 mice, 
macrophages that have been constantly exposed to high IL-10 levels in the pleural cavity may 
overcome IL-10-mediated downregulation, being cross-activated by malaria parasites in blood 
through TLR engagement.  
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How do these results from a laboratory model fit with data obtained from other models and 
from human studies of helminth-plasmodial co-infection in endemic areas? 
As explained in section 1.3, co-infections of intestinal nematodes or S. mansoni and P. 
falciparum were shown in multiple studies to result in stronger malaria attacks defined by increased 
parasitaemia linked to fever, or to multiplicity of plasmodial infections (42, 167, 170, 173, 238, 242). 
A link between young age and worsened malaria could be found in some studies; older co-infected 
patients are less affected by a detrimental effect of the worms (30, 31). Shift to a Th2-like response 
or suppression of anti-plasmodial Th1 responses has been hypothesized to explain this effect (66). 
Though the immune status of human patients in endemic areas strongly differs from that of naive 
laboratory mice, such results are underlined by some experimental data from mice co-infected with 
S. mansoni and P. chabaudi (102), H. polygyrus and P. chabaudi (248) or E. caproni and P. yoelii (174). 
Moreover, a previous infection with the intestinal worm E. caproni resulted in enhanced 
susceptibility to P. yoelii sporozoites in BALB/c mice (175).  Other co-infection systems with S. 
mansoni and P. berghei yoelii did not find alterations in parasitaemia (142), but this might be due to 
the different capacity of S. mansoni-derived antigens to skew Th1 responses (36, 69). Since Th1 
responses are necessary for blood or liver stage malaria parasite control, any alteration consisting in 
its down-regulation or shift to Th2 may impair parasite elimination. Results from the present work 
seem to disagree with these studies.  
On the other hand, worm infections have been linked to protection from malaria pathology 
in adult patients (166, 169), in whom worms are more prevalent than in children (68). Results were 
mirrored by studies in mice showing that P. berghei co-infection after injection of B. pahangi L3 
larvae were also protected from CM (263). It is expectable that if worms have immunoregulatory 
properties impairing Th1-dependent parasitaemia control, they might also modify the outcome of 
the Th1-dependent CM pathology. Results showed here agree with previous literature in the latter 
case.   
There are unique features of L. sigmodontis and by extension filarial infections that are not 
shared with other helminths and make them unique in a co-infection setting with malaria, resulting 
beneficial even in enhancing anti-malarial mechanisms which are usually hampered by immune 
responses mediated by non-filarial worms: a) the presence of worms in the pleural cavity and Mf in 
blood (in BALB/c mice) allows a close contact between worm stages and immune cells; b) different 
stages of L. sigmodontis induce different kinds of responses; thus, though adult worms induce 
immunoregulation, Mf stimulate inflammation; and c) a Th1 component of anti-L. sigmodontis 
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immunity is linked to responses against Wolbachia bacteria emerging from damaged worms (25), 
possibly allowing cross-activation of immune cells by engaging similar TLRs than malaria parasites.    
Most of the relevant variables associated with protective malaria outcomes in the present 
co-infection model (microfilaraemia, IL-10-derived immunosuppression, similar combined Th1/Th2 
responses against the worms), are present in filaria patients living in endemic areas, making it 
theoretically possible to directly compare between the results presented here and the human 
situation. Filariae may constitute a natural counterbalance of the high virulence of P. falciparum, 
protecting co-infected individuals from pathology and high parasitaemia and favouring their survival 
to malaria. By doing so, filariae would not only protect the host, but they would ultimately ensure 
their own survival as parasites, and indeed they would allow malaria transmission from co-infected 
subjects for prolonged periods of time.         
In order to solve the current debate on the effect of worms and plasmodial co-infections in 
human populations more precise investigations linking immunological variables (such as APC 
function, T cell or antibody isotype polarization, cytokine patterns) with the characteristics of the life 
cycles of particular nematodes and with diverse transmission intensities and patient’s age should be 
undertaken. Given the heterogeneity of body niches occupied by different nematode groups and the 
variable capabilities of immune stimulation that they exert on the host it seems unlikely, however, 
that a unifying conclusion on a protective or detrimental effect of any worm infection on malaria can 
be raised. Thus, whereas a clear beneficial outcome has been described here involving different 
mechanisms derived from intrinsic characteristics of filarial worms, co-infection studies using other 
nematode species caused impaired malaria control.  
Given the similarities between the murine parasites used here and their human counterparts, 
it is likely that immune mechanisms occurring in individuals co-infected with filariae and Plasmodium 
reflect those describe here, and that these subjects may enjoy a natural protection against malaria 
parasites. In consequence, since anti-filarial mass-treatments are currently being carried out in 
endemic countries, there is a clear risk of impairing such mechanisms, increasing malaria morbidity 
and mortality. Urgent analyses should be performed in co-infected patients to determine the extent 
in which data from the present murine model is representative for human beings. 
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Figure 4.1: Summary of the effects of L. 
sigmodontis on P. berghei after co-
infection. L. sigmodontis has been shown 
to influence the course of P. berghei
infections through different mechanisms 
that were dependent on IL-10. This 
cytokine induced protection against P. 
berghei sporozoite challenge in BALB/c 
mice. Such protection was related to the 
presence of Mf in blood, favoured by IL-
10, which in turn correlated with higher 
CD8+ T cell numbers in spleen. 
Additionally, CD8+ T cell numbers were 
increased in the liver of co-infected mice, 
potentially impairing intrahepatic parasite 
development. In co-infected C57BL/6 
mice CM was prevented in an IL-10-
dependent manner, presenting these 
mice lower CD8+ T cells in the brain. IFN-γ 
levels remained unaltered in co-infected 
mice. Macrophages were increased in the 
spleen in co-infected mice from both 
strains, potentially accounting for 
improved parasitaemia control. Red 
arrows denote impairment, whereas 
green arrows represent enhancement.
Dotted lines denote not fully 
demonstrated hypothesess. 
 - 98 - 
 
5. References 
 
 
1. Achtman, A. H., M. Khan, I. C. MacLennan, and J. Langhorne. 2003. Plasmodium chabaudi chabaudi infection in 
mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol 
171:317-324. 
2. Al-Qaoud, K. M., B. Fleischer, and A. Hoerauf. 1998. The Xid defect imparts susceptibility to experimental 
murine filariosis--association with a lack of antibody and IL-10 production by B cells in response to 
phosphorylcholine. Int Immunol 10:17-25. 
3. Al-Qaoud, K. M., E. Pearlman, T. Hartung, J. Klukowski, B. Fleischer, and A. Hoerauf. 2000. A new mechanism 
for IL-5-dependent helminth control: neutrophil accumulation and neutrophil-mediated worm encapsulation in 
murine filariasis are abolished in the absence of IL-5. Int Immunol 12:899-908. 
4. Al-Qaoud, K. M., A. Taubert, H. Zahner, B. Fleischer, and A. Hoerauf. 1997. Infection of BALB/c mice with the 
filarial nematode Litomosoides sigmodontis: role of CD4+ T cells in controlling larval development. Infect Immun 
65:2457-2461. 
5. Amani, V., A. M. Vigario, E. Belnoue, M. Marussig, L. Fonseca, D. Mazier, and L. Renia. 2000. Involvement of 
IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium 
berghei infection. Eur J Immunol 30:1646-1655. 
6. Amante, F. H., A. C. Stanley, L. M. Randall, Y. Zhou, A. Haque, K. McSweeney, A. P. Waters, C. J. Janse, M. F. 
Good, G. R. Hill, and C. R. Engwerda. 2007. A role for natural regulatory T cells in the pathogenesis of 
experimental cerebral malaria. The American journal of pathology 171:548-559. 
7. Amino, R., S. Thiberge, B. Martin, S. Celli, S. Shorte, F. Frischknecht, and R. Menard. 2006. Quantitative 
imaging of Plasmodium transmission from mosquito to mammal. Nat Med 12:220-224. 
8. Babayan, S., T. Attout, S. Specht, A. Hoerauf, G. Snounou, L. Renia, M. Korenaga, O. Bain, and C. Martin. 2005. 
Increased early local immune responses and altered worm development in high-dose infections of mice 
susceptible to the filaria Litomosoides sigmodontis. Med Microbiol Immunol 194:151-162. 
9. Babayan, S., M. N. Ungeheuer, C. Martin, T. Attout, E. Belnoue, G. Snounou, L. Renia, M. Korenaga, and O. 
Bain. 2003. Resistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with 
early differences in parasite development and in localized immune reactions. Infect Immun 71:6820-6829. 
10. Baird, J. K. 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol 
Today 11:105-111. 
11. Bate, C. A., J. Taverne, and J. H. Playfair. 1988. Malarial parasites induce TNF production by macrophages. 
Immunology 64:227-231. 
12. Belnoue, E., M. Kayibanda, J. C. Deschemin, M. Viguier, M. Mack, W. A. Kuziel, and L. Renia. 2003. CCR5 
deficiency decreases susceptibility to experimental cerebral malaria. Blood 101:4253-4259. 
13. Belnoue, E., M. Kayibanda, A. M. Vigario, J. C. Deschemin, N. van Rooijen, M. Viguier, G. Snounou, and L. 
Renia. 2002. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral 
malaria. J Immunol 169:6369-6375. 
14. Berendt, A. R., D. J. Ferguson, and C. I. Newbold. 1990. Sequestration in Plasmodium falciparum malaria: sticky 
cells and sticky problems. Parasitol Today 6:247-254. 
15. Berendt, A. R., D. L. Simmons, J. Tansey, C. I. Newbold, and K. Marsh. 1989. Intercellular adhesion molecule-1 is 
an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341:57-59. 
16. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. The foreign 
antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512-518. 
17. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by 
dendritic cells. Nature 440:808-812. 
18. Blue, M. L., K. A. Craig, P. Anderson, K. R. Branton, Jr., and S. F. Schlossman. 1988. Evidence for specific 
association between class I major histocompatibility antigens and the CD8 molecules of human 
suppressor/cytotoxic cells. Cell 54:413-421. 
19. Bogitsh, B. J., C. E. Carter, and T. N. Oeltmann. 2005. Human Parasitology, Third Edition ed. Elsevier, London. 
20. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Hilliard, and M. Berger. 1995. Normal bronchial 
epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in 
cystic fibrosis. American journal of respiratory cell and molecular biology 13:257-261. 
21. Bongfen, S. E., R. Torgler, J. F. Romero, L. Renia, and G. Corradin. 2007. Plasmodium berghei-infected primary 
hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. J Immunol 
178:7054-7063. 
22. Bouharoun-Tayoun, H., P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi, and P. Druilhe. 1990. Antibodies 
that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth 
and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172:1633-1641. 
23. Bouharoun-Tayoun, H., and P. Druilhe. 1992. Plasmodium falciparum malaria: evidence for an isotype 
imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 60:1473-
1481. 
      References 
 
 - 99 - 
24. Boyd, A. W., S. O. Wawryk, G. F. Burns, and J. V. Fecondo. 1988. Intercellular adhesion molecule 1 (ICAM-1) has 
a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci U S A 85:3095-3099. 
25. Brattig, N. W., C. Bazzocchi, C. J. Kirschning, N. Reiling, D. W. Buttner, F. Ceciliani, F. Geisinger, H. Hochrein, M. 
Ernst, H. Wagner, C. Bandi, and A. Hoerauf. 2004. The major surface protein of Wolbachia endosymbionts in 
filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol 173:437-445. 
26. Brattig, N. W., D. W. Buttner, and A. Hoerauf. 2001. Neutrophil accumulation around Onchocerca worms and 
chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes and infection / Institut Pasteur 
3:439-446. 
27. Brattig, N. W., B. Lepping, C. Timmann, D. W. Buttner, Y. Marfo, C. Hamelmann, and R. D. Horstmann. 2002. 
Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but 
mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial 
density. J Infect Dis 185:1148-1154. 
28. Brattig, N. W., U. Rathjens, M. Ernst, F. Geisinger, A. Renz, and F. W. Tischendorf. 2000. Lipopolysaccharide-like 
molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in 
the sequence of inflammatory and antiinflammatory responses of human monocytes. Microbes Infect 2:1147-
1157. 
29. Briand, V., L. Watier, L. E. H. JY, A. Garcia, and M. Cot. 2005. Coinfection with Plasmodium falciparum and 
schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children? Am J Trop 
Med Hyg 72:702-707. 
30. Brutus, L., L. Watier, V. Briand, V. Hanitrasoamampionona, H. Razanatsoarilala, and M. Cot. 2006. Parasitic co-
infections: does Ascaris lumbricoides protect against Plasmodium falciparum infection? Am J Trop Med Hyg 
75:194-198. 
31. Brutus, L., L. Watier, V. Hanitrasoamampionona, H. Razanatsoarilala, and M. Cot. 2007. Confirmation of the 
Protective Effect of Ascaris lumbricoides on Plasmodium falciparum Infection: Results of a Randomized Trial in 
Madagascar. Am J Trop Med Hyg 77:1091-1095. 
32. Buttner, D. W., and P. Racz. 1983. Macro- and microfilariae in nodules from onchocerciasis patients in the 
Yemen Arab Republic. Tropenmedizin und Parasitologie 34:113-121. 
33. Buttner, D. W., G. von Laer, E. Mannweiler, and M. Buttner. 1982. Clinical, parasitological and serological 
studies on onchocerciasis in the Yemen Arab Republic. Tropenmedizin und Parasitologie 33:201-212. 
34. Carlson, J., H. Helmby, A. V. Hill, D. Brewster, B. M. Greenwood, and M. Wahlgren. 1990. Human cerebral 
malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336:1457-1460. 
35. Carvalho, L. H., G. Sano, J. C. Hafalla, A. Morrot, M. A. Curotto de Lafaille, and F. Zavala. 2002. IL-4-secreting 
CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat Med 
8:166-170. 
36. Cervi, L., A. S. MacDonald, C. Kane, F. Dzierszinski, and E. J. Pearce. 2004. Cutting edge: dendritic cells copulsed 
with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct 
intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. 
J Immunol 172:2016-2020. 
37. Collart, M. A., D. Belin, J. D. Vassalli, S. de Kossodo, and P. Vassalli. 1986. Gamma interferon enhances 
macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are 
controlled by short-lived repressors. J Exp Med 164:2113-2118. 
38. Cooper, P. J., M. Chico, C. Sandoval, I. Espinel, A. Guevara, M. M. Levine, G. E. Griffin, and T. B. Nutman. 2001. 
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to 
recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect 
Immun 69:1574-1580. 
39. Cowman, A. F., and B. S. Crabb. 2006. Invasion of red blood cells by malaria parasites. Cell 124:755-766. 
40. Curfs, J. H., C. C. Hermsen, P. Kremsner, S. Neifer, J. H. Meuwissen, N. Van Rooyen, and W. M. Eling. 1993. 
Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology 
107 ( Pt 2):125-134. 
41. Chakravarty, S., I. A. Cockburn, S. Kuk, M. G. Overstreet, J. B. Sacci, and F. Zavala. 2007. CD8+ T lymphocytes 
protective against malaria liver stages are primed in skin-draining lymph nodes. Nat Med 13:1035-1041. 
42. Chaorattanakawee, S., O. Natalang, H. Hananantachai, M. Nacher, A. Brockman, F. Nosten, S. Looareesuwan, 
and J. Patarapotikul. 2003. Trichuris trichiura infection is associated with the multiplicity of Plasmodium 
falciparum infections, in Thailand. Annals of tropical medicine and parasitology 97:199-202. 
43. Chen, L., and F. Sendo. 2001. Cytokine and chemokine mRNA expression in neutrophils from CBA/NSlc mice 
infected with Plasmodium berghei ANKA that induces experimental cerebral malaria. Parasitology international 
50:139-143. 
44. Chen, L., Z. Zhang, and F. Sendo. 2000. Neutrophils play a critical role in the pathogenesis of experimental 
cerebral malaria. Clinical and experimental immunology 120:125-133. 
45. Chen, W. F., and A. Zlotnik. 1991. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 147:528-534. 
46. Chensue, S. W., K. Warmington, J. H. Ruth, and S. L. Kunkel. 1997. Effect of slow release IL-12 and IL-10 on 
inflammation, local macrophage function and the regional lymphoid response during mycobacterial (Th1) and 
schistosomal (Th2) antigen-elicited pulmonary granuloma formation. Inflamm Res 46:86-92. 
47. Christensen, J. E., A. Nansen, T. Moos, B. Lu, C. Gerard, J. P. Christensen, and A. R. Thomsen. 2004. Efficient T-
cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J Neurosci 24:4849-4858. 
48. Daehnel, K., I. Gillette-Ferguson, A. G. Hise, E. Diaconu, M. J. Harling, F. P. Heinzel, and E. Pearlman. 2007. 
Filaria/Wolbachia activation of dendritic cells and development of Th1-associated responses is dependent on 
References 
 - 100 - 
Toll-like receptor 2 in a mouse model of ocular onchocerciasis (river blindness). Parasite immunology 29:455-
465. 
49. Das, D., S. Kumar, P. K. Sahoo, and A. P. Dash. 2005. A survey of bancroftian filariasis for microfilariae & 
circulating antigenaemia in two villages of Madhya Pradesh. The Indian journal of medical research 121:771-775. 
50. de Kossodo, S., and G. E. Grau. 1993. Profiles of cytokine production in relation with susceptibility to cerebral 
malaria. J Immunol 151:4811-4820. 
51. de Souza, J. B., and E. M. Riley. 2002. Cerebral malaria: the contribution of studies in animal models to our 
understanding of immunopathogenesis. Microbes Infect 4:291-300. 
52. De Souza, J. B., K. H. Williamson, T. Otani, and J. H. Playfair. 1997. Early gamma interferon responses in lethal 
and nonlethal murine blood-stage malaria. Infect Immun 65:1593-1598. 
53. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10(IL-10) inhibits 
cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 
174:1209-1220. 
54. Demols, A., J. L. Van Laethem, E. Quertinmont, C. Degraef, M. Delhaye, A. Geerts, and J. Deviere. 2002. 
Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. American 
journal of physiology 282:G1105-1112. 
55. deWalick, S., F. H. Amante, K. A. McSweeney, L. M. Randall, A. C. Stanley, A. Haque, R. D. Kuns, K. P. 
MacDonald, G. R. Hill, and C. R. Engwerda. 2007. Cutting edge: conventional dendritic cells are the critical APC 
required for the induction of experimental cerebral malaria. J Immunol 178:6033-6037. 
56. Diallo, T. O., F. Remoue, A. M. Schacht, N. Charrier, J. P. Dompnier, S. Pillet, O. Garraud, A. N'Diaye A, A. 
Capron, M. Capron, and G. Riveau. 2004. Schistosomiasis co-infection in humans influences inflammatory 
markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol 26:365-369. 
57. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage 
costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151:1224-1234. 
58. Doetze, A., J. Satoguina, G. Burchard, T. Rau, C. Loliger, B. Fleischer, and A. Hoerauf. 2000. Antigen-specific 
cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-
10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 12:623-630. 
59. Dong, C., and R. A. Flavell. 2001. Th1 and Th2 cells. Current opinion in hematology 8:47-51. 
60. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J 
Immunol 165:1453-1462. 
61. Doolan, D. L., and S. L. Hoffman. 1999. IL-12 and NK cells are required for antigen-specific adaptive immunity 
against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J Immunol 163:884-892. 
62. Dreyer, G., Z. Medeiros, M. J. Netto, N. C. Leal, L. G. de Castro, and W. F. Piessens. 1999. Acute attacks in the 
extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. 
Trans R Soc Trop Med Hyg 93:413-417. 
63. Dreyer, G., J. Noroes, and D. Addiss. 1997. The silent burden of sexual disability associated with lymphatic 
filariasis. Acta Trop 63:57-60. 
64. Dreyer, G., J. Noroes, J. Figueredo-Silva, and W. F. Piessens. 2000. Pathogenesis of lymphatic disease in 
bancroftian filariasis: a clinical perspective. Parasitol Today 16:544-548. 
65. Dreyer, G., A. Santos, J. Noroes, A. Rocha, and D. Addiss. 1996. Amicrofilaraemic carriers of adult Wuchereria 
bancrofti. Trans R Soc Trop Med Hyg 90:288-289. 
66. Druilhe, P., A. Tall, and C. Sokhna. 2005. Worms can worsen malaria: towards a new means to roll back malaria? 
Trends in parasitology 21:359-362. 
67. Duerr, H. P., K. Dietz, H. Schulz-Key, D. W. Buttner, and M. Eichner. 2003. Density-dependent parasite 
establishment suggests infection-associated immunosuppression as an important mechanism for parasite 
density regulation in onchocerciasis. Trans R Soc Trop Med Hyg 97:242-250. 
68. Duerr, H. P., K. Dietz, H. Schulz-Key, D. W. Buttner, and M. Eichner. 2004. The relationships between the 
burden of adult parasites, host age and the microfilarial density in human onchocerciasis. Int J Parasitol 34:463-
473. 
69. Elias, D., H. Akuffo, C. Thors, A. Pawlowski, and S. Britton. 2005. Low dose chronic Schistosoma mansoni 
infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clinical and experimental 
immunology 139:398-404. 
70. Engwerda, C. R., L. Beattie, and F. H. Amante. 2005. The importance of the spleen in malaria. Trends Parasitol 
21:75-80. 
71. Engwerda, C. R., T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye. 2002. Locally up-
regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine 
cerebral malaria. J Exp Med 195:1371-1377. 
72. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting 
function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 151:2390-2398. 
73. Evans, K. J., D. S. Hansen, N. van Rooijen, L. A. Buckingham, and L. Schofield. 2006. Severe malarial anemia of 
low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood 
107:1192-1199. 
74. Fagarasan, S., and T. Honjo. 2000. T-Independent immune response: new aspects of B cell biology. Science 
290:89-92. 
75. Faler, B. J., R. A. Macsata, D. Plummer, L. Mishra, and A. N. Sidawy. 2006. Transforming growth factor-beta and 
wound healing. Perspectives in vascular surgery and endovascular therapy 18:55-62. 
      References 
 
 - 101 - 
76. Fernandez, S., P. Jose, M. G. Avdiushko, A. M. Kaplan, and D. A. Cohen. 2004. Inhibition of IL-10 receptor 
function in alveolar macrophages by Toll-like receptor agonists. J Immunol 172:2613-2620. 
77. Finbloom, D. S., and K. D. Winestock. 1995. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the 
differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 
155:1079-1090. 
78. Franks, S., K. A. Koram, G. E. Wagner, K. Tetteh, D. McGuinness, J. G. Wheeler, F. Nkrumah, L. Ranford-
Cartwright, and E. M. Riley. 2001. Frequent and persistent, asymptomatic Plasmodium falciparum infections in 
African infants, characterized by multilocus genotyping. J Infect Dis 183:796-804. 
79. Frevert, U., S. Engelmann, S. Zougbede, J. Stange, B. Ng, K. Matuschewski, L. Liebes, and H. Yee. 2005. 
Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol 3:e192. 
80. Frischknecht, F., P. Baldacci, B. Martin, C. Zimmer, S. Thiberge, J. C. Olivo-Marin, S. L. Shorte, and R. Menard. 
2004. Imaging movement of malaria parasites during transmission by Anopheles mosquitoes. Cell Microbiol 
6:687-694. 
81. Garcia, J. E., A. Puentes, and M. E. Patarroyo. 2006. Developmental biology of sporozoite-host interactions in 
Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev 19:686-707. 
82. Giovarelli, M., P. Musiani, A. Modesti, P. Dellabona, G. Casorati, A. Allione, M. Consalvo, F. Cavallo, F. di 
Pierro, C. De Giovanni, and et al. 1995. Local release of IL-10 by transfected mouse mammary adenocarcinoma 
cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-
dependent immune memory. J Immunol 155:3112-3123. 
83. Gonzalez-Aseguinolaza, G., L. Van Kaer, C. C. Bergmann, J. M. Wilson, J. Schmieg, M. Kronenberg, T. 
Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji. 2002. Natural killer T cell ligand alpha-galactosylceramide 
enhances protective immunity induced by malaria vaccines. J Exp Med 195:617-624. 
84. Gordon, S. 2003. Alternative activation of macrophages. Nat Rev Immunol 3:23-35. 
85. Gorelik, L., and R. A. Flavell. 2002. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2:46-53. 
86. Graham, A. L., T. J. Lamb, A. F. Read, and J. E. Allen. 2005. Malaria-filaria coinfection in mice makes malarial 
disease more severe unless filarial infection achieves patency. J Infect Dis 191:410-421. 
87. Gratchev, A., J. Kzhyshkowska, K. Kothe, I. Muller-Molinet, S. Kannookadan, J. Utikal, and S. Goerdt. 2006. 
Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger 
signals. Immunobiology 211:473-486. 
88. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor 
(cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212. 
89. Grau, G. E., P. Pointaire, P. F. Piguet, C. Vesin, H. Rosen, I. Stamenkovic, F. Takei, and P. Vassalli. 1991. Late 
administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral 
malaria. Eur J Immunol 21:2265-2267. 
90. Grau, G. E., F. Tacchini-Cottier, C. Vesin, G. Milon, J. N. Lou, P. F. Piguet, and P. Juillard. 1993. TNF-induced 
microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. European 
cytokine network 4:415-419. 
91. Gray, C. A., and R. A. Lawrence. 2002. A role for antibody and Fc receptor in the clearance of Brugia malayi 
microfilariae. Eur J Immunol 32:1114-1120. 
92. Greene, B. M., M. M. Fanning, and J. J. Ellner. 1983. Non-specific suppression of antigen-induced lymphocyte 
blastogenesis in Onchocerca volvulus infection in man. Clinical and experimental immunology 52:259-265. 
93. Groux, H., M. Bigler, J. E. de Vries, and M. G. Roncarolo. 1998. Inhibitory and stimulatory effects of IL-10 on 
human CD8+ T cells. J Immunol 160:3188-3193. 
94. Guevara Patino, J. A., A. A. Holder, J. S. McBride, and M. J. Blackman. 1997. Antibodies that inhibit malaria 
merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human 
antibodies. J Exp Med 186:1689-1699. 
95. Hafalla, J. C., G. Sano, L. H. Carvalho, A. Morrot, and F. Zavala. 2002. Short-term antigen presentation and 
single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc Natl Acad Sci U 
S A 99:11819-11824. 
96. Hall, N., M. Karras, J. D. Raine, J. M. Carlton, T. W. Kooij, M. Berriman, L. Florens, C. S. Janssen, A. Pain, G. K. 
Christophides, K. James, K. Rutherford, B. Harris, D. Harris, C. Churcher, M. A. Quail, D. Ormond, J. Doggett, H. 
E. Trueman, J. Mendoza, S. L. Bidwell, M. A. Rajandream, D. J. Carucci, J. R. Yates, 3rd, F. C. Kafatos, C. J. Janse, 
B. Barrell, C. M. Turner, A. P. Waters, and R. E. Sinden. 2005. A comprehensive survey of the Plasmodium life 
cycle by genomic, transcriptomic, and proteomic analyses. Science 307:82-86. 
97. Hansen, D. S., N. J. Bernard, C. Q. Nie, and L. Schofield. 2007. NK cells stimulate recruitment of CXCR3+ T cells 
to the brain during Plasmodium berghei-mediated cerebral malaria. J Immunol 178:5779-5788. 
98. Hansen, D. S., K. J. Evans, M. C. D'Ombrain, N. J. Bernard, A. C. Sexton, L. Buckingham, A. A. Scalzo, and L. 
Schofield. 2005. The natural killer complex regulates severe malarial pathogenesis and influences acquired 
immune responses to Plasmodium berghei ANKA. Infect Immun 73:2288-2297. 
99. Hansen, D. S., and L. Schofield. 2004. Regulation of immunity and pathogenesis in infectious diseases by CD1d-
restricted NKT cells. Int J Parasitol 34:15-25. 
100. Hansen, D. S., M. A. Siomos, L. Buckingham, A. A. Scalzo, and L. Schofield. 2003. Regulation of murine cerebral 
malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 18:391-402. 
101. Helmby, H., G. Jonsson, and M. Troye-Blomberg. 2000. Cellular changes and apoptosis in the spleens and 
peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect Immun 68:1485-
1490. 
References 
 - 102 - 
102. Helmby, H., M. Kullberg, and M. Troye-Blomberg. 1998. Altered immune responses in mice with concomitant 
Schistosoma mansoni and Plasmodium chabaudi infections. Infect Immun 66:5167-5174. 
103. Herbert, D. R., C. Holscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, 
H. Mossmann, B. Claussen, I. Forster, and F. Brombacher. 2004. Alternative macrophage activation is essential 
for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 
20:623-635. 
104. Herrera, M. A., F. Rosero, S. Herrera, P. Caspers, D. Rotmann, F. Sinigaglia, and U. Certa. 1992. Protection 
against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell 
epitope: correlation of serum gamma interferon levels with protection. Infect Immun 60:154-158. 
105. Hill, A. V., C. E. Allsopp, D. Kwiatkowski, N. M. Anstey, P. Twumasi, P. A. Rowe, S. Bennett, D. Brewster, A. J. 
McMichael, and B. M. Greenwood. 1991. Common west African HLA antigens are associated with protection 
from severe malaria. Nature 352:595-600. 
106. Hirunpetcharat, C., F. Finkelman, I. A. Clark, and M. F. Good. 1999. Malaria parasite-specific Th1-like T cells 
simultaneously reduce parasitemia and promote disease. Parasite Immunol 21:319-329. 
107. Hirunpetcharat, C., and M. F. Good. 1998. Deletion of Plasmodium berghei-specific CD4+ T cells adoptively 
transferred into recipient mice after challenge with homologous parasite. Proc Natl Acad Sci U S A 95:1715-
1720. 
108. Hoerauf, A., and N. Brattig. 2002. Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2. 
Trends Parasitol 18:25-31. 
109. Hoerauf, A., J. Satoguina, M. Saeftel, and S. Specht. 2005. Immunomodulation by filarial nematodes. Parasite 
Immunol 27:417-429. 
110. Hoffman, S. L., and D. L. Doolan. 2000. Malaria vaccines-targeting infected hepatocytes. Nat Med 6:1218-1219. 
111. Hoffmann, W., G. Petit, H. Schulz-Key, D. Taylor, O. Bain, and L. Le Goff. 2000. Litomosoides sigmodontis in 
mice: reappraisal of an old model for filarial research. Parasitol Today 16:387-389. 
112. Hoffmann, W. H., A. W. Pfaff, H. Schulz-Key, and P. T. Soboslay. 2001. Determinants for resistance and 
susceptibility to microfilaraemia in Litomosoides sigmodontis filariasis. Parasitology 122:641-649. 
113. Horauf, A., and B. Fleischer. 1997. Immune responses to filarial infection in laboratory mice. Med Microbiol 
Immunol 185:207-215. 
114. Hsu, D. H., K. W. Moore, and H. Spits. 1992. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma 
synthesis and lymphokine-activated killer activity. Int Immunol 4:563-569. 
115. Hubner, M. P., B. Pasche, S. Kalaydjiev, P. T. Soboslay, A. Lengeling, H. Schulz-Key, E. Mitre, and W. H. 
Hoffmann. 2008. Microfilariae of the filarial nematode Litomosoides sigmodontis exacerbate the course of 
lipopolysaccharide-induced sepsis in mice. Infect Immun 76:1668-1677. 
116. Hunt, N. H., J. Golenser, T. Chan-Ling, S. Parekh, C. Rae, S. Potter, I. M. Medana, J. Miu, and H. J. Ball. 2006. 
Immunopathogenesis of cerebral malaria. Int J Parasitol 36:569-582. 
117. Ito, S., P. Ansari, M. Sakatsume, H. Dickensheets, N. Vazquez, R. P. Donnelly, A. C. Larner, and D. S. Finbloom. 
1999. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by 
suppressing tyrosine phosphorylation of STAT1. Blood 93:1456-1463. 
118. Jakeman, G. N., A. Saul, W. L. Hogarth, and W. E. Collins. 1999. Anaemia of acute malaria infections in non-
immune patients primarily results from destruction of uninfected erythrocytes. Parasitology 119 ( Pt 2):127-133. 
119. Janeway, C. A., P. Travers, M. Walport, and M. J. Shlomchik. 2001. Immunobiology. The immune system in 
health and disease.  5th edition. 
120. Jennings, V. M., J. K. Actor, A. A. Lal, and R. L. Hunter. 1997. Cytokine profile suggesting that murine cerebral 
malaria is an encephalitis. Infection and immunity 65:4883-4887. 
121. Jinquan, T., C. G. Larsen, B. Gesser, K. Matsushima, and K. Thestrup-Pedersen. 1993. Human IL-10 is a 
chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J 
Immunol 151:4545-4551. 
122. John, C. C., P. O. Sumba, J. H. Ouma, B. L. Nahlen, C. L. King, and J. W. Kazura. 2000. Cytokine responses to 
Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. Infect Immun 
68:5198-5204. 
123. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. 
Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-
deficient mice. Nature 369:31-37. 
124. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3:984-
993. 
125. King, C. L., M. Connelly, M. P. Alpers, M. Bockarie, and J. W. Kazura. 2001. Transmission intensity determines 
lymphocyte responsiveness and cytokine bias in human lymphatic filariasis. J Immunol 166:7427-7436. 
126. King, C. L., S. Mahanty, V. Kumaraswami, J. S. Abrams, J. Regunathan, K. Jayaraman, E. A. Ottesen, and T. B. 
Nutman. 1993. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction 
of a regulatory T helper type 2 lymphocyte subset. J Clin Invest 92:1667-1673. 
127. Kloetzel, P. M. 2004. Generation of major histocompatibility complex class I antigens: functional interplay 
between proteasomes and TPPII. Nature immunology 5:661-669. 
128. Korenromp, E. L. 2005. Malaria Incidence Estimates at Country Level for the Year 2004 — Proposed Estimates 
and Draft Report (World Health Organization, Roll Back Malaria, Geneva, 2005). 
129. Korten, S., L. Volkmann, M. Saeftel, K. Fischer, M. Taniguchi, B. Fleischer, and A. Hoerauf. 2002. Expansion of 
NK cells with reduction of their inhibitory Ly-49A, Ly-49C, and Ly-49G2 receptor-expressing subsets in a murine 
helminth infection: contribution to parasite control. J Immunol 168:5199-5206. 
      References 
 
 - 103 - 
130. Korten, S., G. Wildenburg, K. Darge, and D. W. Buttner. 1998. Mast cells in onchocercomas from patients with 
hyperreactive onchocerciasis (sowda). Acta Trop 70:217-231. 
131. Kossodo, S., C. Monso, P. Juillard, T. Velu, M. Goldman, and G. E. Grau. 1997. Interleukin-10 modulates 
susceptibility in experimental cerebral malaria. Immunology 91:536-540. 
132. Kraal, G. 1992. Cells in the marginal zone of the spleen. International review of cytology 132:31-74. 
133. Krishnegowda, G., A. M. Hajjar, J. Zhu, E. J. Douglass, S. Uematsu, S. Akira, A. S. Woods, and D. C. Gowda. 
2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of 
Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and 
regulation of GPI activity. The Journal of biological chemistry 280:8606-8616. 
134. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic 
enterocolitis. Cell 75:263-274. 
135. Kurtis, J. D., D. E. Lanar, M. Opollo, and P. E. Duffy. 1999. Interleukin-10 responses to liver-stage antigen 1 
predict human resistance to Plasmodium falciparum. Infect Immun 67:3424-3429. 
136. Langhorne, J., S. Gillard, B. Simon, S. Slade, and K. Eichmann. 1989. Frequencies of CD4+ T cells reactive with 
Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during 
infection. Int Immunol 1:416-424. 
137. Lawrence, R. A. 1996. Lymphatic filariasis: what mice can tell us. Parasitol Today 12:267-271. 
138. Lawrence, R. A., J. E. Allen, W. F. Gregory, M. Kopf, and R. M. Maizels. 1995. Infection of IL-4-deficient mice 
with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a T helper 2-
dominated immune response. J Immunol 154:5995-6001. 
139. Le Goff, L., T. J. Lamb, A. L. Graham, Y. Harcus, and J. E. Allen. 2002. IL-4 is required to prevent filarial 
nematode development in resistant but not susceptible strains of mice. Int J Parasitol 32:1277-1284. 
140. Le Hesran, J. Y., J. Akiana, H. M. Ndiaye el, M. Dia, P. Senghor, and L. Konate. 2004. Severe malaria attack is 
associated with high prevalence of Ascaris lumbricoides infection among children in rural Senegal. Trans R Soc 
Trop Med Hyg 98:397-399. 
141. Leiriao, P., M. M. Mota, and A. Rodriguez. 2005. Apoptotic Plasmodium-infected hepatocytes provide antigens 
to liver dendritic cells. J Infect Dis 191:1576-1581. 
142. Lewinsohn, R. 1975. Anaemia in mice with concomitant Schistosoma mansoni and Plasmodium berghei yoelii 
infection. Trans R Soc Trop Med Hyg 69:51-56. 
143. Li, C., I. Corraliza, and J. Langhorne. 1999. A defect in interleukin-10 leads to enhanced malarial disease in 
Plasmodium chabaudi chabaudi infection in mice. Infect Immun 67:4435-4442. 
144. Li, C., L. A. Sanni, F. Omer, E. Riley, and J. Langhorne. 2003. Pathology of Plasmodium chabaudi chabaudi 
infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and 
exacerbated by anti-transforming growth factor beta antibodies. Infect Immun 71:4850-4856. 
145. Loke, P., A. S. MacDonald, A. Robb, R. M. Maizels, and J. E. Allen. 2000. Alternatively activated macrophages 
induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol 30:2669-2678. 
146. Lou, J., Y. R. Donati, P. Juillard, C. Giroud, C. Vesin, N. Mili, and G. E. Grau. 1997. Platelets play an important 
role in TNF-induced microvascular endothelial cell pathology. The American journal of pathology 151:1397-1405. 
147. Lou, J., R. Lucas, and G. E. Grau. 2001. Pathogenesis of cerebral malaria: recent experimental data and possible 
applications for humans. Clin Microbiol Rev 14:810-820, table of contents. 
148. Lucas, R., J. N. Lou, P. Juillard, M. Moore, H. Bluethmann, and G. E. Grau. 1997. Respective role of TNF 
receptors in the development of experimental cerebral malaria. Journal of neuroimmunology 72:143-148. 
149. Luty, A. J., M. Bongartz, P. Rezbach, J. F. Faucher, M. R. Hollingdale, and P. G. Kremsner. 2001. Plasmodium 
falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during 
uncomplicated malaria in African children. European cytokine network 12:647-653. 
150. Luty, A. J., B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, S. 
Ulbert, F. Migot-Nabias, B. Dubois, P. Deloron, and P. G. Kremsner. 1998. Parasite antigen-specific interleukin-
10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria. European 
cytokine network 9:639-646. 
151. Mahanty, S., M. Ravichandran, U. Raman, K. Jayaraman, V. Kumaraswami, and T. B. Nutman. 1997. Regulation 
of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis. Infect 
Immun 65:1742-1747. 
152. Makgoba, M. W., M. E. Sanders, G. E. Ginther Luce, M. L. Dustin, T. A. Springer, E. A. Clark, P. Mannoni, and S. 
Shaw. 1988. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature 331:86-88. 
153. McGregor, I. A. 1972. Immunology of malarial infection and its possible consequences. British medical bulletin 
28:22-27. 
154. Medana, I. M., N. P. Day, T. T. Hien, N. T. Mai, D. Bethell, N. H. Phu, J. Farrar, M. M. Esiri, N. J. White, and G. D. 
Turner. 2002. Axonal injury in cerebral malaria. Am J Pathol 160:655-666. 
155. Medana, I. M., N. H. Hunt, and G. Chaudhri. 1997. Tumor necrosis factor-alpha expression in the brain during 
fatal murine cerebral malaria: evidence for production by microglia and astrocytes. The American journal of 
pathology 150:1473-1486. 
156. Meis, J. F., J. P. Verhave, P. H. Jap, F. Hess, and J. H. Meuwissen. 1981. An ultrastructural study of developing 
stages of exo-erythrocytic Plasmodium berghei in rat hepatocytes. Parasitology 82:195-204. 
157. Meis, J. F., J. P. Verhave, P. H. Jap, and J. H. Meuwissen. 1985. Fine structure of exoerythrocytic merozoite 
formation of Plasmodium berghei in rat liver. The Journal of protozoology 32:694-699. 
158. Melrose, W. D. 2002. Lymphatic filariasis: new insights into an old disease. Int J Parasitol 32:947-960. 
References 
 - 104 - 
159. Mellouk, S., S. J. Green, C. A. Nacy, and S. L. Hoffman. 1991. IFN-gamma inhibits development of Plasmodium 
berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J Immunol 
146:3971-3976. 
160. Mitchell, A. J., A. M. Hansen, L. Hee, H. J. Ball, S. M. Potter, J. C. Walker, and N. H. Hunt. 2005. Early cytokine 
production is associated with protection from murine cerebral malaria. Infect Immun 73:5645-5653. 
161. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 
receptor. Annual review of immunology 19:683-765. 
162. Moormann, A. M., C. C. John, P. O. Sumba, D. Tisch, P. Embury, and J. W. Kazura. 2006. Stability of interferon-
gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-
related adhesive protein in residents of a malaria holoendemic area. Am J Trop Med Hyg 74:585-590. 
163. Morrot, A., J. C. Hafalla, I. A. Cockburn, L. H. Carvalho, and F. Zavala. 2005. IL-4 receptor expression on CD8+ T 
cells is required for the development of protective memory responses against liver stages of malaria parasites. J 
Exp Med 202:551-560. 
164. Mueller, A. K., M. Deckert, K. Heiss, K. Goetz, K. Matuschewski, and D. Schluter. 2007. Genetically attenuated 
Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. The American 
journal of pathology 171:107-115. 
165. Murray, H. W., G. L. Spitalny, and C. F. Nathan. 1985. Activation of mouse peritoneal macrophages in vitro and 
in vivo by interferon-gamma. J Immunol 134:1619-1622. 
166. Nacher, M., F. Gay, P. Singhasivanon, S. Krudsood, S. Treeprasertsuk, D. Mazier, I. Vouldoukis, and S. 
Looareesuwan. 2000. Ascaris lumbricoides infection is associated with protection from cerebral malaria. 
Parasite Immunol 22:107-113. 
167. Nacher, M., P. Singhasivanon, F. Gay, U. Silachomroon, W. Phumratanaprapin, and S. Looareesuwan. 2001. 
Contemporaneous and successive mixed Plasmodium falciparum and Plasmodium vivax infections are 
associated with Ascaris lumbricoides: an immunomodulating effect? The Journal of parasitology 87:912-915. 
168. Nacher, M., P. Singhasivanon, U. Silachamroon, S. Treeprasertsuk, S. Vannaphan, B. Traore, F. Gay, and S. 
Looareesuwan. 2001. Helminth infections are associated with protection from malaria-related acute renal 
failure and jaundice in Thailand. The American journal of tropical medicine and hygiene 65:834-836. 
169. Nacher, M., P. Singhasivanon, B. Traore, S. Dejvorakul, W. Phumratanaprapin, S. Looareesuwan, and F. Gay. 
2001. Short report: Hookworm infection is associated with decreased body temperature during mild 
Plasmodium falciparum malaria. Am J Trop Med Hyg 65:136-137. 
170. Nacher, M., P. Singhasivanon, S. Yimsamran, W. Manibunyong, N. Thanyavanich, R. Wuthisen, and S. 
Looareesuwan. 2002. Intestinal helminth infections are associated with increased incidence of Plasmodium 
falciparum malaria in Thailand. The Journal of parasitology 88:55-58. 
171. Newbold, C. I., R. Pinches, D. J. Roberts, and K. Marsh. 1992. Plasmodium falciparum: the human agglutinating 
antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol 75:281-292. 
172. Nitcheu, J., O. Bonduelle, C. Combadiere, M. Tefit, D. Seilhean, D. Mazier, and B. Combadiere. 2003. Perforin-
dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. 
J Immunol 170:2221-2228. 
173. Nkuo-Akenji, T. K., P. C. Chi, J. F. Cho, K. K. Ndamukong, and I. Sumbele. 2006. Malaria and helminth co-
infection in children living in a malaria endemic setting of mount Cameroon and predictors of anemia. The 
Journal of parasitology 92:1191-1195. 
174. Noland, G. S., T. K. Graczyk, B. Fried, E. J. Fitzgerald, and N. Kumar. 2005. Exacerbation of Plasmodium yoelii 
malaria in Echinostoma caproni infected mice and abatement through anthelmintic treatment. The Journal of 
parasitology 91:944-948. 
175. Noland, G. S., T. K. Graczyk, B. Fried, and N. Kumar. 2007. Enhanced malaria parasite transmission from 
helminth co-infected mice. Am J Trop Med Hyg 76:1052-1056. 
176. O'Farrell, A. M., Y. Liu, K. W. Moore, and A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation 
by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. The EMBO journal 
17:1006-1018. 
177. O'Garra, A., and P. Vieira. 2007. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 
7:425-428. 
178. Ocana-Morgner, C., K. A. Wong, F. Lega, J. Dotor, F. Borras-Cuesta, and A. Rodriguez. 2007. Role of TGF-beta 
and PGE2 in T cell responses during Plasmodium yoelii infection. Eur J Immunol 37:1562-1574. 
179. Ockenhouse, C. F., S. Schulman, and H. L. Shear. 1984. Induction of crisis forms in the human malaria parasite 
Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J Immunol 133:1601-
1608. 
180. Oeuvray, C., H. Bouharoun-Tayoun, H. Gras-Masse, E. Bottius, T. Kaidoh, M. Aikawa, M. C. Filgueira, A. Tartar, 
and P. Druilhe. 1994. Merozoite surface protein-3: a malaria protein inducing antibodies that promote 
Plasmodium falciparum killing by cooperation with blood monocytes. Blood 84:1594-1602. 
181. Osborne, J., and E. Devaney. 1999. Interleukin-10 and antigen-presenting cells actively suppress Th1 cells in 
BALB/c mice infected with the filarial parasite Brugia pahangi. Infect Immun 67:1599-1605. 
182. Osborne, J., and E. Devaney. 1998. The L3 of Brugia induces a Th2-polarized response following activation of an 
IL-4-producing CD4-CD8- alphabeta T cell population. Int Immunol 10:1583-1590. 
183. Osborne, J., S. J. Hunter, and E. Devaney. 1996. Anti-interleukin-4 modulation of the Th2 polarized response to 
the parasitic nematode Brugia pahangi. Infect Immun 64:3461-3466. 
184. Ottesen, E. A. 1992. The Wellcome Trust Lecture. Infection and disease in lymphatic filariasis: an immunological 
perspective. Parasitology 104 Suppl:S71-79. 
      References 
 
 - 105 - 
185. Oxenham, S. L., C. D. Mackenzie, and D. A. Denham. 1984. Increased activity of macrophages from mice 
infected with Brugia pahangi: in vitro adherence to microfilariae. Parasite Immunol 6:141-156. 
186. Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, 
D. C. Bartholomeu, R. T. Gazzinelli, and D. T. Golenbock. 2007. Malaria hemozoin is immunologically inert but 
radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A 
104:1919-1924. 
187. Patterson, B. K., M. Czerniewski, J. Andersson, Y. Sullivan, F. Su, D. Jiyamapa, Z. Burki, and A. Landay. 1999. 
Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by 
IL-10 in CD4-positive lymphocytes. Clinical immunology (Orlando, Fla 91:254-262. 
188. Petit, G., M. Diagne, P. Marechal, D. Owen, D. Taylor, and O. Bain. 1992. Maturation of the filaria Litomosoides 
sigmodontis in BALB/c mice; comparative susceptibility of nine other inbred strains. Annales de parasitologie 
humaine et comparee 67:144-150. 
189. Petney, T. N., and R. H. Andrews. 1998. Multiparasite communities in animals and humans: frequency, structure 
and pathogenic significance. Int J Parasitol 28:377-393. 
190. Pfaff, A. W., H. Schulz-Key, P. T. Soboslay, S. M. Geiger, and W. H. Hoffmann. 2000. Litomosoides sigmodontis: 
dynamics of the survival of microfilariae in resistant and susceptible strains of mice. Exp Parasitol 94:67-74. 
191. Phillips, R. S. 2001. Current status of malaria and potential for control. Clin Microbiol Rev 14:208-226. 
192. Picot, S., F. Peyron, J. P. Vuillez, G. Barbe, K. Marsh, and P. Ambroise-Thomas. 1990. Tumor necrosis factor 
production by human macrophages stimulated in vitro by Plasmodium falciparum. Infect Immun 58:214-216. 
193. Pied, S., J. Roland, A. Louise, D. Voegtle, V. Soulard, D. Mazier, and P. A. Cazenave. 2000. Liver CD4-CD8- 
NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit 
inhibitory activity against the parasite liver stage in vitro. J Immunol 164:1463-1469. 
194. Pierrot, C., S. Wilson, H. Lallet, S. Lafitte, F. M. Jones, W. Daher, M. Capron, D. W. Dunne, and J. Khalife. 2006. 
Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of 
different cross-reactive antibody subclasses induced by human schistosomiasis and malaria. Infect Immun 
74:3347-3354. 
195. Piguet, P. F., C. D. Kan, C. Vesin, A. Rochat, Y. Donati, and C. Barazzone. 2001. Role of CD40-CVD40L in mouse 
severe malaria. The American journal of pathology 159:733-742. 
196. Pober, J. S., M. A. Gimbrone, Jr., L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. 
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and 
immune interferon. J Immunol 137:1893-1896. 
197. Potocnjak, P., N. Yoshida, R. S. Nussenzweig, and V. Nussenzweig. 1980. Monovalent fragments (Fab) of 
monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med 
151:1504-1513. 
198. Potter, S., T. Chan-Ling, H. J. Ball, H. Mansour, A. Mitchell, L. Maluish, and N. H. Hunt. 2006. Perforin mediated 
apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol 
36:485-496. 
199. Pozzi, L. A., J. W. Maciaszek, and K. L. Rock. 2005. Both dendritic cells and macrophages can stimulate naive 
CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol 
175:2071-2081. 
200. Pradel, G., S. Garapaty, and U. Frevert. 2002. Proteoglycans mediate malaria sporozoite targeting to the liver. 
Mol Microbiol 45:637-651. 
201. Prlic, M., G. Hernandez-Hoyos, and M. J. Bevan. 2006. Duration of the initial TCR stimulus controls the 
magnitude but not functionality of the CD8+ T cell response. J Exp Med 203:2135-2143. 
202. Quinnell, R. J., J. Bethony, and D. I. Pritchard. 2004. The immunoepidemiology of human hookworm infection. 
Parasite Immunol 26:443-454. 
203. Rest, J. R. 1982. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg 
76:410-415. 
204. Reyburn, H., R. Mbatia, C. Drakeley, J. Bruce, I. Carneiro, R. Olomi, J. Cox, W. M. Nkya, M. Lemnge, B. M. 
Greenwood, and E. M. Riley. 2005. Association of transmission intensity and age with clinical manifestations 
and case fatality of severe Plasmodium falciparum malaria. Jama 293:1461-1470. 
205. Riley, E. M., G. Andersson, L. N. Otoo, S. Jepsen, and B. M. Greenwood. 1988. Cellular immune responses to 
Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. 
Clinical and experimental immunology 73:17-22. 
206. Roberts, D. J., A. G. Craig, A. R. Berendt, R. Pinches, G. Nash, K. Marsh, and C. I. Newbold. 1992. Rapid 
switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357:689-692. 
207. Rohn, W. M., Y. J. Lee, and E. N. Benveniste. 1996. Regulation of class II MHC expression. Critical reviews in 
immunology 16:311-330. 
208. Roland, J., V. Soulard, C. Sellier, A. M. Drapier, J. P. Di Santo, P. A. Cazenave, and S. Pied. 2006. NK cell 
responses to Plasmodium infection and control of intrahepatic parasite development. J Immunol 177:1229-
1239. 
209. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned 
cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 
341:323-326. 
210. Rosenberg, R., R. A. Wirtz, I. Schneider, and R. Burge. 1990. An estimation of the number of malaria sporozoites 
ejected by a feeding mosquito. Trans R Soc Trop Med Hyg 84:209-212. 
References 
 - 106 - 
211. Rossato, M., S. Cencig, S. Gasperini, M. A. Cassatella, and F. Bazzoni. 2007. IL-10 modulates cytokine gene 
transcription by protein synthesis-independent and dependent mechanisms in lipopolysaccharide-treated 
neutrophils. Eur J Immunol 37:3176-3189. 
212. Rowe, A., J. Obeiro, C. I. Newbold, and K. Marsh. 1995. Plasmodium falciparum rosetting is associated with 
malaria severity in Kenya. Infect Immun 63:2323-2326. 
213. Ruangjirachuporn, W., B. A. Afzelius, H. Helmby, A. V. Hill, B. M. Greenwood, J. Carlson, K. Berzins, P. 
Perlmann, and M. Wahlgren. 1992. Ultrastructural analysis of fresh Plasmodium falciparum-infected 
erythrocytes and their cytoadherence to human leukocytes. Am J Trop Med Hyg 46:511-519. 
214. Rudin, W., N. Favre, G. Bordmann, and B. Ryffel. 1997. Interferon-gamma is essential for the development of 
cerebral malaria. Eur J Immunol 27:810-815. 
215. Saeftel, M., M. Arndt, S. Specht, L. Volkmann, and A. Hoerauf. 2003. Synergism of gamma interferon and 
interleukin-5 in the control of murine filariasis. Infect Immun 71:6978-6985. 
216. Saeftel, M., L. Volkmann, S. Korten, N. Brattig, K. Al-Qaoud, B. Fleischer, and A. Hoerauf. 2001. Lack of 
interferon-gamma confers impaired neutrophil granulocyte function and imparts prolonged survival of adult 
filarial worms in murine filariasis. Microbes Infect 3:203-213. 
217. Sanni, L. A., W. Jarra, C. Li, and J. Langhorne. 2004. Cerebral edema and cerebral hemorrhages in interleukin-
10-deficient mice infected with Plasmodium chabaudi. Infect Immun 72:3054-3058. 
218. Sano, G., J. C. Hafalla, A. Morrot, R. Abe, J. J. Lafaille, and F. Zavala. 2001. Swift development of protective 
effector functions in naive CD8(+) T cells against malaria liver stages. J Exp Med 194:173-180. 
219. Santin, A. D., P. L. Hermonat, A. Ravaggi, S. Bellone, S. Pecorelli, J. J. Roman, G. P. Parham, and M. J. Cannon. 
2000. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific 
CD8(+) cytotoxic T lymphocytes. Journal of virology 74:4729-4737. 
220. Sartono, E., Y. C. Kruize, A. Kurniawan, R. M. Maizels, and M. Yazdanbakhsh. 1997. Depression of antigen-
specific interleukin-5 and interferon-gamma responses in human lymphatic filariasis as a function of clinical 
status and age. J Infect Dis 175:1276-1280. 
221. Satoguina, J., M. Mempel, J. Larbi, M. Badusche, C. Loliger, O. Adjei, G. Gachelin, B. Fleischer, and A. Hoerauf. 
2002. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth 
infection (onchocerciasis). Microbes and infection / Institut Pasteur 4:1291-1300. 
222. Satoguina, J. S., E. Weyand, J. Larbi, and A. Hoerauf. 2005. T regulatory-1 cells induce IgG4 production by B 
cells: role of IL-10. J Immunol 174:4718-4726. 
223. Scheller, L. F., R. A. Wirtz, and A. F. Azad. 1994. Susceptibility of different strains of mice to hepatic infection 
with Plasmodium berghei. Infect Immun 62:4844-4847. 
224. Schofield, L. 1990. The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the 
malaria parasite? Bulletin of the World Health Organization 68 Suppl:66-73. 
225. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat Rev Immunol 5:722-
735. 
226. Schofield, L., S. Novakovic, P. Gerold, R. T. Schwarz, M. J. McConville, and S. D. Tachado. 1996. 
Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell 
adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite 
cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 156:1886-1896. 
227. Schofield, L., J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig. 1987. Gamma 
interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666. 
228. Schwarzer, E., F. Turrini, D. Ulliers, G. Giribaldi, H. Ginsburg, and P. Arese. 1992. Impairment of macrophage 
functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp 
Med 176:1033-1041. 
229. Senaldi, G., C. Vesin, R. Chang, G. E. Grau, and P. F. Piguet. 1994. Role of polymorphonuclear neutrophil 
leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun 
62:1144-1149. 
230. Shapiro, A. E., E. M. Tukahebwa, J. Kasten, S. E. Clarke, P. Magnussen, A. Olsen, N. B. Kabatereine, R. 
Ndyomugyenyi, and S. Brooker. 2005. Epidemiology of helminth infections and their relationship to clinical 
malaria in southwest Uganda. Trans R Soc Trop Med Hyg 99:18-24. 
231. Shin, S. C., J. P. Vanderberg, and J. A. Terzakis. 1982. Direct infection of hepatocytes by sporozoites of 
Plasmodium berghei. The Journal of protozoology 29:448-454. 
232. Sibson, N. R., A. M. Blamire, V. H. Perry, J. Gauldie, P. Styles, and D. C. Anthony. 2002. TNF-alpha reduces 
cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain 
125:2446-2459. 
233. Singhal, T. 2004. Management of severe malaria. Indian journal of pediatrics 71:81-88. 
234. Smith, J. H. 1995. Malaria: Clinical Laboratory Features. Clinical Microbiology Newsletter 17:185-192. 
235. Smyth, M. J., S. L. Strobl, H. A. Young, J. R. Ortaldo, and A. C. Ochoa. 1991. Regulation of lymphokine-activated 
killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. 
Inhibition by transforming growth factor-beta. J Immunol 146:3289-3297. 
236. Snapper, C. M., and W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig 
isotype production. Science 236:944-947. 
237. Snapper, C. M., C. Peschel, and W. E. Paul. 1988. IFN-gamma stimulates IgG2a secretion by murine B cells 
stimulated with bacterial lipopolysaccharide. J Immunol 140:2121-2127. 
      References 
 
 - 107 - 
238. Sokhna, C., J. Y. Le Hesran, P. A. Mbaye, J. Akiana, P. Camara, M. Diop, A. Ly, and P. Druilhe. 2004. Increase of 
malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malaria 
journal 3:43. 
239. Specht, S., M. Saeftel, M. Arndt, E. Endl, B. Dubben, N. A. Lee, J. J. Lee, and A. Hoerauf. 2006. Lack of 
eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infection and 
immunity 74:5236-5243. 
240. Specht, S., L. Volkmann, T. Wynn, and A. Hoerauf. 2004. Interleukin-10 (IL-10) counterregulates IL-4-dependent 
effector mechanisms in Murine Filariasis. Infect Immun 72:6287-6293. 
241. Spessotto, P., P. Dri, R. Bulla, G. Zabucchi, and P. Patriarca. 1995. Human eosinophil peroxidase enhances 
tumor necrosis factor and hydrogen peroxide release by human monocyte-derived macrophages. Eur J Immunol 
25:1366-1373. 
242. Spiegel, A., A. Tall, G. Raphenon, J. F. Trape, and P. Druilhe. 2003. Increased frequency of malaria attacks in 
subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 97:198-
199. 
243. Steel, C., and T. B. Nutman. 2003. CTLA-4 in filarial infections: implications for a role in diminished T cell 
reactivity. J Immunol 170:1930-1938. 
244. Steers, N., R. Schwenk, D. J. Bacon, D. Berenzon, J. Williams, and U. Krzych. 2005. The immune status of 
Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites. Eur J Immunol 
35:2335-2346. 
245. Stevenson, M. M., and M. F. Tam. 1993. Differential induction of helper T cell subsets during blood-stage 
Plasmodium chabaudi AS infection in resistant and susceptible mice. Clinical and experimental immunology 
92:77-83. 
246. Stevenson, M. M., M. F. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage 
Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent 
mechanism. J Immunol 155:2545-2556. 
247. Stewart, M. J., and J. P. Vanderberg. 1988. Malaria sporozoites leave behind trails of circumsporozoite protein 
during gliding motility. The Journal of protozoology 35:389-393. 
248. Su, Z., M. Segura, K. Morgan, J. C. Loredo-Osti, and M. M. Stevenson. 2005. Impairment of protective immunity 
to blood-stage malaria by concurrent nematode infection. Infect Immun 73:3531-3539. 
249. Su, Z., M. Segura, and M. M. Stevenson. 2006. Reduced protective efficacy of a blood-stage malaria vaccine by 
concurrent nematode infection. Infect Immun 74:2138-2144. 
250. Su, Z., and M. M. Stevenson. 2000. Central role of endogenous gamma interferon in protective immunity 
against blood-stage Plasmodium chabaudi AS infection. Infect Immun 68:4399-4406. 
251. Sung, J. L., J. T. Lin, and J. D. Gorham. 2003. CD28 co-stimulation regulates the effect of transforming growth 
factor-beta1 on the proliferation of naive CD4+ T cells. International immunopharmacology 3:233-245. 
252. Taubert, A., and H. Zahner. 2001. Cellular immune responses of filaria (Litomosoides sigmodontis) infected 
BALB/c mice detected on the level of cytokine transcription. Parasite Immunol 23:453-462. 
253. Taverne, J., C. A. Bate, D. A. Sarkar, A. Meager, G. A. Rook, and J. H. Playfair. 1990. Human and murine 
macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol 12:33-
43. 
254. Taylor, M. D., A. Harris, S. A. Babayan, O. Bain, A. Culshaw, J. E. Allen, and R. M. Maizels. 2007. CTLA-4 and 
CD4+CD25+ Regulatory T Cells Inhibit Protective Immunity to Filarial Parasites In Vivo. J Immunol 179:4626-
4634. 
255. Taylor, M. D., A. Harris, M. G. Nair, R. M. Maizels, and J. E. Allen. 2006. F4/80+ alternatively activated 
macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection. J Immunol 
176:6918-6927. 
256. Taylor, M. D., L. LeGoff, A. Harris, E. Malone, J. E. Allen, and R. M. Maizels. 2005. Removal of regulatory T cell 
activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 174:4924-4933. 
257. Thompson, J. G. 1933. Immunity in malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 
26:483-514. 
258. Thylefors, B., and M. Alleman. 2006. Towards the elimination of onchocerciasis. Annals of tropical medicine and 
parasitology 100:733-746. 
259. Timmann, C., R. S. Abraha, C. Hamelmann, D. W. Buttner, B. Lepping, Y. Marfo, N. Brattig, and R. D. 
Horstmann. 2003. Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type 
responses to Onchocerca volvulus. The British journal of dermatology 149:782-787. 
260. Truty, M. J., and R. Urrutia. 2007. Basics of TGF-beta and pancreatic cancer. Pancreatology 7:423-435. 
261. Urban, B. C., D. J. Ferguson, A. Pain, N. Willcox, M. Plebanski, J. M. Austyn, and D. J. Roberts. 1999. 
Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400:73-77. 
262. van de Sand, C., S. Horstmann, A. Schmidt, A. Sturm, S. Bolte, A. Krueger, M. Lutgehetmann, J. M. Pollok, C. 
Libert, and V. T. Heussler. 2005. The liver stage of Plasmodium berghei inhibits host cell apoptosis. Mol 
Microbiol 58:731-742. 
263. van den Broek, M. E., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W. K. Lutz, C. J. Melief, R. M. Zinkernagel, 
and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. The Journal of experimental 
medicine 184:1781-1790. 
264. van der Heyde, H. C., I. Gramaglia, G. Sun, and C. Woods. 2005. Platelet depletion by anti-CD41 (alphaIIb) mAb 
injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by 
altering the levels of pathogenic cytokines. Blood 105:1956-1963. 
References 
 - 108 - 
265. Villadangos, J. A., and W. R. Heath. 2005. Life cycle, migration and antigen presenting functions of spleen and 
lymph node dendritic cells: limitations of the Langerhans cells paradigm. Seminars in immunology 17:262-272. 
266. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Arico, L. Moretta, and A. Moretta. 2005. NK-
dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 
triggering receptor. Blood 106:566-571. 
267. Volkmann, L., M. Saeftel, O. Bain, K. Fischer, B. Fleischer, and A. Hoerauf. 2001. Interleukin-4 is essential for 
the control of microfilariae in murine infection with the filaria Litomosoides sigmodontis. Infect Immun 69:2950-
2956. 
268. von der Weid, T., N. Honarvar, and J. Langhorne. 1996. Gene-targeted mice lacking B cells are unable to 
eliminate a blood stage malaria infection. J Immunol 156:2510-2516. 
269. von der Weid, T., and J. Langhorne. 1993. Altered response of CD4+ T cell subsets to Plasmodium chabaudi 
chabaudi in B cell-deficient mice. Int Immunol 5:1343-1348. 
270. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1995. Interleukin (IL)-10 inhibits nuclear factor 
kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different 
mechanisms. The Journal of biological chemistry 270:9558-9563. 
271. Weil, G. J., R. M. Ramzy, R. Chandrashekar, A. M. Gad, R. C. Lowrie, Jr., and R. Faris. 1996. Parasite 
antigenemia without microfilaremia in bancroftian filariasis. Am J Trop Med Hyg 55:333-337. 
272. Weiser, S., J. Miu, H. J. Ball, and N. H. Hunt. 2007. Interferon-gamma synergises with tumour necrosis factor 
and lymphotoxin-alpha to enhance the mRNA and protein expression of adhesion molecules in mouse brain 
endothelial cells. Cytokine 37:84-91. 
273. Weiss, W. R., M. Sedegah, R. L. Beaudoin, L. H. Miller, and M. F. Good. 1988. CD8+ T cells 
(cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad 
Sci U S A 85:573-576. 
274. Weiss, W. R., M. Sedegah, J. A. Berzofsky, and S. L. Hoffman. 1993. The role of CD4+ T cells in immunity to 
malaria sporozoites. J Immunol 151:2690-2698. 
275. Wenk, P., E. Kellermann, and V. Seeger. 1993. Turnover of microfilariae in small mammals. 1. Disintegration of 
microfilariae (Litomosoides sigmodontis) (Filarioidea: Nematoda) after intravenous injection into Sigmodon 
hispidus, the cotton rat. Trop Med Parasitol 44:299-304. 
276. WHO. 1995. Lymphatic filariasis. 
277. WHO. 2005. World Malaria Report 2005. 
278. WHO, W. H. O. 2003. The world health report 2003: shaping the future. 
279. Wickramasinghe, S. N., and S. H. Abdalla. 2000. Blood and bone marrow changes in malaria. Baillieres Best 
Pract Res Clin Haematol 13:277-299. 
280. Wildenburg, G., M. Kromer, and D. W. Buttner. 1996. Dependence of eosinophil granulocyte infiltration into 
nodules on the presence of microfilariae producing Onchocerca volvulus. Parasitology research 82:117-124. 
281. Wildenburg, G., A. Plenge-Bonig, A. Renz, P. Fischer, and D. W. Buttner. 1997. Distribution of mast cells and 
their correlation with inflammatory cells around Onchocerca gutturosa, O. tarsicola, O. ochengi, and O. flexuosa. 
Parasitology research 83:109-120. 
282. Wilson, N. S., G. M. Behrens, R. J. Lundie, C. M. Smith, J. Waithman, L. Young, S. P. Forehan, A. Mount, R. J. 
Steptoe, K. D. Shortman, T. F. de Koning-Ward, G. T. Belz, F. R. Carbone, B. S. Crabb, W. R. Heath, and J. A. 
Villadangos. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs 
cross-presentation and antiviral immunity. Nature immunology 7:165-172. 
283. Wohlleben, G., C. Trujillo, J. Muller, Y. Ritze, S. Grunewald, U. Tatsch, and K. J. Erb. 2004. Helminth infection 
modulates the development of allergen-induced airway inflammation. Int Immunol 16:585-596. 
284. Wykes, M. N., X. Q. Liu, S. Jiang, C. Hirunpetcharat, and M. F. Good. 2007. Systemic tumor necrosis factor 
generated during lethal Plasmodium infections impairs dendritic cell function. J Immunol 179:3982-3987. 
285. Xie, H., O. Bain, and S. A. Williams. 1994. Molecular phylogenetic studies on filarial parasites based on 5S 
ribosomal spacer sequences. Parasite (Paris, France) 1:141-151. 
286. Xu, H., A. N. Hodder, H. Yan, P. E. Crewther, R. F. Anders, and M. F. Good. 2000. CD4+ T cells acting 
independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical 
membrane antigen 1 immunization. J Immunol 165:389-396. 
287. Xu, X., K. Sumita, C. Feng, X. Xiong, H. Shen, S. Maruyama, M. Kanoh, and Y. Asano. 2001. Down-regulation of 
IL-12 p40 gene in Plasmodium berghei-infected mice. J Immunol 167:235-241. 
288. Yan, Y., G. Inuo, N. Akao, S. Tsukidate, and K. Fujita. 1997. Down-regulation of murine susceptibility to cerebral 
malaria by inoculation with third-stage larvae of the filarial nematode Brugia pahangi. Parasitology 114 ( Pt 
4):333-338. 
289. Yanez, D. M., D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. C. van der Heyde. 1996. Participation of 
lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 157:1620-
1624. 
290. Ye, Z., H. Huang, S. Hao, S. Xu, H. Yu, S. Van Den Hurk, and J. Xiang. 2007. IL-10 has a distinct 
immunoregulatory effect on naive and active T cell subsets. J Interferon Cytokine Res 27:1031-1038. 
291. Yoneto, T., S. Waki, T. Takai, Y. Tagawa, Y. Iwakura, J. Mizuguchi, H. Nariuchi, and T. Yoshimoto. 2001. A 
critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage 
Plasmodium berghei XAT infection. J Immunol 166:6236-6241. 
292. Yoneto, T., T. Yoshimoto, C. R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi. 1999. Gamma interferon 
production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither 
NO production nor NK cell activation is critical. Infect Immun 67:2349-2356. 
      References 
 
 - 109 - 
293. Zheng, L. M., D. M. Ojcius, F. Garaud, C. Roth, E. Maxwell, Z. Li, H. Rong, J. Chen, X. Y. Wang, J. J. Catino, and I. 
King. 1996. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J Exp Med 
184:579-584. 
294. Zhu, J., G. Krishnegowda, and D. C. Gowda. 2005. Induction of proinflammatory responses in macrophages by 
the glycosylphosphatidylinositols of Plasmodium falciparum: the requirement of extracellular signal-regulated 
kinase, p38, c-Jun N-terminal kinase and NF-kappaB pathways for the expression of proinflammatory cytokines 
and nitric oxide. The Journal of biological chemistry 280:8617-8627. 
295. Zinkernagel, R. M., and P. C. Doherty. 1974. Immunological surveillance against altered self components by 
sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 251:547-548. 
 
 
 
 
 
  - 110 - 
6. Acknowledgements 
 
A PhD is a fundamental part in the training of a scientist, and I am glad to have done it here in 
Bonn. My experiences in the pleasant and difficult moments, both sides always linked to science, will 
surely be invaluable for me in the future. During this time I have received help and collaboration from 
many people that I want to mention.   
I want to first thank Prof. Dr. Achim Hörauf for his supervision during this time and  for allowing 
me to carry out the co-infection project, thus making it possible for me to work in the fields of both 
immunology and malaria.  
I also want to thank Prof. Dr. Waldemar Kolanus for accepting the co-supervision of this work 
and for offering me the opportunity to present my data in his institute. I would like to extend my 
gratitude to PD Dr. Gerhild van Echten-Deckert and to Prof. Dr. Gerhard von der Emde for taking part in 
my thesis commission.  
I am grateful to Dr. Sabine Specht for her supervision of my daily work and critically reading this 
manuscript, instilling rigorousness and conciseness into me as the essential values for doing science. I 
also thank her for her help with my experiments, especially with those requiring such long days that 
frequently turned into long nights of exhausting manual and mental work. I am also grateful to Dr. 
Michael Saeftel for his supervision in the very first part of my stay in Bonn, leading my first steps in the 
exciting project I have undertaken. 
Many other people have offered me their invaluable help with my experiments, particularly 
with the aforementioned, which always required the participation of the whole team for many hours. 
First I must mention Bettina Dubben, who particularly in the first part of my PhD contributed decisively 
to them. I would also like to mention Tobias Killian, Claudia Stephan, Cristina Thaben, Kim Schmidt, 
Sebastian Ziewer, Jutta Frank, Laura Wilden and Rodica Mutiu. Special thanks to Susanne Deininger and 
Laura Layland for their useful suggestions to improve this manuscript. They, together with many other 
colleagues in the institute (Alex, Sridhar, Tomabu, Ken, Judith, Salem, Ana, Kathrin, Uta, Sandy, Sonja, 
Theo), have made a nice working atmosphere for me, and I am grateful for that.  
Time spent outside the lab (even in the mensa) is also an essential part of life, and in this regard 
I must thank all my friends in Bonn, with whom I have shared so many unforgettable moments: Damià, 
Valentina, Esti, Arbia, Panos, Áurea, Basilis, Matthias, and those who were not in Bonn, but still 
remained close to me: Rubén, Iria, María, Iván, Aitor, Luis.    
And regarding important things in life I am in debt to Sarita, who has been there to share good 
and bad moments. With her love and care she has given me the serenity to overcome any difficulty. 
Being by my side, she has encouraged me to pursue all my aspirations and dreams. I hope to be able to 
thank you throughout time as well.  
Finally I want to thank my family for offering me always their unconditional support and 
encouragement for any of my objectives and projects I have undertaken, no matter how difficult or 
unattainable they may have appeared. My success will always be also yours.  
 
  - 111 - 
7. Declaration/Erklärung 
 
An Eides statt versichere ich, dass ich die Arbeit mit dem Titel “Filarial nematodes protect 
against malaria in a murine co-infection model” selbst und ohne jede Hilfe angefertigt habe, 
dass diese oder eine ähnliche Arbeit noch keine anderer Stelle als Dissertation eingereicht 
würde. Ich habe früher noch keinen Promotionsversuch unternommen. 
 
This thesis has been written independently and with no other sources and aids than stated 
 
Bonn, April 2008 
 
 
 
 
Daniel Fernández Ruiz 
 
 
 
 
 
             Curriculum vitae 
 
 - 113 - 
Communications 
 
Oral presentations 
 
Fernández Ruiz D, Dubben B, Hoerauf A, and Saeftel M “Filarial infection leads to prolonged 
survival in Plasmodium berghei (ANKA) co-infected mice” 9th symposium "Infection and Immune 
Defence", Rothenfels, Germany, 11th-13th March 2005 
 
Fernández Ruiz D, Dubben B, Killian T, Stephan C, Hoerauf A, and Saeftel M. “Previous filarial 
infection protects Plasmodium berghei (ANKA) co-infected C57BL/6 mice against death through 
cerebral malaria% 36. Jahrestagung der Deutschen Gesellschaft für Immunologie (36th Annual 
Meeting of the German Society of Immunology), Kiel, Germany, 21st-24th September 2005 
 
Fernández Ruiz D, Dubben B, Killian T, Stephan C, Hoerauf A, and Saeftel M. “Previous filarial 
infection protects Plasmodium berghei (ANKA) co-infected C57BL/6 mice against death from 
cerebral malaria” 22.Jahrestagung der Deutsche Gesellschaft für Parasitologie (22nd Annual 
Meeting of the German Society of Parasitology), Vienna, Austria, 22nd-25th February 2006 
 
Invited speaker “An immune analysis of the co-infection of malaria and filariasis in mice” Lunch 
seminars at the LIMES institute, organized by Prof. Waldemar Kolanus. Life and Medical Sciences 
Center, University of Bonn. April, 2007 
 
 
Posters 
 
Saeftel M, Fernández Ruiz D, Dubben B, and Hoerauf A “Co-infection with filariae leads to 
prolonged survival in Plasmodium berghei (ANKA) infected mice” First Annual BioMalPar 
Conference on Biology and Pathology of the Malaria Parasite, Heidelberg, Germany, 2nd-4th March 
2005 
 
Fernández Ruiz D, Saeftel M, Dubben B, Killian T, Hoerauf A, and Specht S. “Essential role of IL-10 
for the protection against cerebral malaria induced by a filarial infection” 1st Joint Meeting of 
European National Societies of Immunology, Paris, France, 6th-9th September 2006 
 
Publications 
 
Fernández Ruiz D, Dubben B, Saeftel M, Hoerauf A, and Specht S. “Filarial infection induces IL-10-
dependent protection against malaria in mice” Submitted to Microbes and Infection 
 
Fernández Ruiz D, Saeftel M, Dubben B, Killian T, Hoerauf A, and Specht S. “IL-10 induced by filarial 
infection ameliorates cerebral malaria in P. berghei ANKA co-infected mice” In preparation 
 
 
